125742 S1 M5 5351 bnt162 01 interim3 adverse events

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 16 Plus Documents

338

Document text

Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Fina
l 1.0 BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of col
lection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
1 µg 
You
nger 10015  29APR20
20 23:00  Pain Mil
d 0  29APR20
20  9:23  
29APR20
20 23:00  Ten
derness  Mod
erate  0  29APR20
20  9:23  
20M
AY2020 23:00  Pain Mil
d 21 0 29APR20
20  9:23  
10018  29APR20
20 Pain Mil
d 0  29APR20
20  9:53  
29APR20
20 Ten
derness  Mod
erate  0  29APR20
20  9:53  
20M
AY2020 23:00  Pain Mil
d 21 0 29APR20
20  9:53  
20M
AY2020 23:00  Ten
derness  Mil
d 21 0 29APR20
20  9:53  
10025  26M
AY2020 22:00  Pain Mil
d 21 0 05M
AY2020  9:06  
26M
AY2020 22:00  Ten
derness  Mil
d 21 0 05M
AY2020  9:06  
10033  05M
AY2020 20:00  Ten
derness  Mil
d 0  05M
AY2020 10:03  
28M
AY2020 20:00  Ten
derness  Mil
d 23 2 05M
AY2020 10:03  
10040  08M
AY2020 20:31  Pain Mil
d 0  08M
AY2020  8:51  
08M
AY2020 20:31  Ten
derness  Mil
d 0  08M
AY2020  8:51  
09M
AY2020 21:20  Pain Mil
d 1  08M
AY2020  8:51  
09M
AY2020 21:20  Ten
derness  Mil
d 1  08M
AY2020  8:51  
30M
AY2020 21:18  Pain Mod
erate  22 1 08M
AY2020  8:51 
30M
AY2020 21:18  Ten
derness  Seve
re 22 1 08M
AY2020  8:51  
30M
AY2020 21:18  Indu
ration/Swelling  Mod
erate  22 1 08M
AY2020  8:51  
 
Progra
m: Lsa
f_locR_1.sas           (Page 1 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 1
FDA-CBER-2021-5683-0049996
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reacti
ons - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
1 µg 
You
nger 10040  31M
AY2020 21:04  Pain Seve
re 23 2 08M
AY2020  8:51  
31M
AY2020 21:04  Ten
derness  Seve
re 23 2 08M
AY2020  8:51  
01J
UN2020 21:10  Pain Mod
erate  24 3 08M
AY2020  8:51  
01J
UN2020 21:10  Ten
derness  Mod
erate  24 3 08M
AY2020  8:51  
02J
UN2020 21:00  Pain Seve
re 25 4 08M
AY2020  8:51  
02J
UN2020 21:00  Ten
derness  Seve
re 25 4 08M
AY2020  8:51  
03J
UN2020 21:15  Pain Mod
erate  26 5 08M
AY2020  8:51  
03J
UN2020 21:15  Ten
derness  Mod
erate  26 5 08M
AY2020  8:51  
10041  08M
AY2020 20:25  Pain Mil
d 0  08M
AY2020  9:06  
08M
AY2020 20:2
5 Ten
derness  Mil
d 0  08M
AY2020  9:06  
09M
AY2020 21:20  Pain Mil
d 1  08M
AY2020  9:06  
09M
AY2020 21:20  Ten
derness  Mil
d 1  08M
AY2020  9:06  
29M
AY2020 22:10  Pain Mil
d 21 0 08M
AY2020  9:06  
29M
AY2020 22:10  Ten
derness  Seve
re 21 0 08M
AY2020  9:06  
30M
AY2020 21:18  Pain Mod
erate  22 1 08M
AY2020  9:06  
30M
AY2020 21:18  Ten
derness  Seve
re 22 1 08M
AY2020  9:06  
30M
AY2020 21:18  Indu
ration/Swelling  Mod
erate  22 1 08M
AY2020  9:06  
31M
AY2020 21:04  Pain Mod
erate  23 2 08M
AY2020  9:06  
 
Progra
m: Lsa
f_locR_1.sas           (Page 2 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 2
FDA-CBER-2021-5683-0049997
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV
2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
1 µg 
You
nger 10041  31M
AY2020 21:04  Ten
derness  Mod
erate  23 2 08M
AY2020  9:06  
01J
UN2020 21:13  Pain Mil
d 24 3 08M
AY2020  9:06  
10052  08M
AY2020 23:00  Ten
derness  Mil
d 0  08M
AY2020  9:51  
09M
AY2020 23:10  Ten
derness  Mil
d 1  08M
AY2020  9:51  
02J
UN2020  Pain Mod
erate  25 4 08M
AY2020  9:51  
02J
UN2020  Ten
derness  Mod
erate  25 4 08M
AY2020  9:51  
3 µg 
You
nger 10170  31J
UL2020 20:00  Pain Mil
d 0  31J
UL2020  8:00  
31J
UL2020 20:00  Ten
derness  Mil
d 0  31J
UL2020  8:00  
01AUG
2020 20:05  Ten
derness  Mil
d 1  31J
UL2020  8:00  
21AUG
2020 20:04  Ten
derness  Mil
d 21 0 31J
UL2020  8:00  
10194  22J
UL2020 21:15  Pain Mil
d 0  22J
UL2020  8:00  
22J
UL2020 21:15  Ten
derness  Mil
d 0  22J
UL2020  8:00  
23J
UL2020 21:45  Pain Mil
d 1  22J
UL2020  8:00  
23J
UL2020 21:45  Ten
derness  Mil
d 1  22J
UL2020  8:00  
12AUG
2020 22:15  Ten
derness  Mil
d 21 0 22J
UL2020  8:00  
13AUG
2020 21:45  Ten
derness  Mil
d 22 1 22J
UL2020  8:00  
14AUG
2020 22:00  Ten
derness  Mil
d 23 2 22J
UL2020  8:00  
17AUG
2020 22:00  Pain Mil
d 26 5 22J
UL2020  8:00  
 
Progra
m: Lsa
f_locR_1.sas           (Page 3 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 3
FDA-CBER-2021-5683-0049998
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
3 µg 
You
nger 10194  17AUG
2020 22:00  Ten
derness  Mil
d 26 5 22J
UL2020  8:00  
17AUG
2020 22:00  Erythe
ma/Redness  Mil
d 26 5 22J
UL2020  8:00  
17AUG
2020 22:00  Indu
ration/Swelling  Mil
d 26 5 22J
UL2020  8:00  
10204  12AUG
2020 21:45  Pain Mil
d 21 0 22J
UL2020  8:45  
12AUG
2020 21:45  Ten
derness  Mil
d 21 0 22J
UL2020  8:45  
13AUG
2020 22:00  Ten
derness  Mil
d 22 1 22J
UL2020  8:45  
17AUG
2020 21:40  Pain Mil
d 26 5 22J
UL2020  8:45  
17AUG
2020 21:40  Ten
derness  Mil
d 26 5 22J
UL2020  8:45  
10212  22J
UL2020 20:30  Ten
derness  Mil
d 0  22J
UL2020  9:15  
23J
UL2020 21:30  Ten
derness  Mil
d 1  22J
UL2020  9:15  
24J
UL2020 20:30  Ten
derness  Mil
d 2  22J
UL2020  9:15  
25J
UL2020 20:45  Ten
derness  Mil
d 3  22J
UL2020  9:15  
26J
UL2020 20:40  Ten
derness  Mil
d 4  22J
UL2020  9:15  
27J
UL2020 20:45  Ten
derness  Mil
d 5  22J
UL2020  9:15  
12AUG
2020 21:30  Ten
derness  Mil
d 21 0 22J
UL2020  9:15  
13AUG
2020 20:00  Ten
derness  Mil
d 22 1 22J
UL2020  9:15  
14AUG
2020 20:00  Ten
derness  Mil
d 23 2 22J
UL2020  9:15  
15AUG
2020 22:30  Ten
derness  Mil
d 24 3 22J
UL2020  9:15  
 
Progra
m: Lsa
f_locR_1.sas           (Page 4 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 4
FDA-CBER-2021-5683-0049999
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based
 on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost  
imm
unization  Date/t
ime of prime 
imm
unization  
3 µg 
You
nger 10212  16AUG
2020 21:00  Ten
derness  Mil
d 25 4 22J
UL2020  9:15  
17AUG
2020  Ten
derness  Mil
d 26 5 22J
UL2020  9:15  
10226  31J
UL2020 20:00  Pain Mil
d 0  31J
UL2020  8:45  
31J
UL2020 20:00  Ten
derness  Mil
d 0  31J
UL2020  8:45  
01AUG
2020 20:00  Pain Mod
erate  1  31J
UL2020  8:45  
01AUG
2020 20:00  Ten
derness  Mod
erate  1  31J
UL2020  8:45  
02AUG
2020 20:00  Pain Mil
d 2  31J
UL2020  8:45  
02AUG
2020 20:00  Ten
derness  Mil
d 2  31J
UL2020  8:45  
03AUG
2020 20:00  Ten
derness  Mil
d 3  31J
UL2020  8:45  
21AUG
2020 20:00  Pain Mod
erate  21 0 31J
UL2020  8:45  
21AUG
2020 20:00  Ten
derness  Mod
erate  21 0 31J
UL2020  8:45  
22AUG
2020 20:00  Pain Mod
erate  22 1 31J
UL2020  8:45  
22AUG
2020 20:00  Ten
derness  Mil
d 22 1 31J
UL2020  8:45 
23AUG
2020 20:00  Pain Mil
d 23 2 31J
UL2020  8:45  
23AUG
2020 20:00  Ten
derness  Mil
d 23 2 31J
UL2020  8:45  
24AUG
2020 20:00  Ten
derness  Mil
d 24 3 31J
UL2020  8:45  
10227  31J
UL2020 18:00  Ten
derness  Mil
d 0  31J
UL2020  9:15  
01AUG
2020 18:00  Ten
derness  Mil
d 1  31J
UL2020  9:15  
 
Progra
m: Lsa
f_locR_1.sas           (Page 5 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 5
FDA-CBER-2021-5683-0050000
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
10 µg
 
You
nger 10001  15M
AY2020 20:00  Ten
derness  Mil
d 21 0 24APR20
20 10:15  
10003  29APR20
20 19:10  Pain Mil
d 1  28APR20
20  8:30  
29APR20
20 19:10  Ten
derness  Mil
d 1  28APR20
20  8:30  
19M
AY2020 20:35  Pain Mil
d 21 0 28APR20
20  8:30  
19M
AY2020 20:35  Ten
derness  Mil
d 21 0 28APR20
20  8:30  
20M
AY2020 20:25  Pain Mil
d 22 1 28APR20
20  8:30  
20M
AY2020 20:25  Ten
derness  Mil
d 22 1 28APR20
20  8:30 
21M
AY2020 20:30  Ten
derness  Mil
d 23 2 28APR20
20  8:30  
22M
AY2020 20:15  Ten
derness  Mil
d 24 3 28APR20
20  8:30  
23M
AY2020 20:20  Ten
derness  Mil
d 25 4 28APR20
20  8:30  
24M
AY2020 20:25  Ten
derness  Mil
d 26 5 28APR20
20  8:30  
25M
AY2020 20:10  Ten
derness  Mil
d 27 6 28APR20
20  8:30  
26M
AY2020 20:15  Ten
derness  Mil
d 28 7 28APR20
20  8:30  
10004  24APR20
20 22:15  Ten
derness  Mil
d 0  24APR20
20  9:15  
25APR20
20 21:00  Ten
derness  Mil
d 1  24APR20
20  9:15  
15M
AY2020 21:30  Pain Mil
d 21 0 24APR20
20  9:15  
15M
AY2020 21:30  Ten
derness  Mil
d 21 0 24APR20
20  9:15  
16M
AY2020 22:15  Pain Mil
d 22 1 24APR20
20  9:15  
 
Progra
m: Lsa
f_locR_1.sas           (Page 6 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 6
FDA-CBER-2021-5683-0050001
Bio
NTech RNA Pharmaceuticals GmbH / Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
10 µg
 
You
nger 10004  16M
AY2020 22:15  Ten
derness  Mil
d 22 1 24APR20
20  9:15  
17M
AY2020 23:15  Pain Mil
d 23 2 24APR20
20  9:15  
17M
AY2020 23:15  Ten
derness  Mil
d 23 2 24APR20
20  9:15  
18M
AY2020 23:00  Pain Mil
d 24 3 24APR20
20  9:15  
18M
AY2020 23:00  Ten
derness  Mil
d 24 3 24APR20
20  9:15  
10005  24APR20
20 21:00  Ten
derness  Mod
erate  0  24APR20
20 11:15  
25APR20
20 19:30  Ten
derness  Mod
erate  1  24APR20
20 11:15  
15M
AY2020 19:00  Pain Mil
d 21 0 24APR20
20 11:15  
15M
AY2020 19:00  Ten
derness  Mil
d 21 0 24APR20
20 11:15  
16M
AY2020 19:00  Pain Mil
d 22 1 24APR20
20 11:15  
16M
AY2020 19:00  Ten
derness  Mil
d 22 1 24APR20
20 11:15  
10006  29APR20
20 22:00  Pain Mil
d 1  28APR20
20  9:00  
29APR20
20 22:00  Ten
derness  Mil
d 1  28APR20
20  9:00  
19M
AY2020 22:00  Ten
derness  Mil
d 21 0 28APR20
20  9:00  
20M
AY2020 22:00  Ten
derness  Mil
d 22 1 28APR20
20  9:00  
10007  23APR20
20 20:00  Pain Mil
d 0  23APR20
20 11:08  
24APR20
20  9:10  Pain Mil
d 1  23APR20
20 11:08  
24APR20
20  9:10  Ten
derness  Mil
d 1  23APR20
20 11:08  
 
Progra
m: Lsa
f_locR_1.sas           (Page 7 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 7
FDA-CBER-2021-5683-0050002
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3-1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prim
e 
imm
unization  
10 µg
 
You
nger 10007  25APR20
20  9:00  Pain Mil
d 2  23APR20
20 11:08  
26APR20
20 20:00  Pain Mil
d 3  23APR20
20 11:08  
27APR20
20 20:00  Pain Mil
d 4  23APR20
20 11:08  
28APR20
20 20:00  Pain Mil
d 5  23APR20
20 11:08  
14M
AY2020  Pain Mil
d 21 0 23APR20
20 11:08  
14M
AY2020  Ten
derness  Mod
erate  21 0 23APR20
20 11:08  
15M
AY2020 20:00  Pain Mod
erate  22 1 23APR20
20 11:08  
15M
AY2020 20:00  Ten
derness  Mil
d 22 1 23APR20
20 11:08  
15M
AY2020 20:00  Indu
ration/Swelling  Mil
d 22 1 23APR20
20 11:08  
16M
AY2020 20:00  Pain Mil
d 23 2 23APR20
20 11:08  
16M
AY2020 20:00  Ten
derness  Mil
d 23 2 23APR20
20 11:08  
17M
AY2020 20:00  Pain Mil
d 24 3 23APR20
20 11:08  
17M
AY2020 20:00  Ten
derness  Mil
d 24 3 23APR20
20 11:08  
18M
AY2020 20:00  Pain Mil
d 25 4 23APR20
20 11:
08 
18M
AY2020 20:00  Ten
derness  Mil
d 25 4 23APR20
20 11:08  
10008  28APR20
20 22:00  Ten
derness  Mod
erate  0  28APR20
20  9:30  
29APR20
20 22:00  Ten
derness  Mil
d 1  28APR20
20  9:30  
19M
AY2020 22:00  Ten
derness  Mil
d 21 0 28APR20
20  9:30  
 
Progra
m: Lsa
f_locR_1.sas           (Page 8 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 8
FDA-CBER-2021-5683-0050003
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
10 µg
 
You
nger 10008  20M
AY2020 22:00  Ten
derness  Mil
d 22 1 28APR20
20  9:30  
21M
AY2020 22:00  Ten
derness  Mil
d 23 2 28APR20
20  9:30  
10009  28APR20
20 21:00  Pain Mil
d 0  28APR20
20 10:00  
28APR20
20 21:00  Ten
derness  Mil
d 0  28APR20
20 10:00  
29APR20
20 20:30  Ten
derness  Mil
d 1  28APR20
20 10:00  
30APR20
20 20:00  Ten
derness  Mil
d 2  28APR20
20 10:00  
19M
AY2020 22:00  Pain Mil
d 21 0 28APR20
20 10:00  
19M
AY2020 22:00  Ten
derness  Mil
d 21 0 28APR20
20 10:00  
20M
AY2020 19:00  Pain Mil
d 22 1 28APR20
20 10:00  
20M
AY2020 19:00  Ten
derness  Mil
d 22 1 28APR20
20 10:00  
21M
AY2020 19:00  Ten
derness  Mil
d 23 2 28APR20
20 10:00  
10010  25APR20
20 18:15  Pain Seve
re 1  24APR20
20 12:15  
25APR20
20 18:15  Ten
derness  Seve
re 1  24APR20
20 12:15  
26APR20
20 18:15  Pain Mod
erate  2  24APR20
20 12:15  
26APR20
20 18:15  Ten
derness  Mod
erate  2  24APR20
20 12:15  
27APR20
20 18:15  Pain Mod
erate  3  24APR20
20 12:15  
27APR20
20 18:15  Ten
derness  Mod
erate  3  24APR20
20 12:15  
28APR20
20 18:30  Pain Mod
erate  4  24APR20
20 12:15  
 
Progra
m: Lsa
f_locR_1.sas           (Page 9 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 9
FDA-CBER-2021-5683-0050004
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Snap
shot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
10 µg
 
You
nger 10010  28APR20
20 18:30  Ten
derness  Mod
erate  4  24APR20
20 12:15  
29APR20
20 18:30  Pain Mod
erate  5  24APR20
20 12:15  
29APR20
20 18:30  Ten
derness  Mod
erate  5  24APR20
20 12:15  
30APR20
20 18:15  Pain Mil
d 6  24APR20
20 12:15  
30APR20
20 18:15  Ten
derness  Mil
d 6  24APR20
20 12:15  
01M
AY2020 18:45  Pain Mil
d 7  24APR20
20 12:15  
01M
AY2020 18:45  Ten
derness  Mil
d 7  24APR20
20 12:15  
02M
AY2020 19:00  Pain Mil
d 8  24APR20
20 12:15  
02M
AY2020 19:00  Ten
derness  Mil
d 8  24APR20
20 12:15  
10011  25APR20
20  6:30  Pain Mil
d 1  24APR20
20 13:15  
25APR20
20  6:30  Ten
derness  Mil
d 1  24APR20
20 13:15  
26APR20
20  6:15  Ten
derness  Mil
d 2  24APR20
20 13:15  
15M
AY2020 22:00  Pain Mil
d 21 0 24APR20
20 13:15  
15M
AY2020 22:00  Ten
derness  Mil
d 21 0 24APR20
20 13:15  
16M
AY2020 22:00  Pain Mil
d 22 1 24APR20
20 13:15  
16M
AY2020 22:00  Ten
derness  Mil
d 22 1 24APR20
20 13:15  
10017  28APR20
20 22:00  Ten
derness  Mod
erate  0  28APR20
20 10:30  
29APR20
20 20:43  Ten
derness  Mod
erate  1  28APR20
20 10:30  
 
Progra
m: Lsa
f_locR_1.sas           (Page 10 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 10
FDA-CBER-2021-5683-0050005
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of  soli
cited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
10 µg
 
You
nger 10017  19M
AY2020 22:00  Pain Mil
d 21 0 28APR20
20 10:30  
20 µg
 
You
nger 10151  16J
UL2020 18:00  Pain Mil
d 0  16J
UL2020  8:00  
16J
UL2020 18:00  Ten
derness  Mil
d 0  16J
UL2020  8:00  
17J
UL2020 20:00  Pain Mil
d 1  16J
UL2020  8:00  
17J
UL2020 20:00  Ten
derness  Mil
d 1  16J
UL2020  8:00  
18J
UL2020 20:00  Ten
derness  Mil
d 2  16J
UL2020  8:00  
19J
UL2020 20:00  Ten
derness  Mil
d 3  16J
UL2020  8:00  
06AUG
2020 22:00  Pain Mil
d 21 0 16J
UL2020  8:00  
06AUG
2020 22:00  Ten
derness  Mil
d 21 0 16J
UL2020  8:00  
07AUG
2020 22:00  Pain Mil
d 22 1 16J
UL2020  8:00  
07AUG
2020 22:00  Ten
derness  Mil
d 22 1 16J
UL2020  8:00  
08AUG
2020 22:00  Pain Mil
d 23 2 16J
UL2020  8:00  
08AUG
2020 22:00  Ten
derness  Mil
d 23 2 16J
UL2020  8:00  
09AUG
2020 22:00  Pain Mil
d 24 3 16J
UL2020  8:00 
09AUG
2020 22:00  Ten
derness  Mil
d 24 3 16J
UL2020  8:00  
10AUG
2020 22:00  Pain Mil
d 25 4 16J
UL2020  8:00  
10AUG
2020 22:00  Ten
derness  Mil
d 25 4 16J
UL2020  8:00  
11AUG
2020 22:00  Pain Mil
d 26 5 16J
UL2020  8:00  
 
Progra
m: Lsa
f_locR_1.sas           (Page 11 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 11
FDA-CBER-2021-5683-0050006
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
You
nger 10151  11AUG
2020 22:00  Ten
derness  Mil
d 26 5 16J
UL2020  8:00  
12AUG
2020 22:00  Ten
derness  Mil
d 27 6 16J
UL2020  8:00  
10171  16J
UL2020 17:40  Ten
derness  Mil
d 0  16J
UL2020  8:15  
17J
UL2020 20:28  Ten
derness  Mil
d 1  16J
UL2020  8:15  
18J
UL2020 20:10  Ten
derness  Mil
d 2  16J
UL2020  8:15  
19J
UL2020 21:07  Ten
derness  Mil
d 3  16J
UL2020  8:15  
06AUG
2020 20:22  Pain Mod
erate  21 0 16J
UL2020  8:15  
06AUG
2020 20:22  Ten
derness  Mod
erate  21 0 16J
UL2020  8:15  
07AUG
2020 20:10  Pain Mil
d 22 1 16J
UL2020  8:15  
07AUG
2020 20:10  Ten
derness  Mil
d 22 1 16J
UL2020  8:15  
08AUG
2020 20:06  Pain Mil
d 23 2 16J
UL2020  8:15  
08AUG
2020 20:06  Ten
derness  Mil
d 23 2 16J
UL2020  8:15  
09AUG
2020 19:40  Pain Mil
d 24 3 16J
UL2020  8:15  
09AUG
2020 19:40  Ten
derness  Mil
d 24 3 16J
UL2020  8:15  
10AUG
2020 20:13  Pain Mil
d 25 4 16J
UL2020  8:15  
10AUG
2020 20:13  Ten
derness  Mil
d 25 4 16J
UL2020  8:15  
10172  16J
UL2020 20:15  Pain Mod
erate  0  16J
UL2020  8:30  
16J
UL2020 20:15  Ten
derness  Mil
d 0  16J
UL2020  8:30  
 
Progra
m: Lsa
f_locR_1.sas           (Page 12 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 12
FDA-CBER-2021-5683-0050007
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
You
nger 10172  17J
UL2020 20:22  Pain Mil
d 1  16J
UL2020  8:30  
17J
UL2020 20:22  Ten
derness  Mil
d 1  16J
UL2020  8:30  
06AUG
2020 19:50  Pain Mod
erate  21 0 16J
UL2020  8:30  
06AUG
2020 19:50  Ten
derness  Mod
erate  21 0 16J
UL2020  8:30  
10173  17J
UL2020 16:00  Pain Mil
d 1  16J
UL2020  8:45  
17J
UL2020 16:00  Ten
derness  Mil
d 1  16J
UL2020  8:45  
06AUG
2020 22:00  Pain Mil
d 21 0 16J
UL2020  8:45  
06AUG
2020 22:00  Ten
derness  Mod
erate  21 0 16J
UL2020  8:45  
08AUG
2020 22:00  Pain Mil
d 23 2 16J
UL2020  8:45  
08AUG
2020 22:00  Ten
derness  Mil
d 23 2 16J
UL2020  8:45  
09AUG
2020 13:00  Ten
derness  Mil
d 24 3 16J
UL2020  8:45  
10175  17J
UL2020 17:54  Pain Mil
d 1  16J
UL2020  9:00  
17J
UL2020 17:54  Ten
derness  Mil
d 1  16J
UL2020  9:00  
06AUG
2020 21:00  Ten
derness  Mil
d 21 0 16J
UL2020  9:00  
07AUG
2020 21:08  Ten
derness  Mil
d 22 1 16J
UL2020  9:00  
08AUG
2020 21:01  Ten
derness  Mil
d 23 2 16J
UL2020  9:00  
10176  16J
UL2020 21:00  Pain Mil
d 0  16J
UL2020  9:15  
16J
UL2020 21:00  Ten
derness  Mil
d 0  16J
UL2020  9:15  
 
Progra
m: Lsa
f_locR_1.sas           (Page 13 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 13
FDA-CBER-2021-5683-0050008
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on cl
ean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3-1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prim
e 
imm
unization  
20 µg
 
You
nger 10176  17J
UL2020 20:30  Pain Mil
d 1  16J
UL2020  9:15  
17J
UL2020 20:30  Ten
derness  Mil
d 1  16J
UL2020  9:15  
17J
UL2020 20:30  Indu
ration/Swelling  Mil
d 1  16J
UL2020  9:15  
06AUG
2020 22:00  Ten
derness  Mil
d 21 0 16J
UL2020  9:15 
07AUG
2020 22:00  Ten
derness  Mil
d 22 1 16J
UL2020  9:15  
08AUG
2020 21:00  Ten
derness  Mil
d 23 2 16J
UL2020  9:15  
08AUG
2020 21:00  Erythe
ma/Redness  Mil
d 23 2 16J
UL2020  9:15  
09AUG
2020 22:00  Erythe
ma/Redness  Mil
d 24 3 16J
UL2020  9:15  
10178  16J
UL2020 20:15  Pain Mil
d 0  16J
UL2020  9:30  
16J
UL2020 20:15  Ten
derness  Mil
d 0  16J
UL2020  9:30  
17J
UL2020 20:00  Pain Mil
d 1  16J
UL2020  9:30  
17J
UL2020 20:00  Ten
derness  Mil
d 1  16J
UL2020  9:30  
18J
UL2020 20:20  Pain Mil
d 2  16J
UL2020  9:30  
18J
UL2020 20:20  Ten
derness  Mil
d 2  16J
UL2020  9:30  
19J
UL2020 19:40  Ten
derness  Mil
d 3  16J
UL2020  9:30  
20J
UL2020 20:00  Ten
derness  Mil
d 4  16J
UL2020  9:30  
06AUG
2020 19:40  Ten
derness  Mil
d 21 0 16J
UL2020  9:30  
07AUG
2020 19:00  Ten
derness  Mil
d 22 1 16J
UL2020  9:30  
 
Progra
m: Lsa
f_locR_1.sas           (Page 14 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 14
FDA-CBER-2021-5683-0050009
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
You
nger 10178  08AUG
2020 19:30  Ten
derness  Mil
d 23 2 16J
UL2020  9:30  
10179  16J
UL2020 21:00  Pain Mil
d 0  16J
UL2020  9:45  
06AUG
2020 21:0
0 Pain Mil
d 21 0 16J
UL2020  9:45  
06AUG
2020 21:00  Ten
derness  Mil
d 21 0 16J
UL2020  9:45  
10181  16J
UL2020 20:15  Pain Mod
erate  0  16J
UL2020 10:00  
16J
UL2020 20:15  Ten
derness  Mod
erate  0  16J
UL2020 10:00  
17J
UL2020 20:45  Pain Mod
erate  1  16J
UL2020 10:
00 
17J
UL2020 20:45  Ten
derness  Mod
erate  1  16J
UL2020 10:00  
18J
UL2020 20:45  Pain Mil
d 2  16J
UL2020 10:00  
18J
UL2020 20:45  Ten
derness  Mil
d 2  16J
UL2020 10:00  
06AUG
2020 20:30  Pain Mil
d 21 0 16J
UL2020 10:00  
06AUG
2020 20:30  Ten
derness  Mil
d 21 0 16J
UL2020 10:00  
07AUG
2020 21:10  Pain Mil
d 22 1 16J
UL2020 10:00  
07AUG
2020 21:10  Ten
derness  Mil
d 22 1 16J
UL2020 10:00  
08AUG
2020 20:40  Pain Mil
d 23 2 16J
UL2020 10:00  
08AUG
2020 20:40  Ten
derness  Mil
d 23 2 16J
UL2020 10:00  
10182  16J
UL2020 19:31  Pain Mil
d 0  16J
UL2020 10:15  
16J
UL2020 19:31  Ten
derness  Mil
d 0  16J
UL2020 10:15  
 
Progra
m: Lsa
f_locR_1.sas           (Page 15 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 15
FDA-CBER-2021-5683-0050010
Bio
NTech RNA Phar
maceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect num
ber Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
You
nger 10183  16J
UL2020 20:30  Pain Seve
re 0  16J
UL2020 10:30  
16J
UL2020 20:30  Ten
derness  Seve
re 0  16J
UL2020 10:30  
17J
UL2020  0:00  Pain Mod
erate  1  16J
UL2020 10:30  
17J
UL2020  0:00  Ten
derness  Mod
erate  1  16J
UL2020 10:30  
18J
UL2020  7:15  Pain Mil
d 2  16J
UL2020 10:30  
18J
UL2020  7:15  Ten
derness  Mil
d 2  16J
UL2020 10:30  
06AUG
2020 18:30  Pain Mil
d 21 0 16J
UL2020 10:30  
06AUG
2020 18:30  Ten
derness  Mil
d 21 0 16J
UL2020 10:30  
06AUG
2020 18:30  Indu
ration/Swelling  Mil
d 21 0 16J
UL2020 10:30  
07AUG
2020 20:10  Pain Mil
d 22 1 16J
UL2020 10:30  
07AUG
2020 20:10  Ten
derness  Mil
d 22 1 16J
UL2020 10:30  
07AUG
2020 20:10  Indu
ration/Swelling  Mil
d 22 1 16J
UL2020 10:30  
08AUG
2020 20:45  Pain Mil
d 23 2 16J
UL2020 10:30  
08AUG
2020 20:45  Ten
derness  Mil
d 23 2 16J
UL2020 10:30  
09AUG
2020 21:00  Ten
derness  Mil
d 24 3 16J
UL2020 10:30  
10197  16J
UL2020 20:30  Pain Mod
erate  0  16J
UL2020 10:45  
16J
UL2020 20:30  Ten
derness  Mod
erate  0  16J
UL2020 10:45  
17J
UL2020 20:30  Pain Seve
re 1  16J
UL2020 10:45  
 
Progra
m: Lsa
f_locR_1.sas           (Page 16 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 16
FDA-CBER-2021-5683-0050011
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM d
ata received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost  
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
You
nger 10197  17J
UL2020 20:30  Ten
derness  Mod
erate  1  16J
UL2020 10:45  
18J
UL2020 18:30  Pain Mil
d 2  16J
UL2020 10:45  
18J
UL2020 18:30  Ten
derness  Mod
erate  2  16J
UL2020 10:45  
19J
UL2020 18:20  Pain Mil
d 3  16J
UL2020 10:45  
19J
UL2020 18:20  Ten
derness  Mil
d 3  16J
UL2020 10:45  
20J
UL2020 18:00  Ten
derness  Mil
d 4  16J
UL2020 10:45  
06AUG
2020 22:00  Pain Mil
d 21 0 16J
UL2020 10:45  
06AUG
2020 22:00  Ten
derness  Mil
d 21 0 16J
UL2020 10:45  
07AUG
2020 18:30  Pain Mod
erate  22 1 16J
UL2020 10:45  
07AUG
2020 18:30  Ten
derness  Mil
d 22 1 16J
UL2020 10:45  
08AUG
2020 18:30  Pain Mil
d 23 2 16J
UL2020 10:45  
08AUG
2020 18:30  Ten
derness  Mil
d 23 2 16J
UL2020 10:45  
09AUG
2020 18:00  Pain Mil
d 24 3 16J
UL2020 10:45  
09AUG
2020 18:00  Ten
derness  Mil
d 24 3 16J
UL2020 10:45  
10AUG
2020 17:15  Ten
derness  Mil
d 25 4 16J
UL2020 10:45  
30 µg
 
You
nger 10016  29APR20
20 Pain Seve
re 0  29APR20
20  9:03  
29APR20
20 Ten
derness  Seve
re 0  29APR20
20  9:03  
30APR20
20 Pain Mil
d 1  29APR20
20  9:03 
 
Progra
m: Lsa
f_locR_1.sas           (Page 17 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 17
FDA-CBER-2021-5683-0050012
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of d
ays 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10016  30APR20
20 Ten
derness  Mil
d 1  29APR20
20  9:03  
20M
AY2020  Pain Mil
d 21 0 29APR20
20  9:03  
20M
AY2020  Ten
derness  Mil
d 21 0 29APR20
20  9:03  
21M
AY2020  Pain Mod
erate  22 1 29APR20
20  9:03  
21M
AY2020  Ten
derness  Mod
erate  22 1 29APR20
20  9:03  
24M
AY2020  Ten
derness  Mil
d 25 4 29APR20
20  9:03  
10020  20M
AY2020 19:00  Pain Mil
d 21 0 29APR20
20 10:06  
10021  05M
AY2020 20:00  Pain Mil
d 0  05M
AY2020  8:30  
05M
AY2020 20:00  Ten
derness  Mil
d 0  05M
AY2020  8:30  
06M
AY2020 20:00  Pain Mil
d 1  05M
AY2020  8:30  
06M
AY2020 20:00  Ten
derness  Mil
d 1  05M
AY2020  8:30  
10M
AY2020 20:01  Ten
derness  Mil
d 5  05M
AY2020  8:30  
26M
AY2020 20:00  Pain Seve
re 21 0 05M
AY2020  8:30  
26M
AY2020 20:00  Ten
derness  Seve
re 21 0 05M
AY2020  8:30  
27M
AY2020 20:00  Pain Mod
erate  22 1 05M
AY2020  8:30  
27M
AY2020 20:00  Ten
derness  Mod
erate  22 1 05M
AY2020  8:30  
28M
AY2020 20:00  Pain Mod
erate  23 2 05M
AY2020  8:30  
28M
AY2020 20:00  Ten
derness  Mod
erate  23 2 05M
AY2020  8:30  
 
Progra
m: Lsa
f_locR_1.sas           (Page 18 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 18
FDA-CBER-2021-5683-0050013
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0 BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of  col
lection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10028  07M
AY2020 21:27  Pain Mil
d 0  07M
AY2020  8:30  
07M
AY2020 21:27  Ten
derness  Mil
d 0  07M
AY2020  8:30  
08M
AY2020 21:40  Pain Mil
d 1  07M
AY2020  8:30  
08M
AY2020 21:40  Ten
derness  Mil
d 1  07M
AY2020  8:30  
09M
AY2020 22:00  Pain Mil
d 2  07M
AY2020  8:30  
09M
AY2020 22:00  Ten
derness  Mil
d 2  07M
AY2020  8:30  
09M
AY2020 22:00  Erythe
ma/Redness  Mil
d 2  07M
AY2020  8:30  
10M
AY2020 22:00  Pain Mil
d 3  07M
AY2020  8:30  
10M
AY2020 22:00  Ten
derness  Mil
d 3  07M
AY2020  8:30  
10M
AY2020 22:00  Erythe
ma/Redness  Mil
d 3  07M
AY2020  8:30  
28M
AY2020 22:00  Pain Mil
d 21 0 07M
AY2020  8:30  
28M
AY2020 22:00  Ten
derness  Mil
d 21 0 07M
AY2020  8:30  
29M
AY2020 22:00  Pain Mod
erate  22 1 07M
AY2020  8:30  
29M
AY2020 22:00  Ten
derness  Mod
erate  22 1 07M
AY2020  8:30  
10031  07M
AY2020 22:00  Pain Seve
re 0  07M
AY2020  9:00  
07M
AY2020 22:00  Ten
derness  Seve
re 0  07M
AY2020  9:00  
08M
AY2020 22:00  Pain Mil
d 1  07M
AY2020  9:00  
08M
AY2020 22:00  Ten
derness  Mil
d 1  07M
AY2020  9:00  
 
Progra
m: Lsa
f_locR_1.sas           (Page 19 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 19
FDA-CBER-2021-5683-0050014
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reacti
ons - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10031  09M
AY2020 22:00  Ten
derness  Mil
d 2  07M
AY2020  9:00  
28M
AY2020 22:00  Pain Mod
erate  21 0 07M
AY2020  9:00  
28M
AY2020 22:00  Ten
derness  Mod
erate  21 0 07M
AY2020  9:00  
29M
AY2020 22:00  Pain Mil
d 22 1 07M
AY2020  9:00  
29M
AY2020 22:00  Ten
derness  Mod
erate  22 1 07M
AY2020  9:00  
30M
AY2020 22:00  Pain Mil
d 23 2 07M
AY2020  9:00  
30M
AY2020 22:00  Ten
derness  Mil
d 23 2 07M
AY2020  9:00  
31M
AY2020 22:00  Pain Mil
d 24 3 07M
AY2020  9:00  
31M
AY2020 22:00  Ten
derness  Mil
d 24 3 07M
AY2020  9:00  
01J
UN2020 22:00  Ten
derness  Mil
d 25 4 07M
AY2020  9:00  
03J
UN2020 22:00  Ten
derness  Mil
d 27 6 07M
AY2020  9:00  
10032  05M
AY2020 19:00  Ten
derness  Mil
d 0  05M
AY2020  9:00  
06M
AY2020 18:33  Ten
derness  Mil
d 1  05M
AY2020  9:00  
26M
AY2020 19:20  Pain Mil
d 21 0 05M
AY2020  9:00  
26M
AY2020 19:20  Ten
derness  Mil
d 21 0 05M
AY2020  9:00  
27M
AY2020 18:35  Pain Mil
d 22 1 05M
AY2020  9:00  
27M
AY2020 18:35  Ten
derness  Mod
erate  22 1 05M
AY2020  9:00  
10034  05M
AY2020 22:05  Pain Mil
d 0  05M
AY2020  9:30  
 
Progra
m: Lsa
f_locR_1.sas           (Page 20 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 20
FDA-CBER-2021-5683-0050015
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10034  05M
AY2020 22:05  Ten
derness  Mil
d 0  05M
AY2020  9:30  
05M
AY2020 22:05  Indu
ration/Swelling  Mil
d 0  05M
AY2020  9:30  
06M
AY2020 20:10  Ten
derness  Mod
erate  1  05M
AY2020  9:30  
06M
AY2020 20:10  Erythe
ma/Redness  Mil
d 1  05M
AY2020  9:30  
07M
AY2020 20:10  Pain Mil
d 2  05M
AY2020  9:30  
07M
AY2020 20:10  Ten
derness  Mil
d 2  05M
AY2020  9:30  
07M
AY2020 20:10  Erythe
ma/Redness  Mil
d 2  05M
AY2020  9:30 
08M
AY2020 12:15  Pain Mil
d 3  05M
AY2020  9:30  
08M
AY2020 12:15  Ten
derness  Mil
d 3  05M
AY2020  9:30  
08M
AY2020 12:15  Erythe
ma/Redness  Mil
d 3  05M
AY2020  9:30  
08M
AY2020 12:15  Indu
ration/Swelling  Mil
d 3  05M
AY2020  9:30  
09M
AY2020 20:00  Pain Mil
d 4  05M
AY2020  9:30  
09M
AY2020 20:00  Ten
derness  Mod
erate  4  05M
AY2020  9:30  
09M
AY2020 20:00  Erythe
ma/Redness  Mil
d 4  05M
AY2020  9:30  
09M
AY2020 20:00  Indu
ration/Swelling  Mil
d 4  05M
AY2020  9:30  
10M
AY2020 20:00  Pain Mil
d 5  05M
AY2020  9:30  
10M
AY2020 20:00  Ten
derness  Mod
erate  5  05M
AY2020  9:30  
10M
AY2020 20:00  Erythe
ma/Redness  Mil
d 5  05M
AY2020  9:30  
 
Progra
m: Lsa
f_locR_1.sas           (Page 21 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 21
FDA-CBER-2021-5683-0050016
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10034  10M
AY2020 20:00  Indu
ration/Swelling  Mil
d 5  05M
AY2020  9:30  
11M
AY2020 20:10  Erythe
ma/Redness  Mil
d 6  05M
AY2020  9:30  
11M
AY2020 20:10  Indu
ration/Swelling  Mil
d 6  05M
AY2020  9:30  
26M
AY2020 23:00  Pain Mod
erate  21 0 05M
AY2020  9:30  
26M
AY2020 23:00  Ten
derness  Mod
erate  21 0 05M
AY2020  9:30  
27M
AY2020 21:00  Pain Mil
d 22 1 05M
AY2020  9:30  
27M
AY2020 21:00  Ten
derness  Mod
erate  22 1 05M
AY2020  9:30  
28M
AY2020 21:00  Ten
derness  Mil
d 23 2 05M
AY2020  9:30  
10037  05M
AY2020 21:00  Ten
derness  Mil
d 0  05M
AY2020 10:00  
06M
AY2020 21:00  Ten
derness  Mil
d 1  05M
AY2020 10:00  
07M
AY2020 21:00  Pain Mil
d 2  05M
AY2020 10:00  
07M
AY2020 21:00  Ten
derness  Mil
d 2  05M
AY2020 10:00  
26M
AY2020 21:00  Pain Mod
erate  21 0 05M
AY2020 10:00  
26M
AY2020 21:00  Ten
derness  Mod
erate  21 0 05M
AY2020 10:00  
27M
AY2020 21:00  Pain Mod
erate  22 1 05M
AY2020 10:00  
27M
AY2020 21:00  Ten
derness  Mod
erate  22 1 05M
AY2020 10:00  
28M
AY2020 21:00  Pain Mil
d 23 2 05M
AY2020 10:00  
28M
AY2020 21:00  Ten
derness  Mod
erate  23 2 05M
AY2020 10:00  
 
Progra
m: Lsa
f_locR_1.sas           (Page 22 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 22
FDA-CBER-2021-5683-0050017
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10037  29M
AY2020 21:00  Pain Mil
d 24 3 05M
AY2020 10:00  
29M
AY2020 21:00  Ten
derness  Mil
d 24 3 05M
AY2020 10:00  
10038  07M
AY2020 21:00  Pain Mil
d 0  07M
AY2020  9:30  
07M
AY2020 21:00  Ten
derness  Mod
erate  0  07M
AY2020  9:30  
10039  07M
AY2020 22:00  Pain Seve
re 0  07M
AY2020 10:00  
07M
AY2020 22:00  Ten
derness  Mod
erate  0  07M
AY2020 10:00  
08M
AY2020 22:00  Pain Seve
re 1  07M
AY2020 10:00  
08M
AY2020 22:0
0 Ten
derness  Mod
erate  1  07M
AY2020 10:00  
09M
AY2020 22:00  Pain Mil
d 2  07M
AY2020 10:00  
09M
AY2020 22:00  Ten
derness  Mil
d 2  07M
AY2020 10:00  
28M
AY2020 22:00  Pain Seve
re 21 0 07M
AY2020 10:00  
28M
AY2020 22:00  Ten
derness  Mod
erate  21 0 07M
AY2020 10:0
0 
29M
AY2020 22:00  Pain Mod
erate  22 1 07M
AY2020 10:00  
29M
AY2020 22:00  Ten
derness  Mil
d 22 1 07M
AY2020 10:00  
30M
AY2020 22:00  Ten
derness  Mil
d 23 2 07M
AY2020 10:00  
10043  07M
AY2020 20:00  Pain Mil
d 0  07M
AY2020 10:30  
07M
AY2020 20:00  Ten
derness  Mod
erate  0  07M
AY2020 10:30  
08M
AY2020 20:00  Pain Mil
d 1  07M
AY2020 10:30  
 
Progra
m: Lsa
f_locR_1.sas           (Page 23 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 23
FDA-CBER-2021-5683-0050018
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect num
ber Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10043  08M
AY2020 20:00  Ten
derness  Seve
re 1  07M
AY2020 10:30  
08M
AY2020 20:00  Erythe
ma/Redness  Mil
d 1  07M
AY2020 10:30  
08M
AY2020 20:00  Indu
ration/Swelling  Mil
d 1  07M
AY2020 10:30  
09M
AY2020 20:00  Pain Mil
d 2  07M
AY2020 10:30  
09M
AY2020 20:00  Ten
derness  Mod
erate  2  07M
AY2020 10:30  
09M
AY2020 20:00  Erythe
ma/Redness  Mil
d 2  07M
AY2020 10:30  
09M
AY2020 20:00  Indu
ration/Swelling  Mil
d 2  07M
AY2020 10:30  
10M
AY2020 20:00  Pain Mil
d 3  07M
AY2020 10:30  
10M
AY2020 20:00  Ten
derness  Mil
d 3  07M
AY2020 10:30  
10M
AY2020 20:00  Erythe
ma/Redness  Mil
d 3  07M
AY2020 10:30  
10M
AY2020 20:00  Indu
ration/Swelling  Mil
d 3  07M
AY2020 10:30  
11M
AY2020 20:00  Pain Mil
d 4  07M
AY2020 10:30  
11M
AY2020 20:00  Ten
derness  Mil
d 4  07M
AY2020 10:30  
11M
AY2020 20:00  Erythe
ma/Redness  Mil
d 4  07M
AY2020 10:30  
11M
AY2020 20:0
0 Indu
ration/Swelling  Mil
d 4  07M
AY2020 10:30  
12M
AY2020 20:00  Pain Mil
d 5  07M
AY2020 10:30  
12M
AY2020 20:00  Ten
derness  Mil
d 5  07M
AY2020 10:30  
12M
AY2020 20:00  Erythe
ma/Redness  Mil
d 5  07M
AY2020 10:30  
 
Progra
m: Lsa
f_locR_1.sas           (Page 24 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 24
FDA-CBER-2021-5683-0050019
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV
2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10043  12M
AY2020 20:00  Indu
ration/Swelling  Mil
d 5  07M
AY2020 10:30  
28M
AY2020 20:00  Pain Mil
d 21 0 07M
AY2020 10:30  
28M
AY2020 20:00  Ten
derness  Mil
d 21 0 07M
AY2020 10:30  
29M
AY2020 20:00  Pain Mod
erate  22 1 07M
AY2020 10:30  
29M
AY2020 20:00  Ten
derness  Mod
erate  22 1 07M
AY2020 10:30  
30M
AY2020 20:00  Pain Mil
d 23 2 07M
AY2020 10:30  
31M
AY2020 20:00  Pain Mil
d 24 3 07M
AY2020 10:30  
10047  07M
AY2020 23:00  Pain Mil
d 0  07M
AY2020 11:00  
07M
AY2020 23:00  Ten
derness  Mod
erate  0  07M
AY2020 11:00  
08M
AY2020 23:45  Pain Mil
d 1  07M
AY2020 11:00  
08M
AY2020 23:45  Ten
derness  Mil
d 1  07M
AY2020 11:00  
09M
AY2020 23:45  Ten
derness  Mil
d 2  07M
AY2020 11:00  
10M
AY2020 23:40  Ten
derness  Mil
d 3  07M
AY2020 11:00  
28M
AY2020 23:55  Pain Mil
d 21 0 07M
AY2020 11:00  
28M
AY2020 23:55  Ten
derness  Mod
erate  21 0 07M
AY2020 11:00  
29M
AY2020 21:00  Pain Mod
erate  22 1 07M
AY2020 11:00  
29M
AY2020 21:00  Ten
derness  Mod
erate  22 1 07M
AY2020 11:00  
30M
AY2020 23:55  Pain Mil
d 23 2 07M
AY2020 11:00  
 
Progra
m: Lsa
f_locR_1.sas           (Page 25 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 25
FDA-CBER-2021-5683-0050020
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10047  30M
AY2020 23:55  Ten
derness  Mil
d 23 2 07M
AY2020 11:00  
31M
AY2020 22:00  Ten
derness  Mil
d 24 3 07M
AY2020 11:00  
50 µg
 
You
nger 10049  12M
AY2020 19:30  Pain Mil
d 0  12M
AY2020  9:10  
12M
AY2020 19:30  Ten
derness  Mod
erate  0  12M
AY2020  9:10  
13M
AY2020 13:00  Pain Mil
d 1  12M
AY2020  9:10  
13M
AY2020  13:0
0 Ten
derness  Mil
d 1  12M
AY2020  9:10  
02J
UN2020 23:00  Pain Mil
d 21 0 12M
AY2020  9:10  
02J
UN2020 23:00  Ten
derness  Mil
d 21 0 12M
AY2020  9:10  
02J
UN2020 23:00  Indu
ration/Swelling  Mil
d 21 0 12M
AY2020  9:10  
03J
UN2020  7:15  Pain Mil
d 22 1 12M
AY2020   9:10 
03J
UN2020  7:15  Ten
derness  Mil
d 22 1 12M
AY2020  9:10  
03J
UN2020  7:15  Indu
ration/Swelling  Mil
d 22 1 12M
AY2020  9:10  
10050  15M
AY2020 19:15  Pain Mod
erate  0  15M
AY2020  8:45  
15M
AY2020 19:15  Ten
derness  Mod
erate  0  15M
AY2020  8:45  
15M
AY2020 19:1
5 Erythe
ma/Redness  Mil
d 0  15M
AY2020  8:45  
15M
AY2020 19:15  Indu
ration/Swelling  Mil
d 0  15M
AY2020  8:45  
16M
AY2020 19:43  Pain Mod
erate  1  15M
AY2020  8:45  
16M
AY2020 19:43  Ten
derness  Mod
erate  1  15M
AY2020  8:45  
 
Progra
m: Lsa
f_locR_1.sas           (Page 26 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 26
FDA-CBER-2021-5683-0050021
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10050  17M
AY2020 20:17  Pain Mil
d 2  15M
AY2020  8:45  
17M
AY2020 20:17  Ten
derness  Mod
erate  2  15M
AY2020  8:45  
17M
AY2020 20:17  Erythe
ma/Redness  Mod
erate  2  15M
AY2020  8:45  
17M
AY2020 20:17  Indu
ration/Swelling  Mil
d 2  15M
AY2020  8:45  
18M
AY2020 20:00  Pain Mil
d 3  15M
AY2020  8:45  
18M
AY2020 20:00  Ten
derness  Mil
d 3  15M
AY2020  8:45  
18M
AY2020 20:00  Erythe
ma/Redness  Mil
d 3  15M
AY2020  8:45  
18M
AY2020 20:00  Indu
ration/Swelling  Mil
d 3  15M
AY2020  8:45  
19M
AY2020 21:20  Pain Mil
d 4  15M
AY2020  8:45  
19M
AY2020 21:20  Ten
derness  Mil
d 4  15M
AY2020  8:45  
19M
AY2020 21:20  Erythe
ma/Redness  Mil
d 4  15M
AY2020  8:45  
20M
AY2020 19:25  Pain Mil
d 5  15M
AY2020  8:45  
20M
AY2020 19:25  Ten
derness  Mil
d 5  15M
AY2020  8:45  
21M
AY2020 20:13  Pain Mil
d 6  15M
AY2020  8:45  
21M
AY2020 20:13  Ten
derness  Mil
d 6  15M
AY2020  8:45  
10053  12M
AY2020 20:00  Pain Mil
d 0  12M
AY2020 10:13  
12M
AY2020 20:00  Ten
derness  Mil
d 0  12M
AY2020 10:13  
13M
AY2020 20:00  Pain Mil
d 1  12M
AY2020 10:13  
 
Progra
m: Lsa
f_locR_1.sas           (Page 27 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 27
FDA-CBER-2021-5683-0050022
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Fin
al 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10053  13M
AY2020 20:00  Ten
derness  Mod
erate  1  12M
AY2020 10:13  
14M
AY2020 20:00  Ten
derness  Mil
d 2  12M
AY2020 10:13  
15M
AY2020 20:00  Ten
derness  Mil
d 3  12M
AY2020 10:13  
02J
UN2020 20:00  Pain Mil
d 21 0 12M
AY2020 10:13  
02J
UN2020 20:00  Ten
derness  Mil
d 21 0 12M
AY2020 10:13  
03J
UN2020 20:00  Pain Mil
d 22 1 12M
AY2020 10:1
3 
03J
UN2020 20:00  Ten
derness  Mil
d 22 1 12M
AY2020 10:13  
10055  14M
AY2020 21:30  Pain Mil
d 1  13M
AY2020  9:13  
14M
AY2020 21:30  Ten
derness  Mil
d 1  13M
AY2020  9:13  
15M
AY2020 22:00  Pain Mil
d 2  13M
AY2020  9:13  
15M
AY2020 22:00  Ten
derness  Mil
d 2  13M
AY2020  9:13  
03J
UN2020  8:30  Pain Mil
d 21 0 13M
AY2020  9:13  
03J
UN2020  8:30  Ten
derness  Mil
d 21 0 13M
AY2020  9:13  
04J
UN2020 22:48  Ten
derness  Mil
d 22 1 13M
AY2020  9:13  
10056  13M
AY2020 20:30  Pain Mil
d 0  13M
AY2020 10:16  
13M
AY2020 20:30  Ten
derness  Mil
d 0  13M
AY2020 10:16  
14M
AY2020 20:30  Pain Mil
d 1  13M
AY2020 10:16  
14M
AY2020 20:30  Ten
derness  Mil
d 1  13M
AY2020 10:16  
 
Progra
m: Lsa
f_locR_1.sas           (Page 28 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 28
FDA-CBER-2021-5683-0050023
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local
 reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10056  03J
UN2020 21:30  Pain Mil
d 21 0 13M
AY2020 10:16  
03J
UN2020 21:30  Ten
derness  Mil
d 21 0 13M
AY2020 10:16  
04J
UN2020 21:30  Pain Mod
erate  22 1 13M
AY2020 10:16  
04J
UN2020 21:30  Ten
derness  Mod
erate  22 1 13M
AY2020 10:16  
05J
UN2020 21:30  Pain Mil
d 23 2 13M
AY2020 10:16  
05J
UN2020 21:30  Ten
derness  Mil
d 23 2 13M
AY2020 10:16  
06J
UN2020 21:30  Pain Mil
d 24 3 13M
AY2020 10:16  
06J
UN2020 21:30  Ten
derness  Mil
d 24 3 13M
AY2020 10:16  
10057  15M
AY2020 20:00  Pain Mil
d 0  15M
AY2020  9:15  
16M
AY2020 20:00  Pain Mod
erate  1  15M
AY2020  9:15  
16M
AY2020 20:00  Ten
derness  Mod
erate  1  15M
AY2020  9:15  
05J
UN2020 20:38  Pain Mod
erate  21 0 15M
AY2020  9:15  
05J
UN2020 20:38  Ten
derness  Seve
re 21 0 15M
AY2020  9:15  
06J
UN2020 17:30  Pain Mil
d 22 1 15M
AY2020  9:15  
06J
UN2020 17:30  Ten
derness  Mil
d 22 1 15M
AY2020  9:15  
07J
UN2020 14:00  Pain Mil
d 23 2 15M
AY2020  9:15  
07J
UN2020 14:00  Ten
derness  Mil
d 23 2 15M
AY2020  9:15  
08J
UN2020 14:00  Pain Mil
d 24 3 15M
AY2020  9:15  
 
Progra
m: Lsa
f_locR_1.sas           (Page 29 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 29
FDA-CBER-2021-5683-0050024
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10057  08J
UN2020 14:00  Ten
derness  Mil
d 24 3 15M
AY2020  9:15  
10059  13M
AY2020 16:50  Pain Mil
d 0  13M
AY2020 10:46  
13M
AY2020 16:50  Ten
derness  Mod
erate  0  13M
AY2020 10:46  
14M
AY2020 17:00  Pain Mod
erate  1  13M
AY2020 10:46  
14M
AY2020 17:00  Ten
derness  Mod
erate  1  13M
AY2020 10:46  
15M
AY2020 17:50  Pain Mod
erate  2  13M
AY2020 10:46  
15M
AY2020 17:50  Ten
derness  Mod
erate  2  13M
AY2020 10:46  
16M
AY2020 17:30  Pain Mod
erate  3  13M
AY2020 10:46  
16M
AY2020 17:30  Ten
derness  Mod
erate  3  13M
AY2020 10:46  
17M
AY2020 17:15  Pain Mod
erate  4  13M
AY2020 10:46  
17M
AY2020 17:15  Ten
derness  Mod
erate  4  13M
AY2020 10:46  
03J
UN2020 11:50  Pain Mod
erate  21 0 13M
AY2020 10:46  
03J
UN2020 11:50  Ten
derness  Mod
erate  21 0 13M
AY2020 10:46  
04J
UN2020 10:00  Pain Mod
erate  22 1 13M
AY2020 10:46  
04J
UN2020 10:00  Ten
derness  Mod
erate  22 1 13M
AY2020 10:46  
05J
UN2020 18:00  Pain Mod
erate  23 2 13M
AY2020 10:46  
05J
UN2020  18:0
0 Ten
derness  Mod
erate  23 2 13M
AY2020 10:46  
06J
UN2020 17:00  Pain Mod
erate  24 3 13M
AY2020 10:46  
 
Progra
m: Lsa
f_locR_1.sas           (Page 30 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 30
FDA-CBER-2021-5683-0050025
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10059  06J
UN2020 17:00  Ten
derness  Mod
erate  24 3 13M
AY2020 10:46  
07J
UN2020 20:00  Pain Mod
erate  25 4 13M
AY2020 10:46  
07J
UN2020 20:00  Ten
derness  Mod
erate  25 4 13M
AY2020 10:46  
08J
UN2020 14:20  Pain Mil
d 26 5 13M
AY2020 10:46  
08J
UN2020 14:20  Ten
derness  Mil
d 26 5 13M
AY2020 10:46  
10060  14M
AY2020 18:00  Pain Seve
re 1  13M
AY2020 11:16  
14M
AY2020 18:00  Ten
derness  Mil
d 1  13M
AY2020 11:16  
04J
UN2020  6:00  Pain Mil
d 22 1 13M
AY2020 11:16  
04J
UN2020  6:00  Ten
derness  Mil
d 22 1 13M
AY2020 11:16  
10067  15M
AY2020 22:00  Ten
derness  Mil
d 0  15M
AY2020  9:45  
05J
UN2020 22:00  Pain Mil
d 21 0 15M
AY2020  9:45  
05J
UN2020 22:00  Ten
derness  Mil
d 21 0 15M
AY2020  9:45  
06J
UN2020 22:00  Pain Mod
erate  22 1 15M
AY2020  9:45  
06J
UN2020 22:00  Ten
derness  Mod
erate  22 1 15M
AY2020  9:45  
10068  15M
AY2020 22:3
0 Pain Mil
d 0  15M
AY2020 10:15  
15M
AY2020 22:30  Ten
derness  Mod
erate  0  15M
AY2020 10:15  
16M
AY2020 23:00  Pain Mil
d 1  15M
AY2020 10:15  
16M
AY2020 23:00  Ten
derness  Mod
erate  1  15M
AY2020 10:15  
 
Progra
m: Lsa
f_locR_1.sas           (Page 31 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 31
FDA-CBER-2021-5683-0050026
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV
2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost  
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10068  16M
AY2020 23:00  Erythe
ma/Redness  Mil
d 1  15M
AY2020 10:15  
16M
AY2020 23:00  Indu
ration/Swelling  Mil
d 1  15M
AY2020 10:15  
17M
AY2020 22:30  Pain Mil
d 2  15M
AY2020 10:15  
17M
AY2020 22:30  Ten
derness  Mil
d 2  15M
AY2020 10:15  
17M
AY2020 22:30  Erythe
ma/Redness  Mod
erate  2  15M
AY2020 10:15  
17M
AY2020 22:30  Indu
ration/Swelling  Mil
d 2  15M
AY2020 10:15  
18M
AY2020 23:00  Pain Mil
d 3  15M
AY2020 10:15  
18M
AY2020 23:00  Ten
derness  Mil
d 3  15M
AY2020 10:15  
18M
AY2020 23:00  Erythe
ma/Redness  Mod
erate  3  15M
AY2020 10:15  
18M
AY2020 23:00  Indu
ration/Swelling  Mil
d 3  15M
AY2020 10:15  
19M
AY2020 23:00  Pain Mil
d 4  15M
AY2020 10:15  
19M
AY2020 23:00  Ten
derness  Mil
d 4  15M
AY2020 10:15  
19M
AY2020 23:00  Erythe
ma/Redness  Mod
erate  4  15M
AY2020 10:15  
19M
AY2020 23:00  Indu
ration/Swelling  Mil
d 4  15M
AY2020 10:15  
20M
AY2020 23:30  Pain Mil
d 5  15M
AY2020 10:15  
20M
AY2020 23:30  Ten
derness  Mil
d 5  15M
AY2020 10:15  
20M
AY2020 23:30  Erythe
ma/Redness  Mil
d 5  15M
AY2020 10:15  
05J
UN2020 22:30  Pain Mod
erate  21 0 15M
AY2020 10:15  
 
Progra
m: Lsa
f_locR_1.sas           (Page 32 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 32
FDA-CBER-2021-5683-0050027
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10068  05J
UN2020 22:30  Ten
derness  Mod
erate  21 0 15M
AY2020 10:15  
06J
UN2020 22:00  Pain Mod
erate  22 1 15M
AY2020 10:15  
06J
UN2020 22:00  Ten
derness  Mod
erate  22 1 15M
AY2020 10:15  
07J
UN2020 22:30  Pain Mil
d 23 2 15M
AY2020 10:15  
07J
UN2020 22:30  Ten
derness  Mod
erate  23 2 15M
AY2020 10:15  
07J
UN2020 22:3
0 Erythe
ma/Redness  Mil
d 23 2 15M
AY2020 10:15  
08J
UN2020 23:00  Pain Mil
d 24 3 15M
AY2020 10:15  
08J
UN2020 23:00  Ten
derness  Mod
erate  24 3 15M
AY2020 10:15  
08J
UN2020 23:00  Erythe
ma/Redness  Mil
d 24 3 15M
AY2020 10:15  
09J
UN2020 23:00  Pain Mil
d 25 4 15M
AY2020 10:15  
09J
UN2020 23:00  Ten
derness  Mil
d 25 4 15M
AY2020 10:15  
09J
UN2020 23:00  Erythe
ma/Redness  Mil
d 25 4 15M
AY2020 10:15  
10J
UN2020 23:30  Pain Mil
d 26 5 15M
AY2020 10:15  
10J
UN2020 23:30  Ten
derness  Mil
d 26 5 15M
AY2020 10:15  
11J
UN2020 23:0
0 Pain Mil
d 27 6 15M
AY2020 10:15  
11J
UN2020 23:00  Ten
derness  Mil
d 27 6 15M
AY2020 10:15  
10070  16M
AY2020 19:00  Pain Seve
re 1  15M
AY2020 10:45  
16M
AY2020 19:00  Ten
derness  Seve
re 1  15M
AY2020 10:45  
 
Progra
m: Lsa
f_locR_1.sas           (Page 33 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 33
FDA-CBER-2021-5683-0050028
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20
NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost  
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10070  16M
AY2020 19:00  Indu
ration/Swelling  Mod
erate  1  15M
AY2020 10:45  
17M
AY2020 19:00  Pain Mod
erate  2  15M
AY2020 10:45  
17M
AY2020 19:00  Ten
derness  Mod
erate  2  15M
AY2020 10:45  
17M
AY2020 19:0
0 Erythe
ma/Redness  Mil
d 2  15M
AY2020 10:45  
17M
AY2020 19:00  Indu
ration/Swelling  Mod
erate  2  15M
AY2020 10:45  
18M
AY2020 19:15  Ten
derness  Mil
d 3  15M
AY2020 10:45  
18M
AY2020 19:15  Erythe
ma/Redness  Mod
erate  3  15M
AY2020 10:45  
18M
AY2020 19:15  Indu
ration/Swelling  Mod
erate  3  15M
AY2020 10:45  
19M
AY2020 19:00  Erythe
ma/Redness  Mod
erate  4  15M
AY2020 10:45  
05J
UN2020 19:00  Pain Seve
re 21 0 15M
AY2020 10:45  
05J
UN2020 19:00  Ten
derness  Mod
erate  21 0 15M
AY2020 10:45  
06J
UN2020 19:00  Ten
derness  Mil
d 22 1 15M
AY2020 10:45  
07J
UN2020 19:00  Ten
derness  Mil
d 23 2 15M
AY2020 10:45  
10073  16M
AY2020 22:00  Pain Mil
d 1  15M
AY2020 11:15  
16M
AY2020 22:00  Ten
derness  Mil
d 1  15M
AY2020 11:15  
05J
UN2020 22:23  Pain Seve
re 21 0 15M
AY2020 11:15  
05J
UN2020 22:2
3 Ten
derness  Seve
re 21 0 15M
AY2020 11:15  
06J
UN2020 16:10  Pain Seve
re 22 1 15M
AY2020 11:15  
 
Progra
m: Lsa
f_locR_1.sas           (Page 34 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 34
FDA-CBER-2021-5683-0050029
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10073  06J
UN2020 16:10  Ten
derness  Seve
re 22 1 15M
AY2020 11:15  
07J
UN2020 22:46  Pain Seve
re 23 2 15M
AY2020 11:15  
07J
UN2020 22:46  Ten
derness  Seve
re 23 2 15M
AY2020 11:15  
08J
UN2020 23:20  Pain Mod
erate  24 3 15M
AY2020 11:15  
08J
UN2020 23:20  Ten
derness  Mod
erate  24 3 15M
AY2020 11:15  
09J
UN2020  1:04 Pain Mil
d 25 4 15M
AY2020 11:15  
60 µg
 
You
nger 10066  19M
AY2020 21:55  Pain Mod
erate  0  19M
AY2020  8:36  
19M
AY2020 21:55  Ten
derness  Mod
erate  0  19M
AY2020  8:36  
19M
AY2020 21:55  Indu
ration/Swelling  Mod
erate  0  19M
AY2020  8:36  
20M
AY2020 21:54  Pain Mil
d 1  19M
AY2020  8:36  
20M
AY2020 21:54  Ten
derness  Mod
erate  1  19M
AY2020  8:36  
20M
AY2020 21:54  Indu
ration/Swelling  Mod
erate  1  19M
AY2020  8:36  
21M
AY2020 21:55  Pain Mil
d 2  19M
AY2020  8:36  
21M
AY2020 21:55  Ten
derness  Mil
d 2  19M
AY2020  8:36  
21M
AY2020 21:55  Indu
ration/Swelling  Mil
d 2  19M
AY2020  8:36  
22M
AY2020 21:55  Pain Mil
d 3  19M
AY2020  8:36  
22M
AY2020 21:55  Ten
derness  Mil
d 3  19M
AY2020  8:36  
22M
AY2020 21:55  Indu
ration/Swelling  Mil
d 3  19M
AY2020  8:36  
 
Progra
m: Lsa
f_locR_1.sas           (Page 35 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 35
FDA-CBER-2021-5683-0050030
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
60 µg
 
You
nger 10075  22M
AY2020 22:05  Pain Seve
re 0  22M
AY2020  8:50  
22M
AY2020 22:05  Ten
derness  Mod
erate  0  22M
AY2020  8:50  
23M
AY2020 22:00  Pain Seve
re 1  22M
AY2020  8:50  
23M
AY2020 22:00  Ten
derness  Mod
erate  1  22M
AY2020  8:50  
24M
AY2020 22:00  Pain Mil
d 2  22M
AY2020  8:50  
24M
AY2020 22:00  Ten
derness  Mod
erate  2  22M
AY2020  8:50  
25M
AY2020 22:00  Pain Mil
d 3  22M
AY2020  8:50  
25M
AY2020 22:00  Ten
derness  Mil
d 3  22M
AY2020  8:50  
26M
AY2020 22:00  Pain Mil
d 4  22M
AY2020  8:50  
26M
AY2020 22:00  Ten
derness  Mil
d 4  22M
AY2020  8:50  
27M
AY2020 22:30  Pain Mil
d 5  22M
AY2020  8:50  
27M
AY2020 22:30  Ten
derness  Mil
d 5  22M
AY2020  8:50  
10076  22M
AY2020  22:0
0 Pain Mil
d 0  22M
AY2020  9:20  
23M
AY2020 22:00  Pain Mil
d 1  22M
AY2020  9:20  
10078  22M
AY2020 23:15  Pain Mil
d 0  22M
AY2020  9:50  
22M
AY2020 23:15  Ten
derness  Mil
d 0  22M
AY2020  9:50  
23M
AY2020 22:45  Pain Mil
d 1  22M
AY2020  9:50  
23M
AY2020 22:4
5 Ten
derness  Mod
erate  1  22M
AY2020  9:50  
 
Progra
m: Lsa
f_locR_1.sas           (Page 36 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 36
FDA-CBER-2021-5683-0050031
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV
2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reac
tion Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
60 µg
 
You
nger 10083  20M
AY2020 19:21  Pain Mil
d 0  20M
AY2020  9:15  
20M
AY2020 19:21  Ten
derness  Mil
d 0  20M
AY2020  9:15 
21M
AY2020 18:45  Pain Mil
d 1  20M
AY2020  9:15  
21M
AY2020 18:45  Ten
derness  Mil
d 1  20M
AY2020  9:15  
22M
AY2020 20:00  Pain Mil
d 2  20M
AY2020  9:15  
22M
AY2020 20:00  Ten
derness  Mil
d 2  20M
AY2020  9:15  
10084  22M
AY2020 20:30  Pain Mil
d 0  22M
AY2020 10:2
0 
22M
AY2020 20:30  Ten
derness  Mil
d 0  22M
AY2020 10:20  
23M
AY2020 20:30  Ten
derness  Mil
d 1  22M
AY2020 10:20  
10085  22M
AY2020 23:00  Pain Mil
d 0  22M
AY2020 10:50  
22M
AY2020 23:00  Ten
derness  Mod
erate  0  22M
AY2020 10:50  
23M
AY2020 21:50  Pain Mil
d 1  22M
AY2020 10:50  
23M
AY2020 21:50  Ten
derness  Mod
erate  1  22M
AY2020 10:50  
24M
AY2020 22:15  Pain Mil
d 2  22M
AY2020 10:50  
24M
AY2020 22:15  Ten
derness  Mil
d 2  22M
AY2020 10:50  
10089  20M
AY2020 22:00  Pain Mil
d 0  20M
AY2020  9:45  
20M
AY2020 22:00  Ten
derness  Mod
erate  0  20M
AY2020  9:45  
21M
AY2020 22:00  Pain Mil
d 1  20M
AY2020  9:45  
 
Progra
m: Lsa
f_locR_1.sas           (Page 37 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 37
FDA-CBER-2021-5683-0050032
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot  All
 TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
60 µg
 
You
nger 10089  21M
AY2020 22:00  Ten
derness  Mod
erate  1  20M
AY2020  9:45  
22M
AY2020 22:00  Pain Mil
d 2  20M
AY2020  9:45  
22M
AY2020 22:00  Ten
derness  Mil
d 2  20M
AY2020  9:45  
23M
AY2020 22:00  Ten
derness  Mil
d 3  20M
AY2020  9:45  
10093  20M
AY2020 19:00  Pain Mil
d 0  20M
AY2020 10:15  
21M
AY2020 18:45  Pain Mil
d 1  20M
AY2020 10:15  
21M
AY2020 18:45  Ten
derness  Mil
d 1  20M
AY2020 10:15  
10096  19M
AY2020 22:49  Pain Mil
d 0  19M
AY2020  9:08  
19M
AY2020 22:49  Ten
derness  Mil
d 0  19M
AY2020  9:08  
20M
AY2020 19:30  Pain Mil
d 1  19M
AY2020  9:08  
20M
AY2020 19:30  Ten
derness  Mil
d 1  19M
AY2020  9:08  
10103  22M
AY2020 20:48  Pain Mil
d 0  22M
AY2020 11:32  
22M
AY2020 20:48  Ten
derness  Mod
erate  0  22M
AY2020 11:32  
23M
AY2020 15:18  Pain Mil
d 1  22M
AY2020 11:32  
23M
AY2020 15:18  Ten
derness  Mil
d 1  22M
AY2020 11:32  
10104  20M
AY2020 22:0
0 Pain Mil
d 0  20M
AY2020 10:45  
20M
AY2020 22:00  Ten
derness  Mod
erate  0  20M
AY2020 10:45  
21M
AY2020 22:00  Pain Mod
erate  1  20M
AY2020 10:45  
 
Progra
m: Lsa
f_locR_1.sas           (Page 38 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 38
FDA-CBER-2021-5683-0050033
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based
 on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of soli
cited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
60 µg
 
You
nger 10104  21M
AY2020 22:00  Ten
derness  Mod
erate  1  20M
AY2020 10:45  
22M
AY2020 22:00  Pain Mil
d 2  20M
AY2020 10:45  
22M
AY2020 22:00  Ten
derness  Mil
d 2  20M
AY2020 10:45  
23M
AY2020 23:00  Pain Mil
d 3  20M
AY2020 10:45  
23M
AY2020 23:00  Ten
derness  Mil
d 3  20M
AY2020 10:45  
24M
AY2020 22:00  Ten
derness  Mil
d 4  20M
AY2020 10:45  
10 µg
 
Old
er 10274  18SEP2
020 20:00  Ten
derness  Mil
d 22 1 27AUG
2020  9:00  
18SEP2
020 20:00  Erythe
ma/Redness  Mil
d 22 1 27AUG
2020  9:00  
18SEP2
020 20:00  Indu
ration/Swelling  Mil
d 22 1 27AUG
2020  9:00  
19SEP2
020 21:00  Ten
derness  Mil
d 23 2 27AUG
2020  9:00  
19SEP2
020 21:00  Erythe
ma/Redness  Mil
d 23 2 27AUG
2020  9:00  
20SEP2
020 19:45  Erythe
ma/Redness  Mil
d 24 3 27AUG
2020  9:00  
21SEP2
020 20:15  Erythe
ma/Redness  Mil
d 25 4 27AUG
2020  9:0
0 
22SEP2
020 20:00  Erythe
ma/Redness  Mil
d 26 5 27AUG
2020  9:00  
10282  20AUG
2020 18:50  Pain Mil
d 0  20AUG
2020  9:33  
20AUG
2020 18:50  Ten
derness  Mil
d 0  20AUG
2020  9:33  
21AUG
2020 19:00  Pain Mil
d 1  20AUG
2020  9:33  
21AUG
2020 19:00  Ten
derness  Mil
d 1  20AUG
2020  9:33  
 
Progra
m: Lsa
f_locR_1.sas           (Page 39 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 39
FDA-CBER-2021-5683-0050034
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV
2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
10 µg
 
Old
er 10282  10SEP2
020 16:00  Ten
derness  Mil
d 21 0 20AUG
2020  9:33  
11SEP2
020 18:00  Pain Mil
d 22 1 20AUG
2020  9:33  
10283  27AUG
2020 21:00  Pain Mil
d 0  27AUG
2020  9:30  
27AUG
2020 21:00  Ten
derness  Mil
d 0  27AUG
2020  9:30  
28AUG
2020 21:30  Pain Mil
d 1  27AUG
2020  9:30  
28AUG
2020 21:30  Ten
derness  Mil
d 1  27AUG
2020  9:30  
17SEP2
020 21:00  Pain Mil
d 21 0 27AUG
2020  9:30  
17SEP2
020 21:00  Ten
derness  Mil
d 21 0 27AUG
2020  9:30  
18SEP2
020 21:00  Pain Mil
d 22 1 27AUG
2020  9:30  
18SEP2
020 21:00  Ten
derness  Mil
d 22 1 27AUG
2020  9:30  
10286  25AUG
2020 18:30  Ten
derness  Mil
d 0  25AUG
2020  8:30  
26AUG
2020 18:30  Pain Mil
d 1  25AUG
2020  8:30  
26AUG
2020 18:30  Ten
derness  Mil
d 1  25AUG
2020  8:30  
15SEP2
020 20:00  Ten
derness  Mil
d 21 0 25AUG
2020  8:30  
10287  25AUG
2020 21:00  Pain Mil
d 0  25AUG
2020  9:00  
25AUG
2020 21:00  Ten
derness  Mil
d 0  25AUG
2020  9:00  
26AUG
2020  0:00  Ten
derness  Mil
d 1  25AUG
2020  9:00  
15SEP2
020 23:10  Pain Mod
erate  21 0 25AUG
2020  9:00  
 
Progra
m: Lsa
f_locR_1.sas           (Page 40 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 40
FDA-CBER-2021-5683-0050035
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
10 µg
 
Old
er 10287  15SEP2
020 23:10  Ten
derness  Mil
d 21 0 25AUG
2020  9:00  
16SEP2
020 23:00  Pain Mil
d 22 1 25AUG
2020  9:00  
16SEP2
020 23:00  Ten
derness  Mil
d 22 1 25AUG
2020  9:00  
17SEP2
020  0:00  Pain Mil
d 23 2 25AUG
2020  9:00  
17SEP2
020  0:00  Ten
derness  Mil
d 23 2 25AUG
2020  9:00  
18SEP2
020  1:20  Pain Mil
d 24 3 25AUG
2020  9:00  
18SEP2
020  1:20  Ten
derness  Mil
d 24 3 25AUG
2020  9:00  
19SEP2
020  1:15  Pain Mil
d 25 4 25AUG
2020  9:00  
19SEP2
020  1:15  Ten
derness  Mil
d 25 4 25AUG
2020  9:00  
20SEP2
020  1:05  Pain Mil
d 26 5 25AUG
2020  9:00  
20SEP2
020  1:05  Ten
derness  Mil
d 26 5 25AUG
2020  9:00  
10288  25AUG
2020 21:00  Ten
derness  Mil
d 0  25AUG
2020  9:30  
26AUG
2020 21:00  Pain Mil
d 1  25AUG
2020  9:30  
26AUG
2020 21:00  Ten
derness  Mil
d 1  25AUG
2020  9:30  
15SEP2
020 23:00  Pain Mil
d 21 0 25AUG
2020  9:30  
15SEP2
020 23:00  Ten
derness  Mil
d 21 0 25AUG
2020  9:30  
15SEP2
020 23:00  Indu
ration/Swelling  Mil
d 21 0 25AUG
2020  9:30  
16SEP2
020 23:00  Pain Mil
d 22 1 25AUG
2020  9:30  
 
Progra
m: Lsa
f_locR_1.sas           (Page 41 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 41
FDA-CBER-2021-5683-0050036
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3-1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prim
e 
imm
unization  
10 µg
 
Old
er 10288  16SEP2
020 23:00  Indu
ration/Swelling  Mil
d 22 1 25AUG
2020  9:30  
17SEP2
020 23:00  Indu
ration/Swelling  Mil
d 23 2 25AUG
2020  9:30  
18SEP2
020 23:00  Indu
ration/Swelling  Mil
d 24 3 25AUG
2020  9:30  
19SEP2
020 23:00  Erythe
ma/Redness  Mil
d 25 4 25AUG
2020  9:30  
19SEP2
020 23:00  Indu
ration/Swelling  Mil
d 25 4 25AUG
2020  9:30  
20SEP2
020 23:00  Erythe
ma/Redness  Mil
d 26 5 25AUG
2020  9:30  
20SEP2
020 23:00  Indu
ration/Swelling  Mil
d 26 5 25AUG
2020  9:30  
21SEP2
020 23:00  Erythe
ma/Redness  Mil
d 27 6 25AUG
2020  9:30  
21SEP2
020 23:00  Indu
ration/Swelling  Mil
d 27 6 25AUG
2020  9:30  
10298  27AUG
2020 20:15  Pain Mil
d 0  27AUG
2020 10:30  
27AUG
2020 20:15  Ten
derness  Mil
d 0  27AUG
2020 10:30  
28AUG
2020 20:08  Pain Mil
d 1  27AUG
2020  10:3
0 
28AUG
2020 20:08  Ten
derness  Mil
d 1  27AUG
2020 10:30  
29AUG
2020 20:10  Pain Mil
d 2  27AUG
2020 10:30  
29AUG
2020 20:10  Ten
derness  Mil
d 2  27AUG
2020 10:30  
17SEP2
020  1:00  Pain Mil
d 21 0 27AUG
2020 10:30  
17SEP2
020  1:00  Ten
derness  Mod
erate  21 0 27AUG
2020 10:30  
18SEP2
020 10:00  Pain Mil
d 22 1 27AUG
2020 10:30  
 
Progra
m: Lsa
f_locR_1.sas           (Page 42 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 42
FDA-CBER-2021-5683-0050037
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
10 µg
 
Old
er 10298  18SEP2
020 10:00  Ten
derness  Mod
erate  22 1 27AUG
2020 10:30  
19SEP2
020 16:00  Pain Mil
d 23 2 27AUG
2020 10:30  
19SEP2
020 16:00  Ten
derness  Mil
d 23 2 27AUG
2020 10:30  
20SEP2
020 20:00  Pain Mil
d 24 3 27AUG
2020 10:30  
20SEP2
020 20:00  Ten
derness  Mil
d 24 3 27AUG
2020 10:30  
21SEP2
020 20:10  Pain Mil
d 25 4 27AUG
2020 10:3
0 
21SEP2
020 20:10  Ten
derness  Mil
d 25 4 27AUG
2020 10:30  
22SEP2
020 20:05  Pain Mil
d 26 5 27AUG
2020 10:30  
22SEP2
020 20:05  Ten
derness  Mil
d 26 5 27AUG
2020 10:30  
23SEP2
020 20:10  Ten
derness  Mil
d 27 6 27AUG
2020 10:30  
10320  27AUG
2020 19:00  Ten
derness  Mil
d 0  27AUG
2020 11:00  
28AUG
2020 19:00  Ten
derness  Mil
d 1  27AUG
2020 11:00  
17SEP2
020 Pain Mod
erate  21 0 27AUG
2020 11:00  
18SEP2
020 10:00  Pain Mod
erate  22 1 27AUG
2020 11:00  
18SEP2
020 10:00  Ten
derness  Mod
erate  22 1 27AUG
2020 11:00  
19SEP2
020 10:00  Pain Mod
erate  23 2 27AUG
2020 11:00  
19SEP2
020 10:00  Ten
derness  Mil
d 23 2 27AUG
2020 11:00  
20SEP2
020 10:00  Pain Mil
d 24 3 27AUG
2020 11:00  
 
Progra
m: Lsa
f_locR_1.sas           (Page 43 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 43
FDA-CBER-2021-5683-0050038
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Listi
ng of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
10 µg
 
Old
er 10320  20SEP2
020 10:00  Ten
derness  Mil
d 24 3 27AUG
2020 11:00  
21SEP2
020 10:00  Pain Mil
d 25 4 27AUG
2020 11:00  
21SEP2
020 10:00  Ten
derness  Mil
d 25 4 27AUG
2020 11:00  
22SEP2
020 10:30  Pain Mil
d 26 5 27AUG
2020 11:00  
22SEP2
020 10:3
0 Ten
derness  Mil
d 26 5 27AUG
2020 11:00  
23SEP2
020 10:00  Ten
derness  Mil
d 27 6 27AUG
2020 11:00  
20 µg
 
Old
er 20207  09SEP2
020 20:30  Pain Mil
d 0  09SEP2
020  9:00  
09SEP2
020 20:30  Ten
derness  Mil
d 0  09SEP2
020  9:00  
10SEP2
020 20:00  Pain Mil
d 1  09SEP2
020  9:00  
10SEP2
020 20:00  Ten
derness  Mil
d 1  09SEP2
020  9:00  
30SEP2
020 19:00  Ten
derness  Mil
d 21 0 09SEP2
020  9:00  
01O
CT2020 20:00  Pain Mil
d 22 1 09SEP2
020  9:00  
01O
CT2020 20:00  Ten
derness  Mil
d 22 1 09SEP2
020  9:00  
02O
CT2020 20:30  Pain Mil
d 23 2 09SEP2
020  9:00  
02O
CT2020 20:30  Ten
derness  Mil
d 23 2 09SEP2
020  9:00  
20211  08SEP2
020 20:30  Ten
derness  Mil
d 0  08SEP2
020  8:00  
09SEP2
020 20:30  Pain Mil
d 1  08SEP2
020  8:00  
09SEP2
020 20:30  Ten
derness  Mil
d 1  08SEP2
020  8:00  
 
Progra
m: Lsa
f_locR_1.sas           (Page 44 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 44
FDA-CBER-2021-5683-0050039
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV
2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
Old
er 20211  10SEP2
020 20:30  Pain Mil
d 2  08SEP2
020  8:00  
10SEP2
020 20:30  Ten
derness  Mil
d 2  08SEP2
020  8:00  
30SEP2
020 19:30  Pain Mil
d 22 0 08SEP2
020  8:00  
30SEP2
020 19:30  Ten
derness  Mil
d 22 0 08SEP2
020  8:00  
20220  08SEP2
020 21:00  Ten
derness  Mil
d 0  08SEP2
020  9:00  
08SEP2
020 21:00  Indu
ration/Swelling  Mil
d 0  08SEP2
020  9:00  
09SEP2
020 21:00  Ten
derness  Mil
d 1  08SEP2
020  9:00  
09SEP2
020 21:00  Indu
ration/Swelling  Mil
d 1  08SEP2
020  9:00  
30SEP2
020 20:00  Pain Mil
d 22 0 08SEP2
020  9:00  
30SEP2
020 20:00  Ten
derness  Mil
d 22 0 08SEP2
020  9:00  
01O
CT2020 21:00  Pain Mil
d 23 1 08SEP2
020  9:00  
01O
CT2020 21:00  Ten
derness  Mil
d 23 1 08SEP2
020  9:00  
01O
CT2020 21:00  Indu
ration/Swelling  Mil
d 23 1 08SEP2
020  9:00  
02O
CT2020 21:00  Pain Mil
d 24 2 08SEP2
020  9:00  
02O
CT2020 21:00  Ten
derness  Mil
d 24 2 08SEP2
020  9:00  
03O
CT2020 20:00  Pain Mil
d 25 3 08SEP2
020  9:00  
03O
CT2020 20:00  Ten
derness  Mil
d 25 3 08SEP2
020  9:00  
04O
CT2020 20:00  Ten
derness  Mil
d 26 4 08SEP2
020  9:00  
 
Progra
m: Lsa
f_locR_1.sas           (Page 45 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 45
FDA-CBER-2021-5683-0050040
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
Old
er 20220  05O
CT2020 21:00  Ten
derness  Mil
d 27 5 08SEP2
020  9:00  
20227  12SEP2
020 22:10  Ten
derness  Mod
erate  1  11SEP2
020 11:30  
02O
CT2020 22:15  Pain Mil
d 21 0 11SEP2
020 11:30  
02O
CT2020 22:15  Ten
derness  Mil
d 21 0 11SEP2
020 11:30  
03O
CT2020 20:00  Pain Mod
erate  22 1 11SEP2
020 11:30  
03O
CT2020 20:
00 Ten
derness  Mod
erate  22 1 11SEP2
020 11:30  
03O
CT2020 20:00  Indu
ration/Swelling  Mil
d 22 1 11SEP2
020 11:30  
04O
CT2020 21:50  Pain Mod
erate  23 2 11SEP2
020 11:30  
04O
CT2020 21:50  Ten
derness  Mod
erate  23 2 11SEP2
020 11:30  
04O
CT2020 21:50  Indu
ration/Swelling  Mil
d 23 2 11SEP2
020 11:30  
05O
CT2020 22:00  Pain Mil
d 24 3 11SEP2
020 11:30  
05O
CT2020 22:00  Ten
derness  Mil
d 24 3 11SEP2
020 11:30  
20234  10SEP2
020 21:00  Pain Mil
d 1  09SEP2
020  9:30  
11SEP2
020 21:15  Pain Mil
d 2  09SEP2
020  9:30  
12SEP2
020 21:00  Pain Mil
d 3  09SEP2
020  9:30  
30SEP2
020 21:30  Pain Mil
d 21 0 09SEP2
020  9:30  
01O
CT2020 21:00  Pain Mil
d 22 1 09SEP2
020  9:30  
20236  11SEP2
020 21:46  Ten
derness  Mil
d 0  11SEP2
020 10:30  
 
Progra
m: Lsa
f_locR_1.sas           (Page 46 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 46
FDA-CBER-2021-5683-0050041
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost  
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
Old
er 20236  12SEP2
020 21:46  Ten
derness  Mil
d 1  11SEP2
020 10:30  
20237  11SEP2
020 22:00  Pain Mod
erate  0  11SEP2
020  9:00  
11SEP2
020 22:00  Ten
derness  Mod
erate  0  11SEP2
020  9:00  
12SEP2
020 22:15  Pain Mil
d 1  11SEP2
020  9:00  
12SEP2
020 22:15  Ten
derness  Mil
d 1  11SEP2
020  9:00  
02O
CT2020 22:30  Pain Mil
d 21 0 11SEP2
020  9:00  
02O
CT2020 22:30  Ten
derness  Mil
d 21 0 11SEP2
020  9:00  
03O
CT2020 23:00  Pain Mil
d 22 1 11SEP2
020  9:00  
03O
CT2020 23:00  Ten
derness  Mil
d 22 1 11SEP2
020  9:00  
04O
CT2020 22:30  Pain Mil
d 23 2 11SEP2
020  9:00  
04O
CT2020 22:30  Ten
derness  Mil
d 23 2 11SEP2
020  9:00  
20238  11SEP2
020 19:45  Ten
derness  Mod
erate  0  11SEP2
020 10:00  
11SEP2
020 19:45  Indu
ration/Swelling  Mil
d 0  11SEP2
020 10:00  
12SEP2
020 19:30  Ten
derness  Mil
d 1  11SEP2
020 10:00  
02O
CT2020 21:12  Pain Mil
d 21 0 11SEP2
020 10:00  
02O
CT2020 21:12  Ten
derness  Mil
d 21 0 11SEP2
020 10:00  
02O
CT2020 21:12  Indu
ration/Swelling  Mil
d 21 0 11SEP2
020 10:00  
20239  11SEP2
020 22:00  Pain Mil
d 0  11SEP2
020 11:00  
 
Progra
m: Lsa
f_locR_1.sas           (Page 47 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 47
FDA-CBER-2021-5683-0050042
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reac
tion Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
Old
er 20239  11SEP2
020 22:00  Ten
derness  Mod
erate  0  11SEP2
020 11:00  
12SEP2
020 22:00  Pain Mil
d 1  11SEP2
020 11:0
0 
12SEP2
020 22:00  Ten
derness  Mod
erate  1  11SEP2
020 11:00  
02O
CT2020 19:30  Ten
derness  Mil
d 21 0 11SEP2
020 11:00  
03O
CT2020 20:00  Ten
derness  Mod
erate  22 1 11SEP2
020 11:00  
04O
CT2020 20:00  Ten
derness  Mod
erate  23 2 11SEP2
020 11:00  
20241  09SEP2
020 21:45  Pain Mil
d 0  09SEP2
020 10:30  
09SEP2
020 21:45  Ten
derness  Mil
d 0  09SEP2
020 10:30  
10SEP2
020 21:45  Pain Mil
d 1  09SEP2
020 10:30  
10SEP2
020 21:45  Ten
derness  Mil
d 1  09SEP2
020 10:30  
11SEP2
020 21:45  Pain Mil
d 2  09SEP2
020 10:30  
11SEP2
020 21:45  Ten
derness  Mil
d 2  09SEP2
020 10:30  
12SEP2
020 21:45  Ten
derness  Mil
d 3  09SEP2
020 10:30  
30SEP2
020 20:00  Pain Mil
d 21 0 09SEP2
020 10:30  
01O
CT2020  9:30  Pain Mil
d 22 1 09SEP2
020 10:30  
02O
CT2020  9:30  Pain Mil
d 23 2 09SEP2
020 10:30  
03O
CT2020  9:30  Pain Mil
d 24 3 09SEP2
020 10:30  
03O
CT2020  9:30  Ten
derness  Mil
d 24 3 09SEP2
020 10:30  
 
Progra
m: Lsa
f_locR_1.sas           (Page 48 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 48
FDA-CBER-2021-5683-0050043
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
Old
er 20241  04O
CT2020  9:30  Pain Mil
d 25 4 09SEP2
020 10:30  
04O
CT2020  9:30  Ten
derness  Mod
erate  25 4 09SEP2
020 10:30  
05O
CT2020  9:30  Pain Mil
d 26 5 09SEP2
020 10:30  
05O
CT2020  9:30  Ten
derness  Mod
erate  26 5 09SEP2
020 10:30  
06O
CT2020  9:30  Pain Mil
d 27 6 09SEP2
020 10:30  
06O
CT2020  9:30  Ten
derness  Mil
d 27 6 09SEP2
020 10:30  
07O
CT2020  9:07  Pain Mil
d 28 7 09SEP2
020 10:30  
07O
CT2020  9:07  Ten
derness  Mil
d 28 7 09SEP2
020 10:30  
20242  09SEP2
020 22:00  Pain Mil
d 0  09SEP2
020 10:00  
10SEP2
020 23:00  Pain Mil
d 1  09SEP2
020 10:00  
10SEP2
020 23:0
0 Ten
derness  Mil
d 1  09SEP2
020 10:00  
11SEP2
020 22:30  Pain Mil
d 2  09SEP2
020 10:00  
11SEP2
020 22:30  Ten
derness  Mil
d 2  09SEP2
020 10:00  
12SEP2
020 23:00  Pain Mil
d 3  09SEP2
020 10:00  
12SEP2
020 23:00  Ten
derness  Mil
d 3  09SEP2
020 10:00  
13SEP2
020 22:30  Pain Mil
d 4  09SEP2
020 10:00  
13SEP2
020 22:30  Ten
derness  Mil
d 4  09SEP2
020 10:00  
30 µg
 
Old
er 10350  25SEP2
020 20:00  Pain Mil
d 0  25SEP2
020  8:20  
 
Progra
m: Lsa
f_locR_1.sas           (Page 49 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 49
FDA-CBER-2021-5683-0050044
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM d
ata received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3-1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prim
e 
imm
unization  
30 µg
 
Old
er 10350  25SEP2
020 20:00  Ten
derness  Mil
d 0  25SEP2
020  8:20  
26SEP2
020 20:00  Pain Mil
d 1  25SEP2
020  8:20  
26SEP2
020 20:00  Ten
derness  Mil
d 1  25SEP2
020  8:20  
16O
CT2020 20:00  Pain Mod
erate  21 0 25SEP2
020  8:20  
16O
CT2020 20:00  Ten
derness  Mod
erate  21 0 25SEP2
020  8:20  
17O
CT2020 20:00  Pain Mil
d 22 1 25SEP2
020  8:20  
17O
CT2020 20:00  Ten
derness  Mil
d 22 1 25SEP2
020  8:20  
18O
CT2020 20:00  Pain Mil
d 23 2 25SEP2
020  8:20  
18O
CT2020 20:00  Ten
derness  Mil
d 23 2 25SEP2
020  8:20  
10351  25SEP2
020 20:45  Pain Mil
d 0  25SEP2
020  8:50  
25SEP2
020 20:45  Ten
derness  Mod
erate  0  25SEP2
020  8:50  
26SEP2
020 21:40  Pain Mil
d 1  25SEP2
020  8:50  
26SEP2
020 21:40  Ten
derness  Mil
d 1  25SEP2
020  8:50  
16O
CT2020  8:50  Pain Mod
erate  21 0 25SEP2
020  8:50  
16O
CT2020  8:50  Ten
derness  Mod
erate  21 0 25SEP2
020  8:50  
16O
CT2020 21:00  Pain Mod
erate  21 0 25SEP2
020  8:50  
16O
CT2020 21:00  Ten
derness  Mod
erate  21 0 25SEP2
020  8:50  
17O
CT2020 21:00  Pain Mod
erate  22 1 25SEP2
020  8:50 
 
Progra
m: Lsa
f_locR_1.sas           (Page 50 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 50
FDA-CBER-2021-5683-0050045
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV
2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of d
ays 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
Old
er 10351  17O
CT2020 21:00  Ten
derness  Mod
erate  22 1 25SEP2
020  8:50  
18O
CT2020 21:00  Pain Mil
d 23 2 25SEP2
020  8:50  
18O
CT2020 21:00  Ten
derness  Mil
d 23 2 25SEP2
020  8:50  
10353  22SEP2
020 19:00  Pain Mil
d 0  22SEP2
020  8:50  
22SEP2
020 19:00  Ten
derness  Mil
d 0  22SEP2
020  8:50  
22SEP2
020 19:00  Indu
ration/Swelling  Mil
d 0  22SEP2
020  8:50  
23SEP2
020 19:00  Pain Mil
d 1  22SEP2
020  8:50  
23SEP2
020 19:00  Ten
derness  Mil
d 1  22SEP2
020  8:50  
23SEP2
020 19:00  Indu
ration/Swelling  Mil
d 1  22SEP2
020  8:50  
24SEP2
020 20:00  Pain Mil
d 2  22SEP2
020  8:50  
24SEP2
020 20:00  Ten
derness  Mil
d 2  22SEP2
020  8:50  
24SEP2
020 20:00  Indu
ration/Swelling  Mil
d 2  22SEP2
020  8:50  
25SEP2
020 20:00  Pain Mil
d 3  22SEP2
020  8:50  
25SEP2
020 20:00  Ten
derness  Mil
d 3  22SEP2
020  8:50  
26SEP2
020 20:00  Ten
derness  Mil
d 4  22SEP2
020  8:50  
13O
CT2020 20:00  Pain Mod
erate  21 0 22SEP2
020  8:50  
13O
CT2020 20:00  Ten
derness  Mod
erate  21 0 22SEP2
020  8:50  
14O
CT2020 22:00  Pain Mod
erate  22 1 22SEP2
020  8:50  
 
Progra
m: Lsa
f_locR_1.sas           (Page 51 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 51
FDA-CBER-2021-5683-0050046
Bio
NTech RNA Phar
maceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
Old
er 10353  14O
CT2020 22:00  Ten
derness  Mod
erate  22 1 22SEP2
020  8:50  
10358  23SEP2
020 19:30  Pain Mil
d 0  23SEP2
020  8:31  
23SEP2
020 19:30  Ten
derness  Mil
d 0  23SEP2
020  8:31  
24SEP2
020 19:30  Pain Mod
erate  1  23SEP2
020  8:31  
24SEP2
020 19:30  Ten
derness  Mod
erate  1  23SEP2
020  8:31  
14O
CT2020  Pain Mil
d 21 0 23SEP2
020  8:31  
14O
CT2020  Ten
derness  Mil
d 21 0 23SEP2
020  8:31  
15O
CT2020 19:00  Pain Mil
d 22 1 23SEP2
020  8:31  
15O
CT2020 19:00  Ten
derness  Mil
d 22 1 23SEP2
020  8:31  
16O
CT2020 18:30  Pain Mil
d 23 2 23SEP2
020  8:31  
16O
CT2020 18:30  Ten
derness  Mil
d 23 2 23SEP2
020  8:31  
16O
CT2020 18:30  Erythe
ma/Redness  Mil
d 23 2 23SEP2
020  8:31  
17O
CT2020 18:30  Pain Mil
d 24 3 23SEP2
020  8:31  
17O
CT2020 18:30  Ten
derness  Mil
d 24 3 23SEP2
020  8:31  
17O
CT2020 18:30  Indu
ration/Swelling  Mil
d 24 3 23SEP2
020  8:31 
18O
CT2020 19:30  Pain Mil
d 25 4 23SEP2
020  8:31  
18O
CT2020 19:30  Ten
derness  Mil
d 25 4 23SEP2
020  8:31  
18O
CT2020 19:30  Indu
ration/Swelling  Mil
d 25 4 23SEP2
020  8:31  
 
Progra
m: Lsa
f_locR_1.sas           (Page 52 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 52
FDA-CBER-2021-5683-0050047
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on cl
ean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost  
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
Old
er 10358  19O
CT2020 19:00  Pain Mil
d 26 5 23SEP2
020  8:31  
19O
CT2020 19:00  Ten
derness  Mil
d 26 5 23SEP2
020  8:31  
19O
CT2020 19:00  Indu
ration/Swelling  Mil
d 26 5 23SEP2
020  8:31  
20O
CT2020 18:30  Pain Mil
d 27 6 23SEP2
020  8:31  
20O
CT2020 18:30  Ten
derness  Mil
d 27 6 23SEP2
020  8:31  
20O
CT2020 18:30  Indu
ration/Swelling  Mil
d 27 6 23SEP2
020  8:31  
10360  23SEP2
020 21:00  Pain Mil
d 0  23SEP2
020  9:00  
23SEP2
020 21:00  Ten
derness  Mil
d 0  23SEP2
020  9:00  
24SEP2
020 21:15  Pain Mil
d 1  23SEP2
020  9:00  
24SEP2
020 21:15  Ten
derness  Mil
d 1  23SEP2
020  9:00  
25SEP2
020 22:00  Pain Mil
d 2  23SEP2
020  9:00  
25SEP2
020 22:00  Ten
derness  Mil
d 2  23SEP2
020  9:00  
14O
CT2020 22:00  Pain Mil
d 21 0 23SEP2
020  9:00  
14O
CT2020 22:00  Ten
derness  Mil
d 21 0 23SEP2
020  9:00  
15O
CT2020 21:30  Pain Mil
d 22 1 23SEP2
020  9:00  
15O
CT2020 21:30  Ten
derness  Mil
d 22 1 23SEP2
020  9:00  
10361  25SEP2
020 22:30  Pain Mil
d 0  25SEP2
020  9:20  
25SEP2
020 22:30  Ten
derness  Mil
d 0  25SEP2
020  9:20  
 
Progra
m: Lsa
f_locR_1.sas           (Page 53 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 53
FDA-CBER-2021-5683-0050048
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
Old
er 10361  26SEP2
020 22:15  Pain Mil
d 1  25SEP2
020  9:20  
26SEP2
020 22:15  Ten
derness  Mil
d 1  25SEP2
020  9:20  
27SEP2
020 23:00  Ten
derness  Mil
d 2  25SEP2
020  9:20  
16O
CT2020 22:30  Pain Mod
erate  21 0 25SEP2
020  9:20  
16O
CT2020 22:30  Ten
derness  Mod
erate  21 0 25SEP2
020  9:20  
17O
CT2020 23:00  Pain Mil
d 22 1 25SEP2
020  9:20  
17O
CT2020 23:00  Ten
derness  Mod
erate  22 1 25SEP2
020  9:20 
18O
CT2020 23:30  Ten
derness  Mil
d 23 2 25SEP2
020  9:20  
10362  26SEP2
020 20:45  Pain Mil
d 1  25SEP2
020  9:50  
26SEP2
020 20:45  Ten
derness  Mil
d 1  25SEP2
020  9:50  
27SEP2
020 20:45  Ten
derness  Mil
d 2  25SEP2
020  9:50  
10363  25SEP2
020 21:30  Ten
derness  Mod
erate  0  25SEP2
020 10:20  
26SEP2
020 21:30  Ten
derness  Mod
erate  1  25SEP2
020 10:20  
16O
CT2020 21:45  Pain Mil
d 21 0 25SEP2
020 10:20  
16O
CT2020 21:45  Ten
derness  Mil
d 21 0 25SEP2
020 10:20  
17O
CT2020 21:45  Pain Mil
d 22 1 25SEP2
020 10:20  
17O
CT2020 21:
45 Ten
derness  Mod
erate  22 1 25SEP2
020 10:20  
10364  25SEP2
020 22:00  Ten
derness  Mil
d 0  25SEP2
020 10:50  
 
Progra
m: Lsa
f_locR_1.sas           (Page 54 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 54
FDA-CBER-2021-5683-0050049
Bio
NTech RNA Phar
maceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
Old
er 10364  26SEP2
020 22:00  Ten
derness  Mil
d 1  25SEP2
020 10:50  
16O
CT2020 21:30  Ten
derness  Mil
d 21 0 25SEP2
020 10:50  
17O
CT2020 21:00  Ten
derness  Mod
erate  22 1 25SEP2
020 10:50  
18O
CT2020 20:30  Ten
derness  Mil
d 23 2 25SEP2
020 10:50  
10365  23SEP2
020 20:00  Pain Mil
d 0  23SEP2
020  9:43  
23SEP2
020 20:0
0 Ten
derness  Mil
d 0  23SEP2
020  9:43  
24SEP2
020 20:00  Pain Mil
d 1  23SEP2
020  9:43  
24SEP2
020 20:00  Ten
derness  Mil
d 1  23SEP2
020  9:43  
25SEP2
020 20:00  Pain Mil
d 2  23SEP2
020  9:43  
25SEP2
020 20:00  Ten
derness  Mil
d 2  23SEP2
020  9:43  
14O
CT2020 21:00  Pain Mil
d 21 0 23SEP2
020  9:43  
14O
CT2020 21:00  Ten
derness  Mil
d 21 0 23SEP2
020  9:43  
15O
CT2020 21:00  Pain Mil
d 22 1 23SEP2
020  9:43  
15O
CT2020 21:00  Ten
derness  Mil
d 22 1 23SEP2
020  9:43  
16O
CT2020 21:00  Pain Mil
d 23 2 23SEP2
020  9:43 
16O
CT2020 21:00  Ten
derness  Mil
d 23 2 23SEP2
020  9:43  
16O
CT2020 21:00  Erythe
ma/Redness  Mil
d 23 2 23SEP2
020  9:43  
16O
CT2020 21:00  Indu
ration/Swelling  Mil
d 23 2 23SEP2
020  9:43  
 
Progra
m: Lsa
f_locR_1.sas           (Page 55 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 55
FDA-CBER-2021-5683-0050050
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20
NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.1-1: Lis
ting of solicited local reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Loc
al reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost  
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
Old
er 10365  17O
CT2020 21:30  Pain Mil
d 24 3 23SEP2
020  9:43  
17O
CT2020 21:30  Ten
derness  Mil
d 24 3 23SEP2
020  9:43  
17O
CT2020 21:30  Erythe
ma/Redness  Mil
d 24 3 23SEP2
020  9:43  
18O
CT2020 21:00  Erythe
ma/Redness  Mil
d 25 4 23SEP2
020  9:43  
10366  23SEP2
020 21:00  Pain Mil
d 0  23SEP2
020 10:13  
 
Progra
m: Lsa
f_locR_1.sas           (Page 56 of 56) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 56
FDA-CBER-2021-5683-0050051
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on  clea
n SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boo
st 
imm
unization  Date/t
ime of prime 
imm
unization  
1 µg 
You
nger 10015  29APR20
20 23:00  Heada
che Mil
d 0  29APR20
20  9:23  
29APR20
20 23:00  Fatig
ue Mil
d 0  29APR20
20  9:23  
20M
AY2020 23:00  Heada
che Mod
erate  21 0 29APR20
20  9:23  
10018  29APR20
20 Heada
che Mil
d 0  29APR20
20  9:53  
29APR20
20 Fatig
ue Mil
d 0  29APR20
20  9:53  
10025  05M
AY2020 20:45  Fatig
ue Mil
d 0  05M
AY2020  9:06  
05M
AY2020 20:45  Chill
s Mil
d 0  05M
AY2020  9:06  
26M
AY2020 22:00  Heada
che Mil
d 21 0 05M
AY2020  9:06  
26M
AY2020 22:00  Fatig
ue Mil
d 21 0 05M
AY2020  9:06  
26M
AY2020 22:00  Mya
lgia Mil
d 21 0 05M
AY2020  9:06  
26M
AY2020 22:00  Chill
s Mil
d 21 0 05M
AY2020  9:06  
27M
AY2020 22:00  Heada
che Mil
d 22 1 05M
AY2020  9:06  
27M
AY2020 22:00  Fatig
ue Mod
erate  22 1 05M
AY2020  9:06  
28M
AY2020 21:0
0 Fatig
ue Mod
erate  23 2 05M
AY2020  9:06  
29M
AY2020 22:00  Fatig
ue Mil
d 24 3 05M
AY2020  9:06  
30M
AY2020 22:00  Fatig
ue Mil
d 25 4 05M
AY2020  9:06  
10033  27M
AY2020 20:00  Heada
che Mil
d 22 1 05M
AY2020 10:03  
27M
AY2020 20:00  Fatig
ue Mod
erate  22 1 05M
AY2020 10:03  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 1 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 57
FDA-CBER-2021-5683-0050052
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
1 µg 
You
nger 10033  27M
AY2020 20:00  Mya
lgia Mil
d 22 1 05M
AY2020 10:03  
27M
AY2020 20:00  Arthral
gia Mil
d 22 1 05M
AY2020 10:03  
27M
AY2020 20:00  Chill
s Mil
d 22 1 05M
AY2020 10:03  
10036  29M
AY2020 18:00  Heada
che Mod
erate  21 0 08M
AY2020  8:30  
29M
AY2020 18:00  Mya
lgia Mod
erate  21 0 08M
AY2020  8:30  
29M
AY2020 18:00  Chill
s Mod
erate  21 0 08M
AY2020  8:30  
29M
AY2020 18:00  Feve
r Seve
re 21 0 08M
AY2020  8:30  
30M
AY2020 18:00  Heada
che Mod
erate  22 1 08M
AY2020  8:30  
10040  08M
AY2020 20:32  Fatig
ue Mil
d 0  08M
AY2020  8:51  
09M
AY2020 21:23  Fatig
ue Mil
d 1  08M
AY2020  8:51  
13M
AY2020 21:49  Heada
che Mil
d 5  08M
AY2020  8:51  
13M
AY2020 21:4
9 Fatig
ue Mil
d 5  08M
AY2020  8:51  
13M
AY2020 21:49  Mya
lgia Mil
d 5  08M
AY2020  8:51  
13M
AY2020 21:49  Mal
aise Mod
erate  5  08M
AY2020  8:51  
29M
AY2020 22:12  Heada
che Mod
erate  21 0 08M
AY2020  8:51  
29M
AY2020 22:12  Fatig
ue Mod
erate  21 0 08M
AY2020  8:51 
29M
AY2020 22:12  Los
s of Appetite  Mil
d 21 0 08M
AY2020  8:51  
29M
AY2020 22:12  Mal
aise Mil
d 21 0 08M
AY2020  8:51  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 2 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 58
FDA-CBER-2021-5683-0050053
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM d
ata received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reacti
ons - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
1 µg 
You
nger 10040  30M
AY2020 21:19  Nause
a Mil
d 22 1 08M
AY2020  8:51  
30M
AY2020 21:19  Heada
che Mod
erate  22 1 08M
AY2020  8:51  
30M
AY2020 21:19  Fatig
ue Mod
erate  22 1 08M
AY2020  8:51  
30M
AY2020 21:19  Mya
lgia Mod
erate  22 1 08M
AY2020  8:51  
30M
AY2020 21:19  Arthral
gia Mod
erate  22 1 08M
AY2020  8:51  
30M
AY2020 21:19  Los
s of Appetite  Mil
d 22 1 08M
AY2020  8:51  
30M
AY2020 21:19  Mal
aise Mod
erate  22 1 08M
AY2020  8:51  
31M
AY2020 21:05  Heada
che Mod
erate  23 2 08M
AY2020  8:51  
31M
AY2020 21:05  Fatig
ue Seve
re 23 2 08M
AY2020  8:51 
31M
AY2020 21:05  Mya
lgia Mod
erate  23 2 08M
AY2020  8:51  
31M
AY2020 21:05  Los
s of Appetite  Mil
d 23 2 08M
AY2020  8:51  
31M
AY2020 21:05  Mal
aise Mod
erate  23 2 08M
AY2020  8:51  
01J
UN2020 21:10  Nause
a Mil
d 24 3 08M
AY2020  8:51  
01J
UN2020 21:10  Heada
che Mil
d 24 3 08M
AY2020  8:51  
01J
UN2020 21:10  Fatig
ue Mod
erate  24 3 08M
AY2020  8:51  
01J
UN2020 21:10  Mya
lgia Mil
d 24 3 08M
AY2020  8:51  
01J
UN2020 21:10  Arthral
gia Mil
d 24 3 08M
AY2020  8:51  
01J
UN2020 21:10  Los
s of Appetite  Mil
d 24 3 08M
AY2020   8:51 
 
Progra
m: Lsa
f_sysR_1.sas           (Page 3 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 59
FDA-CBER-2021-5683-0050054
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20
NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
1 µg 
You
nger 10040  01J
UN2020 21:10  Mal
aise Mil
d 24 3 08M
AY2020  8:51  
02J
UN2020 21:00  Nause
a Mil
d 25 4 08M
AY2020  8:51  
02J
UN2020 21:00  Heada
che Mod
erate  25 4 08M
AY2020  8:51  
02J
UN2020 21:00  Fatig
ue Mil
d 25 4 08M
AY2020  8:51  
02J
UN2020 21:00  Mya
lgia Mod
erate  25 4 08M
AY2020  8:51  
02J
UN2020 21:00  Arthral
gia Mod
erate  25 4 08M
AY2020  8:51  
02J
UN2020 21:00  Los
s of Appetite  Mil
d 25 4 08M
AY2020  8:51  
02J
UN2020 21:00  Mal
aise Mil
d 25 4 08M
AY2020  8:51  
03J
UN2020 21:15  Heada
che Mil
d 26 5 08M
AY2020  8:51  
03J
UN2020 21:15  Fatig
ue Mil
d 26 5 08M
AY2020  8:51  
03J
UN2020 21:15  Mya
lgia Mil
d 26 5 08M
AY2020  8:51  
03J
UN2020 21:15  Arthral
gia Mil
d 26 5 08M
AY2020  8:51  
10041  08M
AY2020 20:31  Diarrhe
a Mil
d 0  08M
AY2020  9:06  
09M
AY2020 21:23  Fatig
ue Mil
d 1  08M
AY2020  9:06  
10M
AY2020 21:28  Fatig
ue Mil
d 2  08M
AY2020  9:06  
11M
AY2020 21:17  Fatig
ue Mil
d 3  08M
AY2020  9:06  
13M
AY2020 21:50  Fatig
ue Mil
d 5  08M
AY2020  9:06  
13M
AY2020 21:50  Chill
s Mil
d 5  08M
AY2020  9:06  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 4 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 60
FDA-CBER-2021-5683-0050055
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
1 µg 
You
nger 10041  13M
AY2020 21:50  Mal
aise Mil
d 5  08M
AY2020  9:06  
14M
AY2020 21:40  Nause
a Mil
d 6  08M
AY2020  9:06  
14M
AY2020 21:40  Diarrhe
a Mil
d 6  08M
AY2020  9:06  
14M
AY2020 21:40  Heada
che Mod
erate  6  08M
AY2020  9:06  
14M
AY2020 21:40  Fatig
ue Mil
d 6  08M
AY2020  9:06  
29M
AY2020 22:12  Nause
a Mod
erate  21 0 08M
AY2020  9:06  
29M
AY2020 22:12  Heada
che Mod
erate  21 0 08M
AY2020  9:06  
29M
AY2020 22:12  Fatig
ue Mod
erate  21 0 08M
AY2020  9:06  
29M
AY2020 22:12  Mya
lgia Mod
erate  21 0 08M
AY2020  9:06  
29M
AY2020 22:12  Los
s of Appetite  Mod
erate  21 0 08M
AY2020  9:06  
29M
AY2020 22:12  Mal
aise Mil
d 21 0 08M
AY2020  9:06  
30M
AY2020 21:19  Nause
a Mod
erate  22 1 08M
AY2020  9:06  
30M
AY2020 21:19  Heada
che Mod
erate  22 1 08M
AY2020  9:06  
30M
AY2020 21:19  Mya
lgia Mod
erate  22 1 08M
AY2020  9:06  
30M
AY2020 21:1
9 Chill
s Mil
d 22 1 08M
AY2020  9:06  
30M
AY2020 21:19  Los
s of Appetite  Mod
erate  22 1 08M
AY2020  9:06  
30M
AY2020 21:19  Mal
aise Mod
erate  22 1 08M
AY2020  9:06  
31M
AY2020 21:05  Heada
che Mil
d 23 2 08M
AY2020  9:06  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 5 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 61
FDA-CBER-2021-5683-0050056
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of day
s 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
1 µg 
You
nger 10041  31M
AY2020 21:05  Fatig
ue Mil
d 23 2 08M
AY2020  9:06  
31M
AY2020 21:05  Los
s of Appetite  Seve
re 23 2 08M
AY2020  9:06  
31M
AY2020 21:05  Mal
aise Mod
erate  23 2 08M
AY2020  9:06  
01J
UN2020 21:14  Los
s of Appetite  Seve
re 24 3 08M
AY2020  9:06  
01J
UN2020 21:14  Mal
aise Mod
erate  24 3 08M
AY2020  9:06  
02J
UN2020 21:32  Nause
a Mod
erate  25 4 08M
AY2020  9:06  
02J
UN2020 21:32  Los
s of Appetite  Mod
erate  25 4 08M
AY2020  9:06  
02J
UN2020 21:32  Mal
aise Mod
erate  25 4 08M
AY2020  9:06  
03J
UN2020 21:36  Los
s of Appetite  Mod
erate  26 5 08M
AY2020  9:06  
03J
UN2020 21:36  Mal
aise Mod
erate  26 5 08M
AY2020  9:06  
10042  08M
AY2020 22:00  Fatig
ue Mil
d 0  08M
AY2020  9:22  
10045  05M
AY2020 20:30  Fatig
ue Mil
d 0  05M
AY2020 10:33  
10048  08M
AY2020 20:06  Fatig
ue Mil
d 0  08M
AY2020  9:36  
10052  08M
AY2020 23:00  Heada
che Mil
d 0  08M
AY2020  9:51  
13M
AY2020 23:40  Heada
che Mod
erate  5  08M
AY2020  9:51  
30M
AY2020 23:4
4 Fatig
ue Mod
erate  22 1 08M
AY2020  9:51  
02J
UN2020  Heada
che Mod
erate  25 4 08M
AY2020  9:51  
3 µg 
You
nger 10170  31J
UL2020 20:00  Fatig
ue Mod
erate  0  31J
UL2020  8:00  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 6 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 62
FDA-CBER-2021-5683-0050057
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3-1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of p
rime 
imm
unization  
3 µg 
You
nger 10170  01AUG
2020 20:05  Fatig
ue Mil
d 1  31J
UL2020  8:00  
21AUG
2020 20:04  Heada
che Mil
d 21 0 31J
UL2020  8:00  
21AUG
2020 20:04  Fatig
ue Mil
d 21 0 31J
UL2020  8:00  
10194  22J
UL2020 21:15  Heada
che Mil
d 0  22J
UL2020  8:00  
22J
UL2020 21:15  Fatig
ue Mil
d 0  22J
UL2020  8:00  
12AUG
2020 22:15  Heada
che Mod
erate  21 0 22J
UL2020  8:00  
12AUG
2020 22:15  Fatig
ue Mil
d 21 0 22J
UL2020  8:00  
12AUG
2020 22:15  Mal
aise Mod
erate  21 0 22J
UL2020  8:00  
13AUG
2020 21:45  Heada
che Mil
d 22 1 22J
UL2020  8:00  
13AUG
2020 21:45  Fatig
ue Mil
d 22 1 22J
UL2020  8:00  
13AUG
2020 21:45  Mya
lgia Mil
d 22 1 22J
UL2020  8:00  
13AUG
2020 21:45  Mal
aise Mil
d 22 1 22J
UL2020  8:00  
17AUG
2020 22:00  Heada
che Mil
d 26 5 22J
UL2020  8:00  
17AUG
2020 22:00  Mal
aise Mil
d 26 5 22J
UL2020  8:00  
10204  25J
UL2020 23:15  Heada
che Mil
d 3  22J
UL2020  8:45  
10212  23J
UL2020 21:30  Fatig
ue Mil
d 1  22J
UL2020  9:15  
24J
UL2020 20:30  Diarrhe
a Mil
d 2  22J
UL2020  9:15  
24J
UL2020 20:30  Fatig
ue Mil
d 2  22J
UL2020  9:15  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 7 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 63
FDA-CBER-2021-5683-0050058
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of day
s 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
3 µg 
You
nger 10212  12AUG
2020 21:30  Fatig
ue Mil
d 21 0 22J
UL2020  9:15  
13AUG
2020 20:00  Nause
a Mil
d 22 1 22J
UL2020  9:15  
13AUG
2020 20:00  Heada
che Mod
erate  22 1 22J
UL2020  9:15  
13AUG
2020 20:00  Fatig
ue Mod
erate  22 1 22J
UL2020  9:15  
13AUG
2020 20:00  Arthral
gia Mod
erate  22 1 22J
UL2020  9:15  
13AUG
2020 20:00  Los
s of Appetite  Mil
d 22 1 22J
UL2020  9:15  
13AUG
2020 20:00  Mal
aise Mod
erate  22 1 22J
UL2020  9:15  
13AUG
2020 20:00  Feve
r Mod
erate  22 1 22J
UL2020  9:15  
14AUG
2020 20:00  Fatig
ue Mil
d 23 2 22J
UL2020  9:15  
14AUG
2020 20:00  Mal
aise Mil
d 23 2 22J
UL2020  9:15  
10221  31J
UL2020 20:00  Heada
che Mil
d 0  31J
UL2020  9:00  
31J
UL2020 20:00  Fatig
ue Mod
erate  0  31J
UL2020  9:00  
02AUG
2020 20:00  Fatig
ue Mil
d 2  31J
UL2020  9:00  
21AUG
2020 20:00  Fatig
ue Mil
d 21 0 31J
UL2020  9:00  
10224  23AUG
2020 20:00  Heada
che Mod
erate  23 2 31J
UL2020  8:15  
23AUG
2020 20:00  Fatig
ue Mod
erate  23 2 31J
UL2020  8:15 
25AUG
2020 19:00  Heada
che Mil
d 25 4 31J
UL2020  8:15  
25AUG
2020 19:00  Fatig
ue Mil
d 25 4 31J
UL2020  8:15  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 8 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 64
FDA-CBER-2021-5683-0050059
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
3 µg 
You
nger 10224  26AUG
2020 20:0
0 Fatig
ue Mil
d 26 5 31J
UL2020  8:15  
10225  31J
UL2020 20:15  Heada
che Mil
d 0  31J
UL2020  8:30  
31J
UL2020 20:15  Fatig
ue Mod
erate  0  31J
UL2020  8:30  
10226  31J
UL2020 20:00  Heada
che Mil
d 0  31J
UL2020  8:45  
31J
UL2020 20:00  Fatig
ue Mod
erate  0  31J
UL2020  8:45  
01AUG
2020 20:00  Heada
che Mil
d 1  31J
UL2020  8:45  
01AUG
2020 20:00  Fatig
ue Mil
d 1  31J
UL2020  8:45  
01AUG
2020 20:00  Chill
s Mil
d 1  31J
UL2020  8:45  
02AUG
2020 20:00  Heada
che Mil
d 2  31J
UL2020  8:45  
02AUG
2020 20:00  Fatig
ue Mil
d 2  31J
UL2020  8:45  
02AUG
2020 20:00  Chill
s Mil
d 2  31J
UL2020  8:45  
03AUG
2020 20:00  Heada
che Mil
d 3  31J
UL2020  8:45  
03AUG
2020 20:00  Fatig
ue Mil
d 3  31J
UL2020  8:45  
03AUG
2020 20:00  Chill
s Mil
d 3  31J
UL2020  8:45  
04AUG
2020 20:00  Chill
s Mil
d 4  31J
UL2020  8:45  
05AUG
2020 20:00  Chill
s Mil
d 5  31J
UL2020  8:45  
06AUG
2020 20:00  Chill
s Mil
d 6  31J
UL2020  8:45  
07AUG
2020  8:11  Chill
s Mil
d 7  31J
UL2020  8:45  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 9 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 65
FDA-CBER-2021-5683-0050060
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data  rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3-1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of p
rime 
imm
unization  
3 µg 
You
nger 10226  21AUG
2020 20:00  Heada
che Mil
d 21 0 31J
UL2020  8:45  
21AUG
2020 20:00  Fatig
ue Seve
re 21 0 31J
UL2020  8:45  
21AUG
2020 20:00  Mya
lgia Mil
d 21 0 31J
UL2020  8:45  
22AUG
2020 20:00  Heada
che Mod
erate  22 1 31J
UL2020  8:45 
22AUG
2020 20:00  Fatig
ue Mod
erate  22 1 31J
UL2020  8:45  
22AUG
2020 20:00  Mya
lgia Mil
d 22 1 31J
UL2020  8:45  
23AUG
2020 20:00  Heada
che Mod
erate  23 2 31J
UL2020  8:45  
23AUG
2020 20:00  Fatig
ue Mod
erate  23 2 31J
UL2020  8:45  
23AUG
2020 20:00  Mya
lgia Mil
d 23 2 31J
UL2020  8:45  
23AUG
2020 20:00  Chill
s Mil
d 23 2 31J
UL2020  8:45  
24AUG
2020 20:00  Heada
che Mil
d 24 3 31J
UL2020  8:45  
24AUG
2020 20:00  Fatig
ue Mil
d 24 3 31J
UL2020  8:45  
24AUG
2020 20:00  Mya
lgia Mil
d 24 3 31J
UL2020  8:45  
24AUG
2020 20:0
0 Chill
s Mil
d 24 3 31J
UL2020  8:45  
25AUG
2020 20:00  Fatig
ue Mil
d 25 4 31J
UL2020  8:45  
25AUG
2020 20:00  Mya
lgia Mil
d 25 4 31J
UL2020  8:45  
26AUG
2020 20:00  Fatig
ue Mil
d 26 5 31J
UL2020  8:45  
10227  06AUG
2020 18:00  Heada
che Mil
d 6  31J
UL2020  9:15  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 10 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 66
FDA-CBER-2021-5683-0050061
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of day
s 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
3 µg 
You
nger 10227  21AUG
2020  Heada
che Mod
erate  21 0 31J
UL2020  9:15  
10 µg
 
You
nger 10003  19M
AY2020 20:35  Heada
che Mil
d 21 0 28APR20
20  8:30  
10004  25APR20
20 21:00  Diarrhe
a Mil
d 1  24APR20
20  9:15  
26APR20
20 21:30  Diarrhe
a Mil
d 2  24APR20
20  9:15  
15M
AY2020 21:30  Nause
a Mod
erate  21 0 24APR20
20  9:15  
15M
AY2020 21:30  Heada
che Mod
erate  21 0 24APR20
20  9:15  
15M
AY2020 21:30  Fatig
ue Mil
d 21 0 24APR20
20  9:15  
15M
AY2020 21:30  Arthral
gia Mil
d 21 0 24APR20
20  9:15  
15M
AY2020 21:30  Chill
s Seve
re 21 0 24APR20
20  9:15  
16M
AY2020 22:15  Heada
che Mil
d 22 1 24APR20
20  9:15  
16M
AY2020 22:15  Fatig
ue Mil
d 22 1 24APR20
20  9:15  
16M
AY2020 22:15  Mya
lgia Mil
d 22 1 24APR20
20  9:15  
16M
AY2020 22:15  Arthral
gia Mil
d 22 1 24APR20
20  9:15  
16M
AY2020 22:15  Chill
s Mil
d 22 1 24APR20
20  9:15  
16M
AY2020 22:15  Los
s of Appetite  Mil
d 22 1 24APR20
20  9:15  
16M
AY2020 22:15  Mal
aise Mil
d 22 1 24APR20
20  9:15  
17M
AY2020 23:15  Fatig
ue Mil
d 23 2 24APR20
20  9:15  
17M
AY2020 23:15  Mya
lgia Mil
d 23 2 24APR20
20  9:15  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 11 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 67
FDA-CBER-2021-5683-0050062
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
10 µg
 
You
nger 10004  17M
AY2020 23:1
5 Arthral
gia Mil
d 23 2 24APR20
20  9:15  
10005  24APR20
20 13:00  Heada
che Mod
erate  0  24APR20
20 11:15  
24APR20
20 13:00  Fatig
ue Mod
erate  0  24APR20
20 11:15  
25APR20
20 19:30  Heada
che Mil
d 1  24APR20
20 11:15  
25APR20
20 19:30  Fatig
ue Mil
d 1  24APR20
20 11:
15 
28APR20
20 19:45  Fatig
ue Mil
d 4  24APR20
20 11:15  
15M
AY2020 19:00  Heada
che Mil
d 21 0 24APR20
20 11:15  
15M
AY2020 19:00  Fatig
ue Mod
erate  21 0 24APR20
20 11:15  
15M
AY2020 19:00  Mya
lgia Mil
d 21 0 24APR20
20 11:15  
15M
AY2020 19:00  Chill
s Mod
erate  21 0 24APR20
20 11:15  
16M
AY2020 19:00  Fatig
ue Mod
erate  22 1 24APR20
20 11:15  
16M
AY2020 19:00  Mya
lgia Mod
erate  22 1 24APR20
20 11:15  
16M
AY2020 19:00  Arthral
gia Mod
erate  22 1 24APR20
20 11:15  
16M
AY2020 19:00  Chill
s Mod
erate  22 1 24APR20
20 11:15  
16M
AY2020 19:00  Los
s of Appetite  Mod
erate  22 1 24APR20
20 11:15  
16M
AY2020 19:00  Mal
aise Mod
erate  22 1 24APR20
20 11:15  
17M
AY2020 19:00  Heada
che Mod
erate  23 2 24APR20
20 11:15  
17M
AY2020 19:00  Fatig
ue Mod
erate  23 2 24APR20
20 11:15  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 12 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 68
FDA-CBER-2021-5683-0050063
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of day
s 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
10 µg
 
You
nger 10005  18M
AY2020 19:00  Fatig
ue Mil
d 24 3 24APR20
20 11:15  
19M
AY2020 19:00  Fatig
ue Mod
erate  25 4 24APR20
20 11:15  
19M
AY2020 19:00  Mal
aise Mil
d 25 4 24APR20
20 11:15  
20M
AY2020 19:00  Fatig
ue Mod
erate  26 5 24APR20
20 11:15  
21M
AY2020 19:00  Fatig
ue Mod
erate  27 6 24APR20
20 11:15  
21M
AY2020 19:00  Mal
aise Mil
d 27 6 24APR20
20 11:15  
22M
AY2020 19:00  Fatig
ue Mod
erate  28 7 24APR20
20 11:15  
10006  29APR20
20 22:00  Heada
che Mil
d 1  28APR20
20  9:00  
29APR20
20 22:00  Fatig
ue Mil
d 1  28APR20
20  9:00  
19M
AY2020 22:00  Fatig
ue Mil
d 21 0 28APR20
20  9:00  
19M
AY2020 22:00  Chill
s Mil
d 21 0 28APR20
20  9:00  
19M
AY2020 22:00  Feve
r Seve
re 21 0 28APR20
20  9:00  
20M
AY2020 22:00  Nause
a Mil
d 22 1 28APR20
20  9:00  
20M
AY2020 22:00  Fatig
ue Mod
erate  22 1 28APR20
20  9:00  
20M
AY2020 22:00  Mya
lgia Mil
d 22 1 28APR20
20  9:00  
20M
AY2020 22:00  Chill
s Mil
d 22 1 28APR20
20  9:00  
20M
AY2020 22:00  Mal
aise Mil
d 22 1 28APR20
20  9:00  
20M
AY2020 22:00  Feve
r Mil
d 22 1 28APR20
20  9:00  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 13 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 69
FDA-CBER-2021-5683-0050064
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect num
ber Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
10 µg
 
You
nger 10007   Heada
che Mod
erate    23APR20
20 11:08  
 Los
s of App
etite Mil
d   23APR20
20 11:08  
 Mal
aise Mil
d   23APR20
20 11:08  
23APR20
20 20:00  Heada
che Mod
erate  0  23APR20
20 11:08  
24APR20
20  9:00  Heada
che Mil
d 1  23APR20
20 11:08  
24APR20
20  9:00  Mya
lgia Mil
d 1  23APR20
20 11:08  
25APR20
20  9:00  Heada
che Mil
d 2  23APR20
20 11:08  
25APR20
20  9:00  Fatig
ue Mil
d 2  23APR20
20 11:08  
26APR20
20  8:00  Heada
che Mod
erate  3  23APR20
20 11:08  
26APR20
20  8:00  Fatig
ue Mil
d 3  23APR20
20 11:08  
27APR20
20  9:00  Heada
che Mod
erate  4  23APR20
20 11:08  
27APR20
20  9:00  Fatig
ue Mil
d 4  23APR20
20 11:08  
28APR20
20  9:00  Heada
che Mil
d 5  23APR20
20 11:08  
14M
AY2020  Heada
che Mil
d 21 0 23APR20
20 11:08  
14M
AY2020  Fatig
ue Mil
d 21 0 23APR20
20 11:08  
14M
AY2020  Mya
lgia Mod
erate  21 0 23APR20
20 11:08  
14M
AY2020  Mal
aise Mil
d 21 0 23APR20
20 11:08  
15M
AY2020 20:00  Heada
che Mod
erate  22 1 23APR20
20 11:08  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 14 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 70
FDA-CBER-2021-5683-0050065
Bio
NTech RNA Phar
maceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
10 µg
 
You
nger 10007  15M
AY2020 20:00  Fatig
ue Mod
erate  22 1 23APR20
20 11:08  
15M
AY2020 20:00  Mya
lgia Mil
d 22 1 23APR20
20 11:08  
15M
AY2020 20:00  Mal
aise Mil
d 22 1 23APR20
20 11:08  
16M
AY2020 20:00  Heada
che Mil
d 23 2 23APR20
20 11:08  
16M
AY2020 20:00  Fatig
ue Mil
d 23 2 23APR20
20 11:08  
16M
AY2020 20:00  Mya
lgia Mil
d 23 2 23APR20
20 11:08  
16M
AY2020 20:00  Mal
aise Mil
d 23 2 23APR20
20 11:08  
17M
AY2020 20:00  Heada
che Mil
d 24 3 23APR20
20 11:08  
17M
AY2020 20:00  Mya
lgia Mil
d 24 3 23APR20
20 11:08  
18M
AY2020 20:00  Heada
che Mil
d 25 4 23APR20
20 11:08  
18M
AY2020 20:0
0 Mya
lgia Mil
d 25 4 23APR20
20 11:08  
10008  28APR20
20 22:00  Fatig
ue Mil
d 0  28APR20
20  9:30  
19M
AY2020 22:00  Nause
a Seve
re 21 0 28APR20
20  9:30  
19M
AY2020 22:00  Heada
che Mil
d 21 0 28APR20
20  9:30  
19M
AY2020 22:00  Fatig
ue Mod
erate  21 0 28APR20
20  9:30 
19M
AY2020 22:00  Chill
s Seve
re 21 0 28APR20
20  9:30  
19M
AY2020 22:00  Los
s of Appetite  Seve
re 21 0 28APR20
20  9:30  
19M
AY2020 22:00  Mal
aise Seve
re 21 0 28APR20
20  9:30  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 15 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 71
FDA-CBER-2021-5683-0050066
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo GmbH. B
ased on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boo
st 
imm
unization  Date/t
ime of prime 
imm
unization  
10 µg
 
You
nger 10008  19M
AY2020 22:00  Feve
r Mil
d 21 0 28APR20
20  9:30  
20M
AY2020 22:00  Nause
a Mil
d 22 1 28APR20
20  9:30  
20M
AY2020 22:00  Fatig
ue Mil
d 22 1 28APR20
20  9:30  
20M
AY2020 22:00  Chill
s Mil
d 22 1 28APR20
20  9:30  
20M
AY2020 22:00  Los
s of Appetite  Mil
d 22 1 28APR20
20  9:30  
20M
AY2020 22:00  Mal
aise Mil
d 22 1 28APR20
20  9:30  
10009  28APR20
20 21:00  Fatig
ue Mil
d 0  28APR20
20 10:00  
19M
AY2020 22:00  Heada
che Mil
d 21 0 28APR20
20 10:00  
19M
AY2020 22:00  Fatig
ue Mil
d 21 0 28APR20
20 10:00  
19M
AY2020 22:00  Mya
lgia Mil
d 21 0 28APR20
20 10:00  
20M
AY2020 19:00  Heada
che Mil
d 22 1 28APR20
20 10:00  
20M
AY2020 19:00  Fatig
ue Mil
d 22 1 28APR20
20 10:00  
20M
AY2020 19:00  Mya
lgia Mil
d 22 1 28APR20
20 10:
00 
20M
AY2020 19:00  Chill
s Mil
d 22 1 28APR20
20 10:00  
20M
AY2020 19:00  Los
s of Appetite  Mil
d 22 1 28APR20
20 10:00  
10010  24APR20
20 18:15  Fatig
ue Mil
d 0  24APR20
20 12:15  
25APR20
20 18:15  Nause
a Seve
re 1  24APR20
20 12:15  
25APR20
20 18:15  Heada
che Seve
re 1  24APR20
20 12:15  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 16 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 72
FDA-CBER-2021-5683-0050067
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
10 µg
 
You
nger 10010  25APR20
20 18:15  Fatig
ue Seve
re 1  24APR20
20 12:15  
25APR20
20 18:15  Mya
lgia Mod
erate  1  24APR20
20 12:
15 
25APR20
20 18:15  Arthral
gia Mod
erate  1  24APR20
20 12:15  
25APR20
20 18:15  Chill
s Seve
re 1  24APR20
20 12:15  
25APR20
20 18:15  Los
s of Appetite  Mil
d 1  24APR20
20 12:15  
25APR20
20 18:15  Mal
aise Mod
erate  1  24APR20
20 12:15  
26APR20
20 18:15  Nause
a Mod
erate  2  24APR20
20 12:15  
26APR20
20 18:15  Diarrhe
a Mod
erate  2  24APR20
20 12:15  
26APR20
20 18:15  Heada
che Seve
re 2  24APR20
20 12:15  
26APR20
20 18:15  Fatig
ue Mod
erate  2  24APR20
20 12:15  
26APR20
20 18:15  Mya
lgia Mod
erate  2  24APR20
20 12:15  
26APR20
20 18:15  Arthral
gia Mod
erate  2  24APR20
20 12:15  
26APR20
20 18:15  Chill
s Mil
d 2  24APR20
20 12:15  
26APR20
20 18:15  Los
s of Appetite  Mil
d 2  24APR20
20 12:15  
26APR20
20 18:15  Mal
aise Mil
d 2  24APR20
20 12:15  
27APR20
20 18:15  Nause
a Mod
erate  3  24APR20
20 12:15  
27APR20
20 18:15  Diarrhe
a Mil
d 3  24APR20
20 12:15  
27APR20
20 18:15  Heada
che Mod
erate  3  24APR20
20 12:15  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 17 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 73
FDA-CBER-2021-5683-0050068
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reacti
ons - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
10 µg
 
You
nger 10010  27APR20
20 18:15  Fatig
ue Mod
erate  3  24APR20
20 12:15  
27APR20
20 18:15  Mya
lgia Mod
erate  3  24APR20
20 12:15  
27APR20
20 18:15  Arthral
gia Mil
d 3  24APR20
20 12:15  
27APR20
20 18:15  Los
s of Appetite  Mil
d 3  24APR20
20 12:15  
27APR20
20 18:15  Mal
aise Mil
d 3  24APR20
20 12:15  
28APR20
20 18:30  Nause
a Mil
d 4  24APR20
20 12:15  
28APR20
20 18:30  Heada
che Mod
erate  4  24APR20
20 12:15  
28APR20
20 18:30  Fatig
ue Mod
erate  4  24APR20
20 12:15  
28APR20
20 18:30  Mya
lgia Mod
erate  4  24APR20
20 12:15  
28APR20
20 18:30  Arthral
gia Mil
d 4  24APR20
20 12:15  
28APR20
20 18:30  Mal
aise Mil
d 4  24APR20
20 12:15  
29APR20
20 18:30  Heada
che Mod
erate  5  24APR20
20 12:15  
29APR20
20 18:30  Fatig
ue Mod
erate  5  24APR20
20 12:15  
29APR20
20 18:30  Mya
lgia Mod
erate  5  24APR20
20 12:15  
29APR20
20 18:30  Arthral
gia Mil
d 5  24APR20
20 12:15  
29APR20
20 18:30  Mal
aise Mil
d 5  24APR20
20 12:15  
30APR20
20 18:15  Heada
che Mil
d 6  24APR20
20 12:15  
30APR20
20 18:15  Fatig
ue Mod
erate  6  24APR20
20 12:15  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 18 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 74
FDA-CBER-2021-5683-0050069
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of day
s 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
10 µg
 
You
nger 10010  30APR20
20 18:15  Mya
lgia Mil
d 6  24APR20
20 12:15  
30APR20
20 18:15  Mal
aise Mil
d 6  24APR20
20 12:15  
01M
AY2020 18:45  Nause
a Mil
d 7  24APR20
20 12:15  
01M
AY2020 18:45  Diarrhe
a Mil
d 7  24APR20
20 12:15  
01M
AY2020 18:45  Heada
che Mod
erate  7  24APR20
20 12:15  
01M
AY2020 18:45  Fatig
ue Mod
erate  7  24APR20
20 12:15  
01M
AY2020 18:45  Mya
lgia Mod
erate  7  24APR20
20 12:15  
01M
AY2020 18:45  Chill
s Mil
d 7  24APR20
20 12:15  
01M
AY2020 18:45  Los
s of Appetite  Mil
d 7  24APR20
20 12:15  
01M
AY2020 18:45  Mal
aise Mil
d 7  24APR20
20 12:15  
02M
AY2020 19:00  Heada
che Mil
d 8  24APR20
20 12:15  
02M
AY2020 19:00  Fatig
ue Mod
erate  8  24APR20
20 12:15  
02M
AY2020 19:00  Mya
lgia Mod
erate  8  24APR20
20 12:15  
02M
AY2020 19:00  Mal
aise Mil
d 8  24APR20
20 12:15  
10017  28APR20
20 22:00  Heada
che Mil
d 0  28APR20
20 10:30  
19M
AY2020 22:00  Heada
che Mil
d 21 0 28APR20
20 10:30  
19M
AY2020 22:00  Feve
r Mod
erate  21 0 28APR20
20 10:30  
20M
AY2020 21:47  Heada
che Mil
d 22 1 28APR20
20 10:30  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 19 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 75
FDA-CBER-2021-5683-0050070
Bio
NTech RNA Pharmaceuticals GmbH / Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
10 µg
 
You
nger 10017  20M
AY2020 21:47  Mya
lgia Seve
re 22 1 28APR20
20 10:30  
21M
AY2020 21:39  Mya
lgia Mil
d 23 2 28APR20
20 10:30  
10019  20M
AY2020 18:10  Heada
che Seve
re 22 1 28APR20
20 11:00  
20M
AY2020 18:10  Arthral
gia Mil
d 22 1 28APR20
20 11:00  
20M
AY2020 18:10  Los
s of Appetite  Mil
d 22 1 28APR20
20 11:00  
20M
AY2020 18:10  Mal
aise Mil
d 22 1 28APR20
20 11:00  
20M
AY2020 18:10  Feve
r Mil
d 22 1 28APR20
20 11:00  
21M
AY2020 20:00  Heada
che Mil
d 23 2 28APR20
20 11:00  
24M
AY2020 19:20  Heada
che Mil
d 26 5 28APR20
20 11:00  
25M
AY2020 19:55  Heada
che Mil
d 27 6 28APR20
20 11:00  
26M
AY2020 18:4
5 Heada
che Mil
d 28 7 28APR20
20 11:00  
27M
AY2020  7:10  Heada
che Mil
d 29 8 28APR20
20 11:00  
20 µg
 
You
nger 10151  16J
UL2020 18:00  Fatig
ue Mil
d 0  16J
UL2020  8:00  
17J
UL2020 20:00  Nause
a Mil
d 1  16J
UL2020  8:00  
17J
UL2020 20:00  Fatig
ue Mil
d 1  16J
UL2020  8:00  
18J
UL2020 20:00  Fatig
ue Mil
d 2  16J
UL2020  8:00  
06AUG
2020 22:00  Fatig
ue Mil
d 21 0 16J
UL2020  8:00  
07AUG
2020 22:00  Heada
che Mil
d 22 1 16J
UL2020  8:00  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 20 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 76
FDA-CBER-2021-5683-0050071
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3-1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of p
rime 
imm
unization  
20 µg
 
You
nger 10151  07AUG
2020 22:00  Fatig
ue Mod
erate  22 1 16J
UL2020  8:00  
08AUG
2020 22:00  Heada
che Mil
d 23 2 16J
UL2020  8:00  
08AUG
2020 22:00  Fatig
ue Mil
d 23 2 16J
UL2020  8:00  
09AUG
2020 22:00  Fatig
ue Mil
d 24 3 16J
UL2020  8:00 
10AUG
2020 22:00  Fatig
ue Mil
d 25 4 16J
UL2020  8:00  
11AUG
2020 22:00  Fatig
ue Mil
d 26 5 16J
UL2020  8:00  
10171  16J
UL2020 17:40  Fatig
ue Mil
d 0  16J
UL2020  8:15  
16J
UL2020 17:40  Chill
s Mil
d 0  16J
UL2020  8:15  
16J
UL2020 17:40  Mal
aise Mil
d 0  16J
UL2020  8:15  
17J
UL2020 20:28  Fatig
ue Mil
d 1  16J
UL2020  8:15  
17J
UL2020 20:28  Chill
s Mil
d 1  16J
UL2020  8:15  
17J
UL2020 20:28  Mal
aise Mil
d 1  16J
UL2020  8:15  
18J
UL2020 20:10  Fatig
ue Mil
d 2  16J
UL2020  8:15  
06AUG
2020 20:22  Heada
che Mod
erate  21 0 16J
UL2020  8:15  
06AUG
2020 20:22  Fatig
ue Mil
d 21 0 16J
UL2020  8:15  
06AUG
2020 20:22  Mya
lgia Mil
d 21 0 16J
UL2020  8:15  
06AUG
2020 20:22  Chill
s Seve
re 21 0 16J
UL2020  8:15  
06AUG
2020 20:22  Los
s of Appetite  Mod
erate  21 0 16J
UL2020  8:15  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 21 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 77
FDA-CBER-2021-5683-0050072
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of day
s 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
You
nger 10171  06AUG
2020 20:22  Mal
aise Mod
erate  21 0 16J
UL2020  8:15  
06AUG
2020 20:22  Feve
r Seve
re 21 0 16J
UL2020  8:15  
07AUG
2020 20:10  Heada
che Mod
erate  22 1 16J
UL2020  8:15  
07AUG
2020 20:10  Fatig
ue Mil
d 22 1 16J
UL2020  8:15  
07AUG
2020 20:10  Mya
lgia Mil
d 22 1 16J
UL2020  8:15  
07AUG
2020 20:10  Chill
s Mod
erate  22 1 16J
UL2020  8:15  
07AUG
2020 20:10  Los
s of Appetite  Mod
erate  22 1 16J
UL2020  8:15  
07AUG
2020 20:10  Mal
aise Mod
erate  22 1 16J
UL2020  8:15  
07AUG
2020 20:10  Feve
r Mod
erate  22 1 16J
UL2020  8:15  
08AUG
2020 20:06  Heada
che Mod
erate  23 2 16J
UL2020  8:15  
08AUG
2020 20:06  Fatig
ue Mil
d 23 2 16J
UL2020  8:15  
08AUG
2020 20:0
6 Mya
lgia Mil
d 23 2 16J
UL2020  8:15  
08AUG
2020 20:06  Chill
s Mod
erate  23 2 16J
UL2020  8:15  
08AUG
2020 20:06  Los
s of Appetite  Mod
erate  23 2 16J
UL2020  8:15  
08AUG
2020 20:06  Mal
aise Mod
erate  23 2 16J
UL2020  8:15  
09AUG
2020 19:40  Heada
che Mil
d 24 3 16J
UL2020  8:15  
09AUG
2020 19:40  Fatig
ue Mil
d 24 3 16J
UL2020  8:15  
09AUG
2020 19:40  Chill
s Mil
d 24 3 16J
UL2020  8:15  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 22 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 78
FDA-CBER-2021-5683-0050073
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reacti
ons - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
You
nger 10171  09AUG
2020 19:40  Los
s of Appetite  Mil
d 24 3 16J
UL2020  8:15  
09AUG
2020 19:40  Mal
aise Mil
d 24 3 16J
UL2020  8:15  
10AUG
2020 20:13  Heada
che Mil
d 25 4 16J
UL2020  8:15  
10AUG
2020 20:13  Fatig
ue Mil
d 25 4 16J
UL2020  8:15  
10AUG
2020 20:13  Chill
s Mil
d 25 4 16J
UL2020  8:15  
10AUG
2020 20:13  Los
s of Appetite  Mil
d 25 4 16J
UL2020  8:15  
10AUG
2020 20:13  Mal
aise Mil
d 25 4 16J
UL2020  8:15  
10172  16J
UL2020 20:16  Fatig
ue Mil
d 0  16J
UL2020  8:30  
17J
UL2020 20:23  Fatig
ue Mil
d 1  16J
UL2020  8:30  
18J
UL2020 20:41  Fatig
ue Mil
d 2  16J
UL2020  8:30  
19J
UL2020 20:16  Fatig
ue Mil
d 3  16J
UL2020  8:30  
20J
UL2020 20:20  Fatig
ue Mil
d 4  16J
UL2020  8:30  
21J
UL2020 20:15  Fatig
ue Mil
d 5  16J
UL2020  8:30  
06AUG
2020 19:50  Heada
che Mod
erate  21 0 16J
UL2020  8:30  
07AUG
2020  22:0
0 Heada
che Mod
erate  22 1 16J
UL2020  8:30  
10173  17J
UL2020 16:00  Heada
che Seve
re 1  16J
UL2020  8:45  
17J
UL2020 16:00  Fatig
ue Mod
erate  1  16J
UL2020  8:45  
17J
UL2020 16:00  Mya
lgia Mil
d 1  16J
UL2020  8:45  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 23 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 79
FDA-CBER-2021-5683-0050074
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of day
s 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
You
nger 10173  17J
UL2020 16:00  Arthral
gia Mil
d 1  16J
UL2020  8:45  
06AUG
2020 22:00  Heada
che Mod
erate  21 0 16J
UL2020  8:45  
07AUG
2020  4:38  Heada
che Seve
re 22 1 16J
UL2020  8:45  
07AUG
2020  4:38  Mya
lgia Mil
d 22 1 16J
UL2020  8:45  
07AUG
2020  4:38  Chill
s Seve
re 22 1 16J
UL2020  8:45  
07AUG
2020  4:38  Los
s of Appetite  Mod
erate  22 1 16J
UL2020  8:45  
07AUG
2020  4:38  Mal
aise Mod
erate  22 1 16J
UL2020  8:45  
07AUG
2020  4:38  Feve
r Seve
re 22 1 16J
UL2020  8:45  
08AUG
2020 11:00  Heada
che Mod
erate  23 2 16J
UL2020  8:45  
08AUG
2020 11:00  Fatig
ue Mil
d 23 2 16J
UL2020  8:45  
08AUG
2020 11:00  Los
s of Appetite  Mil
d 23 2 16J
UL2020  8:45  
08AUG
2020 11:0
0 Mal
aise Mil
d 23 2 16J
UL2020  8:45  
09AUG
2020 13:00  Heada
che Mil
d 24 3 16J
UL2020  8:45  
10175  16J
UL2020 18:00  Fatig
ue Mil
d 0  16J
UL2020  9:00  
16J
UL2020 18:00  Mya
lgia Mil
d 0  16J
UL2020  9:00  
17J
UL2020 18:04  Fatig
ue Mil
d 1  16J
UL2020  9:00  
07AUG
2020 21:08  Mal
aise Mil
d 22 1 16J
UL2020  9:00  
08AUG
2020 21:01  Mal
aise Mil
d 23 2 16J
UL2020  9:00  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 24 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 80
FDA-CBER-2021-5683-0050075
Bio
NTech RNA Pharmaceuticals GmbH / Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
You
nger 10176  16J
UL2020 21:00  Heada
che Mil
d 0  16J
UL2020  9:15  
16J
UL2020 21:00  Mya
lgia Mil
d 0  16J
UL2020  9:15  
16J
UL2020 21:00  Mal
aise Mil
d 0  16J
UL2020  9:15  
17J
UL2020 20:30  Heada
che Mil
d 1  16J
UL2020  9:15  
17J
UL2020 20:30  Mya
lgia Mil
d 1  16J
UL2020  9:15  
17J
UL2020 20:30  Arthral
gia Mil
d 1  16J
UL2020  9:15  
22J
UL2020 21:00  Fatig
ue Mil
d 6  16J
UL2020  9:15  
06AUG
2020 22:00  Heada
che Mod
erate  21 0 16J
UL2020  9:15  
06AUG
2020 22:00  Mya
lgia Mil
d 21 0 16J
UL2020  9:15  
06AUG
2020 22:00  Chill
s Mil
d 21 0 16J
UL2020  9:15  
06AUG
2020 22:00  Feve
r Mod
erate  21 0 16J
UL2020  9:15  
07AUG
2020 17:00  Heada
che Mil
d 22 1 16J
UL2020  9:15  
07AUG
2020 17:00  Mya
lgia Mod
erate  22 1 16J
UL2020  9:15  
08AUG
2020 21:00  Mya
lgia Mil
d 23 2 16J
UL2020  9:15  
10178  16J
UL2020 20:15  Nause
a Mil
d 0  16J
UL2020  9:30  
16J
UL2020 20:15  Heada
che Mod
erate  0  16J
UL2020  9:30  
16J
UL2020 20:15  Fatig
ue Mil
d 0  16J
UL2020  9:30  
16J
UL2020 20:15  Chill
s Mil
d 0  16J
UL2020  9:30  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 25 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 81
FDA-CBER-2021-5683-0050076
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3-1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of p
rime 
imm
unization  
20 µg
 
You
nger 10178  16J
UL2020 20:15  Los
s of Appetite  Mil
d 0  16J
UL2020  9:30  
16J
UL2020 20:15  Mal
aise Mil
d 0  16J
UL2020  9:30  
17J
UL2020 20:00  Heada
che Mil
d 1  16J
UL2020  9:30  
17J
UL2020 20:00  Fatig
ue Mil
d 1  16J
UL2020  9:30  
17J
UL2020 20:00  Mal
aise Mil
d 1  16J
UL2020  9:30  
21J
UL2020 19:50  Heada
che Mil
d 5  16J
UL2020  9:30  
21J
UL2020 19:50  Fatig
ue Mil
d 5  16J
UL2020  9:30  
06AUG
2020 19:40  Heada
che Mil
d 21 0 16J
UL2020  9:30  
07AUG
2020 19:00  Heada
che Mil
d 22 1 16J
UL2020  9:30 
11AUG
2020 19:45  Heada
che Mil
d 26 5 16J
UL2020  9:30  
10179  16J
UL2020 21:00  Heada
che Mil
d 0  16J
UL2020  9:45  
16J
UL2020 21:00  Fatig
ue Mil
d 0  16J
UL2020  9:45  
16J
UL2020 21:00  Mya
lgia Mil
d 0  16J
UL2020  9:45  
06AUG
2020 21:00  Nause
a Mil
d 21 0 16J
UL2020  9:45  
06AUG
2020 21:00  Heada
che Seve
re 21 0 16J
UL2020  9:45  
06AUG
2020 21:00  Fatig
ue Mil
d 21 0 16J
UL2020  9:45  
07AUG
2020 21:00  Heada
che Mod
erate  22 1 16J
UL2020  9:45  
08AUG
2020 21:00  Heada
che Mod
erate  23 2 16J
UL2020  9:45  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 26 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 82
FDA-CBER-2021-5683-0050077
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV
2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of day
s 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
You
nger 10181  16J
UL2020 20:15  Fatig
ue Mil
d 0  16J
UL2020 10:00  
16J
UL2020 20:15  Mal
aise Mil
d 0  16J
UL2020 10:00  
10183  16J
UL2020 21:00  Nause
a Mod
erate  0  16J
UL2020 10:30  
16J
UL2020 21:00  Heada
che Seve
re 0  16J
UL2020 10:30  
16J
UL2020 21:00  Mya
lgia Seve
re 0  16J
UL2020 10:30  
16J
UL2020 21:00  Chill
s Mod
erate  0  16J
UL2020 10:30  
16J
UL2020 21:00  Los
s of Appetite  Mil
d 0  16J
UL2020 10:30  
16J
UL2020 21:00  Mal
aise Mod
erate  0  16J
UL2020 10:30  
17J
UL2020 21:10  Heada
che Seve
re 1  16J
UL2020 10:30  
17J
UL2020 21:10  Fatig
ue Mod
erate  1  16J
UL2020 10:30  
17J
UL2020 21:10  Mya
lgia Seve
re 1  16J
UL2020 10:30  
17J
UL2020 21:10  Chill
s Mil
d 1  16J
UL2020 10:30  
17J
UL2020 21:10  Los
s of Appetite  Mil
d 1  16J
UL2020 10:30  
17J
UL2020 21:10  Mal
aise Mil
d 1  16J
UL2020 10:30  
18J
UL2020 21:50  Nause
a Mil
d 2  16J
UL2020 10:30  
18J
UL2020 21:50  Heada
che Mod
erate  2  16J
UL2020 10:30  
18J
UL2020 21:50  Fatig
ue Mil
d 2  16J
UL2020 10:30  
18J
UL2020 21:50  Mya
lgia Mod
erate  2  16J
UL2020 10:30  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 27 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 83
FDA-CBER-2021-5683-0050078
Bio
NTech RNA Phar
maceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
You
nger 10183  18J
UL2020 21:50  Los
s of Appetite  Mil
d 2  16J
UL2020 10:30  
18J
UL2020 21:50  Mal
aise Mil
d 2  16J
UL2020 10:30  
19J
UL2020 21:36  Heada
che Mil
d 3  16J
UL2020 10:30  
19J
UL2020 21:36  Mya
lgia Mil
d 3  16J
UL2020 10:30  
06AUG
2020 18:30  Nause
a Mil
d 21 0 16J
UL2020 10:30  
06AUG
2020 18:30  Heada
che Mil
d 21 0 16J
UL2020 10:30  
06AUG
2020 18:30  Fatig
ue Mod
erate  21 0 16J
UL2020 10:30  
06AUG
2020 18:30  Mya
lgia Mod
erate  21 0 16J
UL2020 10:30  
06AUG
2020 18:30  Chill
s Mil
d 21 0 16J
UL2020 10:30  
06AUG
2020 18:30  Los
s of Appetite  Mil
d 21 0 16J
UL2020 10:30  
06AUG
2020 18:30  Mal
aise Mil
d 21 0 16J
UL2020 10:30  
07AUG
2020 20:10  Heada
che Mod
erate  22 1 16J
UL2020 10:30  
07AUG
2020 20:10  Fatig
ue Mil
d 22 1 16J
UL2020 10:30  
07AUG
2020 20:10  Mya
lgia Seve
re 22 1 16J
UL2020 10:30  
07AUG
2020 20:10  Los
s of Appetite  Mil
d 22 1 16J
UL2020 10:30  
08AUG
2020 20:30  Heada
che Mil
d 23 2 16J
UL2020 10:30  
08AUG
2020 20:30  Mya
lgia Mod
erate  23 2 16J
UL2020 10:30  
09AUG
2020 21:00  Mya
lgia Mil
d 24 3 16J
UL2020 10:30  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 28 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 84
FDA-CBER-2021-5683-0050079
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on cl
ean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boo
st 
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
You
nger 10197  16J
UL2020 20:30  Heada
che Mod
erate  0  16J
UL2020 10:45  
16J
UL2020 20:30  Fatig
ue Mod
erate  0  16J
UL2020 10:45  
16J
UL2020 20:30  Mal
aise Mil
d 0  16J
UL2020 10:45  
17J
UL2020  2:30  Nause
a Mil
d 1  16J
UL2020 10:45  
17J
UL2020  2:30  Heada
che Mil
d 1  16J
UL2020 10:45  
17J
UL2020  2:30  Fatig
ue Mod
erate  1  16J
UL2020 10:45  
17J
UL2020  2:30  Mya
lgia Mil
d 1  16J
UL2020 10:45  
17J
UL2020  2:30  Chill
s Mod
erate  1  16J
UL2020 10:45  
17J
UL2020  2:30 Mal
aise Mod
erate  1  16J
UL2020 10:45  
17J
UL2020 20:30  Nause
a Mil
d 1  16J
UL2020 10:45  
17J
UL2020 20:30  Heada
che Mod
erate  1  16J
UL2020 10:45  
17J
UL2020 20:30  Fatig
ue Mod
erate  1  16J
UL2020 10:45  
17J
UL2020 20:30  Mya
lgia Mil
d 1  16J
UL2020 10:45  
17J
UL2020 20:30  Arthral
gia Mil
d 1  16J
UL2020 10:45  
17J
UL2020 20:30  Chill
s Mil
d 1  16J
UL2020 10:45  
17J
UL2020 20:30  Los
s of Appetite  Mod
erate  1  16J
UL2020 10:45  
17J
UL2020 20:30  Mal
aise Mod
erate  1  16J
UL2020 10:45  
18J
UL2020 18:30  Nause
a Mil
d 2  16J
UL2020 10:45  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 29 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 85
FDA-CBER-2021-5683-0050080
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
You
nger 10197  18J
UL2020 18:30  Heada
che Mil
d 2  16J
UL2020 10:45  
18J
UL2020 18:30  Fatig
ue Mil
d 2  16J
UL2020 10:45  
18J
UL2020 18:
30 Mya
lgia Mil
d 2  16J
UL2020 10:45  
18J
UL2020 18:30  Arthral
gia Mil
d 2  16J
UL2020 10:45  
18J
UL2020 18:30  Los
s of Appetite  Mil
d 2  16J
UL2020 10:45  
18J
UL2020 18:30  Mal
aise Mil
d 2  16J
UL2020 10:45  
19J
UL2020 18:20  Arthral
gia Mil
d 3  16J
UL2020 10:45  
20J
UL2020 18:00  Mya
lgia Mil
d 4  16J
UL2020 10:45  
21J
UL2020 16:00  Arthral
gia Mil
d 5  16J
UL2020 10:45  
06AUG
2020 22:00  Nause
a Mod
erate  21 0 16J
UL2020 10:45  
06AUG
2020 22:00  Vomi
ting Mod
erate  21 0 16J
UL2020 10:45  
06AUG
2020 22:00  Diarrhe
a Seve
re 21 0 16J
UL2020 10:45  
06AUG
2020 22:00  Heada
che Mil
d 21 0 16J
UL2020 10:45  
06AUG
2020 22:00  Fatig
ue Mod
erate  21 0 16J
UL2020 10:45  
06AUG
2020 22:00  Mya
lgia Mil
d 21 0 16J
UL2020 10:45  
06AUG
2020 22:00  Arthral
gia Mil
d 21 0 16J
UL2020 10:45  
06AUG
2020 22:0
0 Chill
s Seve
re 21 0 16J
UL2020 10:45  
06AUG
2020 22:00  Los
s of Appetite  Seve
re 21 0 16J
UL2020 10:45  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 30 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 86
FDA-CBER-2021-5683-0050081
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
You
nger 10197  06AUG
2020 22:00  Mal
aise Seve
re 21 0 16J
UL2020 10:45  
06AUG
2020 22:00  Feve
r Mod
erate  21 0 16J
UL2020 10:45  
07AUG
2020 18:30  Nause
a Mod
erate  22 1 16J
UL2020 10:45  
07AUG
2020 18:30  Vomi
ting Mil
d 22 1 16J
UL2020 10:45  
07AUG
2020 18:30  Diarrhe
a Seve
re 22 1 16J
UL2020 10:45  
07AUG
2020 18:30  Heada
che Seve
re 22 1 16J
UL2020 10:45  
07AUG
2020 18:30  Fatig
ue Seve
re 22 1 16J
UL2020 10:45  
07AUG
2020 18:30  Mya
lgia Mod
erate  22 1 16J
UL2020 10:45  
07AUG
2020 18:30  Arthral
gia Mil
d 22 1 16J
UL2020 10:45  
07AUG
2020 18:30  Chill
s Seve
re 22 1 16J
UL2020 10:45  
07AUG
2020 18:30  Los
s of Appetite  Seve
re 22 1 16J
UL2020 10:45  
07AUG
2020 18:30  Mal
aise Seve
re 22 1 16J
UL2020 10:45  
07AUG
2020 18:30  Feve
r Mod
erate  22 1 16J
UL2020 10:45  
08AUG
2020 18:30  Nause
a Mod
erate  23 2 16J
UL2020 10:45  
08AUG
2020 18:30  Vomi
ting Mil
d 23 2 16J
UL2020 10:45  
08AUG
2020 18:30  Diarrhe
a Seve
re 23 2 16J
UL2020 10:45  
08AUG
2020 18:30  Heada
che Mod
erate  23 2 16J
UL2020 10:45  
08AUG
2020 18:30  Fatig
ue Mod
erate  23 2 16J
UL2020 10:45  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 31 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 87
FDA-CBER-2021-5683-0050082
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV
2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of day
s 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
20 µg
 
You
nger 10197  08AUG
2020 18:30  Mya
lgia Mil
d 23 2 16J
UL2020 10:45  
08AUG
2020 18:30  Arthral
gia Mil
d 23 2 16J
UL2020 10:45  
08AUG
2020 18:30  Chill
s Mil
d 23 2 16J
UL2020 10:45  
08AUG
2020 18:30  Los
s of Appetite  Mod
erate  23 2 16J
UL2020 10:45  
08AUG
2020 18:30  Mal
aise Seve
re 23 2 16J
UL2020 10:45  
09AUG
2020 18:00  Nause
a Mil
d 24 3 16J
UL2020 10:45  
09AUG
2020 18:00  Diarrhe
a Mil
d 24 3 16J
UL2020 10:45  
09AUG
2020 18:00  Heada
che Mil
d 24 3 16J
UL2020 10:45  
09AUG
2020 18:00  Fatig
ue Mil
d 24 3 16J
UL2020 10:45  
09AUG
2020 18:00  Arthral
gia Mil
d 24 3 16J
UL2020 10:45  
09AUG
2020 18:00  Mal
aise Mil
d 24 3 16J
UL2020 10:45  
10AUG
2020 17:15  Fatig
ue Mil
d 25 4 16J
UL2020 10:45  
10AUG
2020 17:15  Mya
lgia Mil
d 25 4 16J
UL2020 10:45  
10AUG
2020 17:15  Arthral
gia Mil
d 25 4 16J
UL2020 10:45  
11AUG
2020 18:00  Mya
lgia Mil
d 26 5 16J
UL2020 10:45  
12AUG
2020 16:00  Mya
lgia Mil
d 27 6 16J
UL2020 10:45  
30 µg
 
You
nger 10016  29APR20
20 Nause
a Mod
erate  0  29APR20
20  9:03  
29APR20
20 Heada
che Mod
erate  0  29APR20
20  9:03  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 32 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 88
FDA-CBER-2021-5683-0050083
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Snap
shot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10016  29APR20
20 Fatig
ue Mil
d 0  29APR20
20  9:03 
29APR20
20 Mya
lgia Mil
d 0  29APR20
20  9:03  
29APR20
20 Arthral
gia Mod
erate  0  29APR20
20  9:03  
29APR20
20 Mal
aise Mil
d 0  29APR20
20  9:03  
30APR20
20 20:50  Heada
che Mil
d 1  29APR20
20  9:03  
30APR20
20 20:50  Fatig
ue Mil
d 1  29APR20
20  9:03  
30APR20
20 20:50  Mya
lgia Mod
erate  1  29APR20
20  9:03  
30APR20
20 20:50  Arthral
gia Mod
erate  1  29APR20
20  9:03  
30APR20
20 20:50  Mal
aise Mil
d 1  29APR20
20  9:03  
01M
AY2020 21:00  Heada
che Mil
d 2  29APR20
20  9:03  
02M
AY2020 20:30  Heada
che Mil
d 3  29APR20
20  9:03  
20M
AY2020 20:13  Heada
che Seve
re 21 0 29APR20
20  9:03  
20M
AY2020 20:13  Fatig
ue Mod
erate  21 0 29APR20
20  9:03  
20M
AY2020 20:13  Mya
lgia Mod
erate  21 0 29APR20
20  9:03  
20M
AY2020 20:13  Arthral
gia Seve
re 21 0 29APR20
20  9:03  
20M
AY2020  20:1
3 Chill
s Seve
re 21 0 29APR20
20  9:03  
20M
AY2020 20:13  Mal
aise Seve
re 21 0 29APR20
20  9:03  
21M
AY2020 21:30  Heada
che Seve
re 22 1 29APR20
20  9:03  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 33 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 89
FDA-CBER-2021-5683-0050084
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of  soli
cited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10016  21M
AY2020 21:30  Mya
lgia Mil
d 22 1 29APR20
20  9:03  
21M
AY2020 21:30  Arthral
gia Mil
d 22 1 29APR20
20  9:03  
21M
AY2020 21:30  Chill
s Mod
erate  22 1 29APR20
20  9:03  
21M
AY2020 21:30  Mal
aise Mod
erate  22 1 29APR20
20  9:03  
10020  20M
AY2020  19:0
1 Arthral
gia Mil
d 21 0 29APR20
20 10:06  
21M
AY2020 19:06  Arthral
gia Mil
d 22 1 29APR20
20 10:06  
10021  05M
AY2020 20:01  Heada
che Mil
d 0  05M
AY2020  8:30  
05M
AY2020 20:01  Fatig
ue Mil
d 0  05M
AY2020  8:30  
06M
AY2020 20:01  Heada
che Mil
d 1  05M
AY2020  8:30 
06M
AY2020 20:01  Chill
s Mil
d 1  05M
AY2020  8:30  
06M
AY2020 20:01  Mal
aise Mil
d 1  05M
AY2020  8:30  
10M
AY2020 20:00  Mal
aise Mil
d 5  05M
AY2020  8:30  
26M
AY2020 20:00  Heada
che Seve
re 21 0 05M
AY2020  8:30  
26M
AY2020 20:00  Fatig
ue Mil
d 21 0 05M
AY2020  8:30  
26M
AY2020 20:00  Mya
lgia Seve
re 21 0 05M
AY2020  8:30  
26M
AY2020 20:00  Chill
s Mil
d 21 0 05M
AY2020  8:30  
26M
AY2020 20:00  Mal
aise Seve
re 21 0 05M
AY2020  8:30  
27M
AY2020 20:00  Heada
che Mod
erate  22 1 05M
AY2020  8:30  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 34 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 90
FDA-CBER-2021-5683-0050085
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of day
s 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10021  27M
AY2020 20:00  Mya
lgia Mod
erate  22 1 05M
AY2020  8:30  
27M
AY2020 20:00  Chill
s Mil
d 22 1 05M
AY2020  8:30  
27M
AY2020 20:00  Mal
aise Mod
erate  22 1 05M
AY2020  8:30  
28M
AY2020 20:00  Heada
che Mod
erate  23 2 05M
AY2020  8:30  
28M
AY2020 20:00  Mya
lgia Mod
erate  23 2 05M
AY2020  8:30  
28M
AY2020 20:00  Mal
aise Mod
erate  23 2 05M
AY2020  8:30  
29M
AY2020 20:00  Heada
che Mil
d 24 3 05M
AY2020  8:30  
29M
AY2020 20:00  Mya
lgia Mil
d 24 3 05M
AY2020  8:30  
29M
AY2020 20:00  Mal
aise Mil
d 24 3 05M
AY2020  8:30  
10028  07M
AY2020 21:27  Heada
che Mil
d 0  07M
AY2020  8:30  
08M
AY2020 21:40  Heada
che Mil
d 1  07M
AY2020  8:30  
28M
AY2020 22:00  Heada
che Mod
erate  21 0 07M
AY2020  8:30  
28M
AY2020 22:00  Fatig
ue Mod
erate  21 0 07M
AY2020  8:30  
28M
AY2020 22:00  Mya
lgia Mod
erate  21 0 07M
AY2020  8:30  
28M
AY2020 22:00  Arthral
gia Mod
erate  21 0 07M
AY2020  8:30  
28M
AY2020 22:00  Chill
s Mod
erate  21 0 07M
AY2020  8:30  
28M
AY2020 22:00  Mal
aise Mod
erate  21 0 07M
AY2020  8:30  
29M
AY2020 22:00  Nause
a Mod
erate  22 1 07M
AY2020  8:30  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 35 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 91
FDA-CBER-2021-5683-0050086
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10028  29M
AY2020 22:0
0 Heada
che Mod
erate  22 1 07M
AY2020  8:30  
29M
AY2020 22:00  Fatig
ue Mod
erate  22 1 07M
AY2020  8:30  
29M
AY2020 22:00  Mya
lgia Mod
erate  22 1 07M
AY2020  8:30  
29M
AY2020 22:00  Arthral
gia Mod
erate  22 1 07M
AY2020  8:30  
29M
AY2020 22:00  Chill
s Mod
erate  22 1 07M
AY2020  8:30  
29M
AY2020 22:00  Los
s of Appetite  Mod
erate  22 1 07M
AY2020  8:30  
29M
AY2020 22:00  Mal
aise Mod
erate  22 1 07M
AY2020  8:30  
10031  07M
AY2020 22:00  Heada
che Mod
erate  0  07M
AY2020  9:00  
07M
AY2020 22:00  Fatig
ue Mod
erate  0  07M
AY2020  9:00 
07M
AY2020 22:00  Mya
lgia Seve
re 0  07M
AY2020  9:00  
07M
AY2020 22:00  Arthral
gia Seve
re 0  07M
AY2020  9:00  
07M
AY2020 22:00  Chill
s Mod
erate  0  07M
AY2020  9:00  
07M
AY2020 22:00  Los
s of Appetite  Mil
d 0  07M
AY2020  9:00  
07M
AY2020 22:00  Mal
aise Seve
re 0  07M
AY2020  9:00  
07M
AY2020 22:00  Feve
r Mod
erate  0  07M
AY2020  9:00  
08M
AY2020 21:00  Fatig
ue Mil
d 1  07M
AY2020  9:00  
08M
AY2020 21:00  Mya
lgia Mod
erate  1  07M
AY2020  9:00  
08M
AY2020 21:00  Arthral
gia Mil
d 1  07M
AY2020  9:00  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 36 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 92
FDA-CBER-2021-5683-0050087
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV
2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of day
s 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10031  08M
AY2020 21:00  Mal
aise Mil
d 1  07M
AY2020  9:00  
09M
AY2020 22:00  Fatig
ue Mil
d 2  07M
AY2020  9:00  
28M
AY2020 22:00  Heada
che Seve
re 21 0 07M
AY2020  9:00  
28M
AY2020 22:00  Fatig
ue Mil
d 21 0 07M
AY2020  9:00  
28M
AY2020 22:00  Mya
lgia Seve
re 21 0 07M
AY2020  9:00  
28M
AY2020 22:00  Arthral
gia Seve
re 21 0 07M
AY2020  9:00  
28M
AY2020 22:00  Chill
s Seve
re 21 0 07M
AY2020  9:00  
28M
AY2020 22:0
0 Mal
aise Seve
re 21 0 07M
AY2020  9:00  
28M
AY2020 22:00  Feve
r Mil
d 21 0 07M
AY2020  9:00  
29M
AY2020 22:00  Heada
che Seve
re 22 1 07M
AY2020  9:00  
29M
AY2020 22:00  Fatig
ue Mod
erate  22 1 07M
AY2020  9:00  
29M
AY2020 22:00  Mya
lgia Mod
erate  22 1 07M
AY2020   9:00 
29M
AY2020 22:00  Arthral
gia Mod
erate  22 1 07M
AY2020  9:00  
29M
AY2020 22:00  Chill
s Mod
erate  22 1 07M
AY2020  9:00  
29M
AY2020 22:00  Los
s of Appetite  Mod
erate  22 1 07M
AY2020  9:00  
29M
AY2020 22:00  Mal
aise Seve
re 22 1 07M
AY2020  9:00  
30M
AY2020  22:0
0 Heada
che Mil
d 23 2 07M
AY2020  9:00  
30M
AY2020 22:00  Mya
lgia Mil
d 23 2 07M
AY2020  9:00  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 37 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 93
FDA-CBER-2021-5683-0050088
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10031  30M
AY2020 22:00  Arthral
gia Mil
d 23 2 07M
AY2020  9:00  
30M
AY2020 22:00  Chill
s Mil
d 23 2 07M
AY2020  9:00  
30M
AY2020 22:00  Mal
aise Mil
d 23 2 07M
AY2020  9:00  
31M
AY2020 22:00  Mya
lgia Mil
d 24 3 07M
AY2020  9:00  
31M
AY2020 22:00  Mal
aise Mil
d 24 3 07M
AY2020  9:00  
10032  05M
AY2020 19:00  Heada
che Mil
d 0  05M
AY2020  9:00  
05M
AY2020 19:00  Fatig
ue Mil
d 0  05M
AY2020  9:00  
06M
AY2020 18:34  Los
s of Appetite  Mil
d 1  05M
AY2020  9:00  
06M
AY2020 18:34  Mal
aise Mil
d 1  05M
AY2020  9:00  
26M
AY2020 19:20  Heada
che Mil
d 21 0 05M
AY2020  9:00  
27M
AY2020 18:35  Heada
che Mil
d 22 1 05M
AY2020  9:00  
27M
AY2020 18:35  Fatig
ue Mod
erate  22 1 05M
AY2020  9:00  
27M
AY2020 18:35  Mya
lgia Mod
erate  22 1 05M
AY2020  9:00  
27M
AY2020 18:35  Arthral
gia Mod
erate  22 1 05M
AY2020  9:00  
27M
AY2020 18:35  Los
s of App
etite Mil
d 22 1 05M
AY2020  9:00  
27M
AY2020 18:35  Mal
aise Mod
erate  22 1 05M
AY2020  9:00  
27M
AY2020 18:35  Feve
r Mil
d 22 1 05M
AY2020  9:00  
10034  05M
AY2020 22:05  Heada
che Mod
erate  0  05M
AY2020  9:30  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 38 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 94
FDA-CBER-2021-5683-0050089
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boo
st 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10034  05M
AY2020 22:05  Fatig
ue Mod
erate  0  05M
AY2020  9:30  
05M
AY2020 22:05  Mya
lgia Mod
erate  0  05M
AY2020  9:30  
05M
AY2020 22:05  Chill
s Seve
re 0  05M
AY2020  9:30  
05M
AY2020 22:05  Mal
aise Mil
d 0  05M
AY2020  9:30  
06M
AY2020 20:10  Heada
che Mil
d 1  05M
AY2020  9:30  
06M
AY2020 20:10  Fatig
ue Mod
erate  1  05M
AY2020  9:30  
06M
AY2020 20:10  Los
s of Appetite  Mil
d 1  05M
AY2020  9:30  
06M
AY2020 20:10  Mal
aise Mil
d 1  05M
AY2020  9:30  
08M
AY2020 12:15  Fatig
ue Mil
d 3  05M
AY2020  9:30  
26M
AY2020 23:00  Nause
a Mil
d 21 0 05M
AY2020  9:30  
26M
AY2020 23:00  Heada
che Seve
re 21 0 05M
AY2020  9:30  
26M
AY2020 23:00  Fatig
ue Seve
re 21 0 05M
AY2020  9:30  
26M
AY2020 23:00  Mya
lgia Mod
erate  21 0 05M
AY2020  9:30  
26M
AY2020 23:00  Arthral
gia Mil
d 21 0 05M
AY2020  9:30  
26M
AY2020 23:00  Chill
s Seve
re 21 0 05M
AY2020  9:30  
26M
AY2020 23:00  Mal
aise Seve
re 21 0 05M
AY2020  9:30  
26M
AY2020 23:00  Feve
r Mil
d 21 0 05M
AY2020  9:30  
27M
AY2020 21:00  Heada
che Mil
d 22 1 05M
AY2020  9:30  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 39 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 95
FDA-CBER-2021-5683-0050090
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reac
tion Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10034  27M
AY2020 21:00  Fatig
ue Mil
d 22 1 05M
AY2020  9:30  
27M
AY2020 21:00  Mal
aise Mil
d 22 1 05M
AY2020  9:30  
10037  06M
AY2020 20:00  Heada
che Mil
d 1  05M
AY2020 10:00  
07M
AY2020 21:00  Heada
che Mil
d 2  05M
AY2020 10:00  
07M
AY2020 21:00  Fatig
ue Mil
d 2  05M
AY2020 10:00  
07M
AY2020 21:00  Mal
aise Mil
d 2  05M
AY2020 10:00  
10M
AY2020 21:00  Fatig
ue Mil
d 5  05M
AY2020 10:00  
26M
AY2020 21:00  Nause
a Mil
d 21 0 05M
AY2020 10:00  
26M
AY2020 21:00  Heada
che Mod
erate  21 0 05M
AY2020 10:00  
26M
AY2020 21:00  Fatig
ue Seve
re 21 0 05M
AY2020 10:00  
26M
AY2020 21:00  Mya
lgia Mil
d 21 0 05M
AY2020 10:00  
26M
AY2020 21:0
0 Chill
s Mil
d 21 0 05M
AY2020 10:00  
26M
AY2020 21:00  Mal
aise Mil
d 21 0 05M
AY2020 10:00  
27M
AY2020 21:00  Nause
a Mil
d 22 1 05M
AY2020 10:00  
27M
AY2020 21:00  Heada
che Mod
erate  22 1 05M
AY2020 10:00  
27M
AY2020 21:00  Fatig
ue Mod
erate  22 1 05M
AY2020 10:0
0 
27M
AY2020 21:00  Mya
lgia Mil
d 22 1 05M
AY2020 10:00  
27M
AY2020 21:00  Chill
s Mil
d 22 1 05M
AY2020 10:00  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 40 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 96
FDA-CBER-2021-5683-0050091
Bio
NTech RNA Phar
maceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10037  27M
AY2020 21:0
0 Mal
aise Mil
d 22 1 05M
AY2020 10:00  
28M
AY2020 21:00  Nause
a Mil
d 23 2 05M
AY2020 10:00  
28M
AY2020 21:00  Heada
che Mil
d 23 2 05M
AY2020 10:00  
28M
AY2020 21:00  Fatig
ue Mil
d 23 2 05M
AY2020 10:00  
28M
AY2020 21:00  Mal
aise Mil
d 23 2 05M
AY2020 10:00  
29M
AY2020 21:00  Heada
che Mil
d 24 3 05M
AY2020 10:00  
29M
AY2020 21:00  Fatig
ue Mil
d 24 3 05M
AY2020 10:00  
29M
AY2020 21:00  Mal
aise Mil
d 24 3 05M
AY2020 10:00  
30M
AY2020 21:00  Fatig
ue Mil
d 25 4 05M
AY2020 10:00  
30M
AY2020 21:00  Mal
aise Mil
d 25 4 05M
AY2020  10:0
0 
31M
AY2020 21:00  Mal
aise Mil
d 26 5 05M
AY2020 10:00  
01J
UN2020 21:00  Heada
che Mil
d 27 6 05M
AY2020 10:00  
01J
UN2020 21:00  Mal
aise Mil
d 27 6 05M
AY2020 10:00  
10038  07M
AY2020 21:00  Mya
lgia Mil
d 0  07M
AY2020  9:30  
10039  07M
AY2020 22:00  Heada
che Seve
re 0  07M
AY2020 10:00  
07M
AY2020 22:00  Fatig
ue Seve
re 0  07M
AY2020 10:00  
07M
AY2020 22:00  Mya
lgia Seve
re 0  07M
AY2020 10:00  
07M
AY2020 22:00  Arthral
gia Seve
re 0  07M
AY2020 10:00  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 41 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 97
FDA-CBER-2021-5683-0050092
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boo
st 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10039  07M
AY2020 22:00  Chill
s Seve
re 0  07M
AY2020 10:00  
07M
AY2020 22:00  Mal
aise Seve
re 0  07M
AY2020 10:00  
08M
AY2020 22:00  Heada
che Mod
erate  1  07M
AY2020 10:00  
08M
AY2020 22:00  Fatig
ue Mod
erate  1  07M
AY2020 10:00  
08M
AY2020 22:00  Mya
lgia Mod
erate  1  07M
AY2020 10:00  
08M
AY2020 22:00  Arthral
gia Mod
erate  1  07M
AY2020 10:00  
08M
AY2020 22:00  Mal
aise Mil
d 1  07M
AY2020 10:00  
28M
AY2020 22:00  Heada
che Seve
re 21 0 07M
AY2020 10:00  
28M
AY2020 22:00  Fatig
ue Seve
re 21 0 07M
AY2020 10:00  
28M
AY2020 22:00  Mya
lgia Seve
re 21 0 07M
AY2020 10:00  
28M
AY2020 22:00  Arthral
gia Seve
re 21 0 07M
AY2020 10:00  
28M
AY2020 22:00  Chill
s Seve
re 21 0 07M
AY2020 10:00  
28M
AY2020 22:00  Los
s of App
etite Seve
re 21 0 07M
AY2020 10:00  
28M
AY2020 22:00  Mal
aise Seve
re 21 0 07M
AY2020 10:00  
28M
AY2020 22:00  Feve
r Seve
re 21 0 07M
AY2020 10:00  
29M
AY2020 22:00  Heada
che Mod
erate  22 1 07M
AY2020 10:00  
29M
AY2020 22:00  Fatig
ue Mil
d 22 1 07M
AY2020 10:00  
29M
AY2020 22:00  Mya
lgia Mil
d 22 1 07M
AY2020 10:00  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 42 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 98
FDA-CBER-2021-5683-0050093
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot  All
 TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of col
lection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10039  29M
AY2020 22:00  Arthral
gia Mil
d 22 1 07M
AY2020 10:00  
29M
AY2020 22:00  Mal
aise Mil
d 22 1 07M
AY2020 10:00  
10043  07M
AY2020 20:00  Heada
che Mod
erate  0  07M
AY2020 10:30  
08M
AY2020 20:00  Heada
che Mod
erate  1  07M
AY2020 10:30  
09M
AY2020 20:00  Heada
che Mod
erate  2  07M
AY2020 10:30  
10M
AY2020 20:00  Heada
che Mod
erate  3  07M
AY2020  10:3
0 
11M
AY2020 20:00  Heada
che Mod
erate  4  07M
AY2020 10:30  
12M
AY2020 20:00  Heada
che Mod
erate  5  07M
AY2020 10:30  
13M
AY2020 20:00  Heada
che Mil
d 6  07M
AY2020 10:30  
28M
AY2020 20:00  Heada
che Mil
d 21 0 07M
AY2020 10:30  
29M
AY2020 20:00  Heada
che Mil
d 22 1 07M
AY2020 10:30  
29M
AY2020 20:00  Fatig
ue Mil
d 22 1 07M
AY2020 10:30  
29M
AY2020 20:00  Chill
s Mil
d 22 1 07M
AY2020 10:30  
29M
AY2020 20:00  Mal
aise Mil
d 22 1 07M
AY2020 10:30  
30M
AY2020 20:00  Heada
che Mil
d 23 2 07M
AY2020 10:30  
31M
AY2020 20:00  Heada
che Mil
d 24 3 07M
AY2020 10:30  
10047  07M
AY2020 23:00  Diarrhe
a Mil
d 0  07M
AY2020 11:00  
07M
AY2020 23:00  Heada
che Mil
d 0  07M
AY2020 11:00  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 43 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 99
FDA-CBER-2021-5683-0050094
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of soli
cited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10047  07M
AY2020 23:00  Fatig
ue Mil
d 0  07M
AY2020 11:00  
07M
AY2020 23:00  Mya
lgia Mil
d 0  07M
AY2020 11:00  
07M
AY2020 23:00  Arthral
gia Mil
d 0  07M
AY2020 11:00  
07M
AY2020 23:00  Mal
aise Mil
d 0  07M
AY2020 11:00  
08M
AY2020 23:45  Fatig
ue Mil
d 1  07M
AY2020 11:00  
08M
AY2020 23:45  Mya
lgia Mil
d 1  07M
AY2020 11:00  
08M
AY2020 23:45  Arthral
gia Mil
d 1  07M
AY2020 11:00  
10M
AY2020 23:40  Heada
che Mil
d 3  07M
AY2020 11:00  
10M
AY2020 23:40  Fatig
ue Mil
d 3  07M
AY2020 11:00  
11M
AY2020  0:30  Fatig
ue Mil
d 4  07M
AY2020 11:00  
28M
AY2020 23:55  Heada
che Mil
d 21 0 07M
AY2020 11:00  
28M
AY2020 23:55  Fatig
ue Mil
d 21 0 07M
AY2020 11:00  
28M
AY2020 23:55  Mya
lgia Mil
d 21 0 07M
AY2020 11:00  
28M
AY2020 23:55  Arthral
gia Mil
d 21 0 07M
AY2020 11:00  
28M
AY2020 23:5
5 Mal
aise Mil
d 21 0 07M
AY2020 11:00  
29M
AY2020 21:00  Heada
che Mod
erate  22 1 07M
AY2020 11:00  
29M
AY2020 21:00  Fatig
ue Mod
erate  22 1 07M
AY2020 11:00  
29M
AY2020 21:00  Mya
lgia Mod
erate  22 1 07M
AY2020 11:00  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 44 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 100
FDA-CBER-2021-5683-0050095
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of day
s 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
30 µg
 
You
nger 10047  29M
AY2020 21:00  Arthral
gia Mod
erate  22 1 07M
AY2020 11:00  
29M
AY2020 21:00  Chill
s Mil
d 22 1 07M
AY2020 11:00  
29M
AY2020 21:00  Los
s of A
ppetite  Mil
d 22 1 07M
AY2020 11:00  
29M
AY2020 21:00  Mal
aise Mod
erate  22 1 07M
AY2020 11:00  
29M
AY2020 21:00  Feve
r Mil
d 22 1 07M
AY2020 11:00  
30M
AY2020 23:55  Fatig
ue Mil
d 23 2 07M
AY2020 11:00  
30M
AY2020 23:55  Mya
lgia Mil
d 23 2 07M
AY2020 11:00  
30M
AY2020 23:55  Arthral
gia Mil
d 23 2 07M
AY2020 11:00  
31M
AY2020 22:00  Fatig
ue Mil
d 24 3 07M
AY2020 11:00  
50 µg
 
You
nger 10049  12M
AY2020 19:30  Heada
che Mil
d 0  12M
AY2020  9:10  
12M
AY2020 19:30  Fatig
ue Mil
d 0  12M
AY2020  9:10  
12M
AY2020 19:30  Mal
aise Mil
d 0  12M
AY2020  9:10  
13M
AY2020 13:00  Heada
che Mil
d 1  12M
AY2020  9:10  
13M
AY2020 13:00  Chill
s Mil
d 1  12M
AY2020  9:10  
13M
AY2020 13:00  Los
s of Appetite  Mil
d 1  12M
AY2020  9:10  
13M
AY2020 13:00  Mal
aise Mil
d 1  12M
AY2020  9:10  
13M
AY2020 13:00  Feve
r Mil
d 1  12M
AY2020  9:10  
15M
AY2020 13:40  Mya
lgia Mil
d 3  12M
AY2020  9:10  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 45 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 101
FDA-CBER-2021-5683-0050096
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10049  02J
UN2020 23:00  Heada
che Seve
re 21 0 12M
AY2020   9:10 
02J
UN2020 23:00  Fatig
ue Mod
erate  21 0 12M
AY2020  9:10  
02J
UN2020 23:00  Arthral
gia Mil
d 21 0 12M
AY2020  9:10  
02J
UN2020 23:00  Los
s of Appetite  Seve
re 21 0 12M
AY2020  9:10  
02J
UN2020 23:00  Mal
aise Seve
re 21 0 12M
AY2020  9:10  
02J
UN2020 23:0
0 Feve
r Seve
re 21 0 12M
AY2020  9:10  
03J
UN2020  7:15  Heada
che Seve
re 22 1 12M
AY2020  9:10  
03J
UN2020  7:15  Fatig
ue Mod
erate  22 1 12M
AY2020  9:10  
03J
UN2020  7:15  Arthral
gia Mil
d 22 1 12M
AY2020  9:10  
03J
UN2020  7:15  Los
s of Appetite  Seve
re 22 1 12M
AY2020  9:10  
03J
UN2020  7:15  Mal
aise Seve
re 22 1 12M
AY2020  9:10  
03J
UN2020  7:15  Feve
r Mil
d 22 1 12M
AY2020  9:10  
04J
UN2020  9:00  Heada
che Mod
erate  23 2 12M
AY2020  9:10  
04J
UN2020  9:00  Fatig
ue Mil
d 23 2 12M
AY2020  9:10  
04J
UN2020  9:00  Los
s of Appetite  Mod
erate  23 2 12M
AY2020  9:10  
04J
UN2020  9:00  Mal
aise Mil
d 23 2 12M
AY2020  9:10  
05J
UN2020  9:00  Los
s of Appetite  Mil
d 24 3 12M
AY2020  9:10  
10050  15M
AY2020 19:18  Heada
che Mod
erate  0  15M
AY2020  8:45  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 46 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 102
FDA-CBER-2021-5683-0050097
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of day
s 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10050  15M
AY2020 19:18  Fatig
ue Mod
erate  0  15M
AY2020  8:45  
15M
AY2020 19:18  Mya
lgia Mil
d 0  15M
AY2020  8:45  
15M
AY2020 19:18  Los
s of App
etite Mil
d 0  15M
AY2020  8:45  
15M
AY2020 19:18  Mal
aise Mod
erate  0  15M
AY2020  8:45  
16M
AY2020 19:45  Heada
che Mil
d 1  15M
AY2020  8:45  
16M
AY2020 19:45  Fatig
ue Mod
erate  1  15M
AY2020  8:45  
16M
AY2020 19:45  Chill
s Mil
d 1  15M
AY2020  8:45  
16M
AY2020 19:45  Los
s of Appetite  Mil
d 1  15M
AY2020  8:45  
16M
AY2020 19:45  Mal
aise Mod
erate  1  15M
AY2020  8:45  
17M
AY2020 20:19  Fatig
ue Mod
erate  2  15M
AY2020  8:45  
17M
AY2020 20:19  Los
s of Appetite  Mil
d 2  15M
AY2020  8:45  
17M
AY2020 20:19  Mal
aise Mod
erate  2  15M
AY2020  8:45  
18M
AY2020 20:03  Heada
che Mil
d 3  15M
AY2020  8:45  
18M
AY2020 20:03  Fatig
ue Mil
d 3  15M
AY2020  8:45  
18M
AY2020 20:03  Mal
aise Mil
d 3  15M
AY2020  8:45  
19M
AY2020 21:22  Fatig
ue Mil
d 4  15M
AY2020  8:45  
19M
AY2020 21:22  Mal
aise Mil
d 4  15M
AY2020  8:45  
20M
AY2020 19:24  Heada
che Mil
d 5  15M
AY2020  8:45  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 47 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 103
FDA-CBER-2021-5683-0050098
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10050  20M
AY2020 19:24  Mal
aise Mil
d 5  15M
AY2020  8:45 
21M
AY2020 20:14  Fatig
ue Mil
d 6  15M
AY2020  8:45  
21M
AY2020 20:14  Mal
aise Mil
d 6  15M
AY2020  8:45  
10053  12M
AY2020 20:00  Fatig
ue Mil
d 0  12M
AY2020 10:13  
12M
AY2020 20:00  Chill
s Mil
d 0  12M
AY2020 10:13  
13M
AY2020 20:00  Chill
s Mil
d 1  12M
AY2020  10:1
3 
13M
AY2020 20:00  Feve
r Mod
erate  1  12M
AY2020 10:13  
02J
UN2020 20:00  Heada
che Mil
d 21 0 12M
AY2020 10:13  
02J
UN2020 20:00  Fatig
ue Mil
d 21 0 12M
AY2020 10:13  
02J
UN2020 20:00  Chill
s Mil
d 21 0 12M
AY2020 10:13  
02J
UN2020 20:00  Los
s of Appetite  Mil
d 21 0 12M
AY2020 10:13  
02J
UN2020 20:00  Mal
aise Mod
erate  21 0 12M
AY2020 10:13  
03J
UN2020 20:00  Heada
che Mil
d 22 1 12M
AY2020 10:13  
03J
UN2020 20:00  Fatig
ue Mil
d 22 1 12M
AY2020 10:13  
03J
UN2020 20:00  Chill
s Mil
d 22 1 12M
AY2020 10:13  
03J
UN2020 20:0
0 Los
s of Appetite  Mil
d 22 1 12M
AY2020 10:13  
03J
UN2020 20:00  Mal
aise Mil
d 22 1 12M
AY2020 10:13  
03J
UN2020 20:00  Feve
r Mod
erate  22 1 12M
AY2020 10:13  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 48 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 104
FDA-CBER-2021-5683-0050099
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Listi
ng of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10055  13M
AY2020 17:30  Heada
che Mil
d 0  13M
AY2020  9:13  
13M
AY2020 17:30  Fatig
ue Mil
d 0  13M
AY2020  9:13  
14M
AY2020 21:30  Heada
che Mil
d 1  13M
AY2020  9:13  
14M
AY2020 21:30  Arthral
gia Mod
erate  1  13M
AY2020  9:13  
15M
AY2020  22:0
0 Arthral
gia Mod
erate  2  13M
AY2020  9:13  
03J
UN2020 21:40  Mya
lgia Mil
d 21 0 13M
AY2020  9:13  
03J
UN2020 21:40  Arthral
gia Mod
erate  21 0 13M
AY2020  9:13  
03J
UN2020 21:40  Los
s of Appetite  Mod
erate  21 0 13M
AY2020  9:13  
03J
UN2020 21:40  Mal
aise Mil
d 21 0 13M
AY2020  9:13  
10056  13M
AY2020 20:30  Nause
a Mil
d 0  13M
AY2020 10:16  
13M
AY2020 20:30  Heada
che Mil
d 0  13M
AY2020 10:16  
13M
AY2020 20:30  Fatig
ue Mil
d 0  13M
AY2020 10:16  
13M
AY2020 20:30  Mal
aise Mil
d 0  13M
AY2020 10:16  
14M
AY2020 20:30  Nause
a Mil
d 1  13M
AY2020 10:16  
14M
AY2020 20:30  Heada
che Mod
erate  1  13M
AY2020 10:16  
14M
AY2020 20:30  Fatig
ue Mod
erate  1  13M
AY2020 10:16  
14M
AY2020 20:30  Mya
lgia Mod
erate  1  13M
AY2020 10:16  
14M
AY2020 20:30  Arthral
gia Mil
d 1  13M
AY2020 10:16  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 49 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 105
FDA-CBER-2021-5683-0050100
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV
2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of day
s 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10056  14M
AY2020 20:30  Chill
s Mod
erate  1  13M
AY2020 10:16  
14M
AY2020 20:30  Los
s of Appetite  Mil
d 1  13M
AY2020 10:16  
14M
AY2020 20:30  Mal
aise Mod
erate  1  13M
AY2020 10:16  
15M
AY2020 20:30  Heada
che Mil
d 2  13M
AY2020 10:16  
15M
AY2020 20:30  Fatig
ue Mil
d 2  13M
AY2020 10:16  
15M
AY2020 20:30  Mya
lgia Mil
d 2  13M
AY2020 10:16  
15M
AY2020 20:30  Mal
aise Mil
d 2  13M
AY2020 10:16  
16M
AY2020 20:3
0 Fatig
ue Mil
d 3  13M
AY2020 10:16  
17M
AY2020 20:30  Fatig
ue Mil
d 4  13M
AY2020 10:16  
03J
UN2020 21:30  Nause
a Mil
d 21 0 13M
AY2020 10:16  
03J
UN2020 21:30  Heada
che Seve
re 21 0 13M
AY2020 10:16  
03J
UN2020 21:30  Fatig
ue Seve
re 21 0 13M
AY2020 10:16  
03J
UN2020 21:30  Mya
lgia Mod
erate  21 0 13M
AY2020 10:16  
03J
UN2020 21:30  Arthral
gia Mod
erate  21 0 13M
AY2020 10:16  
03J
UN2020 21:30  Chill
s Seve
re 21 0 13M
AY2020 10:16  
03J
UN2020 21:30  Los
s of Appetite  Seve
re 21 0 13M
AY2020 10:16  
03J
UN2020 21:30  Mal
aise Seve
re 21 0 13M
AY2020 10:16  
03J
UN2020 21:30  Feve
r Seve
re 21 0 13M
AY2020 10:16  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 50 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 106
FDA-CBER-2021-5683-0050101
Bio
NTech RNA  Phar
maceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10056  04J
UN2020 21:30  Heada
che Seve
re 22 1 13M
AY2020 10:16  
04J
UN2020 21:30  Fatig
ue Seve
re 22 1 13M
AY2020 10:16  
04J
UN2020 21:30  Mya
lgia Mod
erate  22 1 13M
AY2020 10:16  
04J
UN2020 21:30  Arthral
gia Mod
erate  22 1 13M
AY2020 10:16  
04J
UN2020 21:30  Chill
s Seve
re 22 1 13M
AY2020 10:16  
04J
UN2020 21:3
0 Los
s of Appetite  Mod
erate  22 1 13M
AY2020 10:16  
04J
UN2020 21:30  Mal
aise Seve
re 22 1 13M
AY2020 10:16  
04J
UN2020 21:30  Feve
r Mod
erate  22 1 13M
AY2020 10:16  
05J
UN2020 21:30  Heada
che Mil
d 23 2 13M
AY2020 10:16  
05J
UN2020 21:30  Fatig
ue Mil
d 23 2 13M
AY2020 10:16  
05J
UN2020 21:30  Mya
lgia Mil
d 23 2 13M
AY2020 10:16  
05J
UN2020 21:30  Arthral
gia Mil
d 23 2 13M
AY2020 10:16  
06J
UN2020 21:30  Fatig
ue Mil
d 24 3 13M
AY2020 10:16  
06J
UN2020 21:30  Mya
lgia Mil
d 24 3 13M
AY2020 10:16  
10057  15M
AY2020 20:00  Mya
lgia Mil
d 0  15M
AY2020  9:15  
15M
AY2020 20:00  Arthral
gia Mil
d 0  15M
AY2020  9:15  
15M
AY2020 20:00  Chill
s Mod
erate  0  15M
AY2020  9:15  
15M
AY2020 20:00  Mal
aise Mil
d 0  15M
AY2020  9:15  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 51 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 107
FDA-CBER-2021-5683-0050102
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boo
st 
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10057  16M
AY2020 20:00  Fatig
ue Mod
erate  1  15M
AY2020  9:15  
16M
AY2020 20:00  Mya
lgia Seve
re 1  15M
AY2020  9:15  
16M
AY2020 20:00  Arthral
gia Seve
re 1  15M
AY2020  9:15  
16M
AY2020 20:00  Chill
s Seve
re 1  15M
AY2020  9:15  
16M
AY2020 20:00  Mal
aise Mod
erate  1  15M
AY2020  9:15  
05J
UN2020 20:37  Fatig
ue Mod
erate  21 0 15M
AY2020  9:15  
05J
UN2020 20:37  Mya
lgia Mod
erate  21 0 15M
AY2020  9:15  
05J
UN2020 20:37  Arthral
gia Mil
d 21 0 15M
AY2020  9:15 
05J
UN2020 20:37  Chill
s Mod
erate  21 0 15M
AY2020  9:15  
05J
UN2020 20:37  Mal
aise Mil
d 21 0 15M
AY2020  9:15  
06J
UN2020 18:30  Diarrhe
a Mil
d 22 1 15M
AY2020  9:15  
06J
UN2020 18:30  Heada
che Mil
d 22 1 15M
AY2020  9:15  
06J
UN2020 18:30  Fatig
ue Mil
d 22 1 15M
AY2020  9:15  
06J
UN2020 18:30  Mya
lgia Mil
d 22 1 15M
AY2020  9:15  
06J
UN2020 18:30  Arthral
gia Mil
d 22 1 15M
AY2020  9:15  
06J
UN2020 18:30  Chill
s Mil
d 22 1 15M
AY2020  9:15  
06J
UN2020 18:30  Mal
aise Mil
d 22 1 15M
AY2020  9:15  
07J
UN2020 14:00  Heada
che Mil
d 23 2 15M
AY2020  9:15  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 52 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 108
FDA-CBER-2021-5683-0050103
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Fina
l 1.0 BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reac
tion Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10057  07J
UN2020 14:00  Mya
lgia Mil
d 23 2 15M
AY2020  9:15  
10059  13M
AY2020 16:50  Heada
che Mil
d 0  13M
AY2020 10:46  
14M
AY2020 17:00  Nause
a Mod
erate  1  13M
AY2020 10:46  
14M
AY2020 17:00  Heada
che Mod
erate  1  13M
AY2020 10:46  
14M
AY2020 17:00  Fatig
ue Seve
re 1  13M
AY2020 10:46  
14M
AY2020 17:00  Mya
lgia Mil
d 1  13M
AY2020 10:46  
14M
AY2020 17:00  Arthral
gia Mil
d 1  13M
AY2020 10:46  
14M
AY2020 17:00  Chill
s Mod
erate  1  13M
AY2020 10:46  
14M
AY2020 17:00  Los
s of Appetite  Seve
re 1  13M
AY2020 10:46  
14M
AY2020 17:00  Mal
aise Seve
re 1  13M
AY2020 10:46  
14M
AY2020 17:00  Feve
r Mod
erate  1  13M
AY2020 10:46  
15M
AY2020 17:50  Nause
a Mod
erate  2  13M
AY2020 10:46  
15M
AY2020 17:50  Heada
che Mod
erate  2  13M
AY2020 10:46  
15M
AY2020 17:50  Fatig
ue Mod
erate  2  13M
AY2020 10:46  
15M
AY2020 17:50  Mya
lgia Mil
d 2  13M
AY2020 10:46  
15M
AY2020 17:50  Arthral
gia Mil
d 2  13M
AY2020 10:46  
15M
AY2020 17:50  Los
s of Appetite  Seve
re 2  13M
AY2020 10:46  
15M
AY2020 17:50  Mal
aise Mod
erate  2  13M
AY2020 10:46  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 53 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 109
FDA-CBER-2021-5683-0050104
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM d
ata received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemi c r
eactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10059  16M
AY2020 17:30  Nause
a Mil
d 3  13M
AY2020 10:46  
16M
AY2020 17:30  Heada
che Mil
d 3  13M
AY2020 10:46  
16M
AY2020 17:30  Fatig
ue Mod
erate  3  13M
AY2020 10:46  
16M
AY2020 17:30  Los
s of Appetite  Mod
erate  3  13M
AY2020 10:46  
16M
AY2020 17:30  Mal
aise Mod
erate  3  13M
AY2020 10:46  
17M
AY2020 17:15  Heada
che Mil
d 4  13M
AY2020 10:46  
17M
AY2020 17:15  Fatig
ue Mil
d 4  13M
AY2020 10:46  
17M
AY2020 17:15  Los
s of Appetite  Mil
d 4  13M
AY2020 10:46  
17M
AY2020 17:15  Mal
aise Mil
d 4  13M
AY2020 10:46  
18M
AY2020 19:00  Heada
che Mil
d 5  13M
AY2020 10:46  
18M
AY2020 19:00  Los
s of Appetite  Mil
d 5  13M
AY2020 10:46  
03J
UN2020 17:30  Nause
a Mod
erate  21 0 13M
AY2020 10:46  
03J
UN2020 17:30  Heada
che Seve
re 21 0 13M
AY2020 10:46  
03J
UN2020 17:30  Fatig
ue Seve
re 21 0 13M
AY2020 10:46  
03J
UN2020 17:30  Mya
lgia Mod
erate  21 0 13M
AY2020 10:46  
03J
UN2020 17:30  Arthral
gia Mod
erate  21 0 13M
AY2020 10:46  
03J
UN2020 17:30  Chill
s Seve
re 21 0 13M
AY2020 10:46  
03J
UN2020 17:30  Los
s of Appetite  Mod
erate  21 0 13M
AY2020 10:4
6 
 
Progra
m: Lsa
f_sysR_1.sas           (Page 54 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 110
FDA-CBER-2021-5683-0050105
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Fina
l 1.0 BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data received on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemic reactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10059  03J
UN2020 17:30  Mal
aise Seve
re 21 0 13M
AY2020 10:46  
03J
UN2020 17:30  Feve
r Mod
erate  21 0 13M
AY2020 10:46  
04J
UN2020 10:0
0 Nause
a Seve
re 22 1 13M
AY2020 10:46  
04J
UN2020 10:00  Heada
che Seve
re 22 1 13M
AY2020 10:46  
04J
UN2020 10:00  Fatig
ue Seve
re 22 1 13M
AY2020 10:46  
04J
UN2020 10:00  Mya
lgia Mod
erate  22 1 13M
AY2020 10:46  
04J
UN2020 10:00  Arthral
gia Mod
erate  22 1 13M
AY2020 10:46  
04J
UN2020 10:00  Chill
s Seve
re 22 1 13M
AY2020 10:46  
04J
UN2020 10:00  Los
s of Appetite  Seve
re 22 1 13M
AY2020 10:46  
04J
UN2020 10:00  Mal
aise Seve
re 22 1 13M
AY2020 10:46  
04J
UN2020 10:00  Feve
r Mil
d 22 1 13M
AY2020 10:46  
05J
UN2020 18:0
0 Nause
a Seve
re 23 2 13M
AY2020 10:46  
05J
UN2020 18:00  Heada
che Seve
re 23 2 13M
AY2020 10:46  
05J
UN2020 18:00  Fatig
ue Mod
erate  23 2 13M
AY2020 10:46  
05J
UN2020 18:00  Mya
lgia Mod
erate  23 2 13M
AY2020 10:46  
05J
UN2020 18:00  Arthral
gia Mod
erate  23 2 13M
AY2020 10:46  
05J
UN2020 18:00  Chill
s Mil
d 23 2 13M
AY2020 10:46  
05J
UN2020 18:00  Los
s of Appetite  Seve
re 23 2 13M
AY2020 10:46  
 
Progra
m: Lsa
f_sysR_1.sas           (Page 55 of 92) 
090177e1959f7374\Approved\Approved On: 27-Nov-2020 03:38 (GMT) 
Page 111
FDA-CBER-2021-5683-0050106
Bio
NTech RNA Pharmaceuticals GmbH /  Listi
ngs - 6. Sn
apshot All TLFs Final 1.0  BNT16
2b1 
BNT16
2-01 Created
 on 20NOV2020   
 
 
 
 
 
 
Staburo G
mbH. Based on clean SDTM data rece
ived on 03NOV2020. Data cut -off: 23O
CT2020.  Listing
 16.2.3 -1.3-1: Lis
ting of solicited systemi c r
eactions - BNT
162b1  
Safety
 set 
 
Dose 
grou
p Subj
ect number  Date/t
ime of collection  Syste
mic reaction  Seve
rity/ 
Inten
sity Num be
r of days 
afte
r prime 
imm
unization  Num be
r of days 
afte
r boost 
imm
unization  Date/t
ime of prime 
imm
unization  
50 µg
 
You
nger 10059  05J
UN2020 18:00  Mal
aise Mod
erate  23 2 13M
AY2020 10:46  
06J
UN2020 17:00  Nause
a Mil
d 24 3 13M
AY2020 10:46  
06J
UN2020 17:00  Heada
che Mil
d 24 3 13M
AY2020 10:46  
06J
UN2020 17:00  Fatig
ue Mil
d 24 3 13M
AY2020 10:46  
06J
UN2020 17:00  Mya
lgia Mil
d 24 3 13M
AY2020 10:46  
06J
UN2020 17:00  Arthral
gia Mil
d 24 3 13M
AY2020 10:46  
06J
UN2020 17:00  Los
s of Appetite  Mil
d 24 3 13M
AY2020 10:46  

…[truncated]